Results (complete table)
Click HERE to show results for all gene sets
Complete results
B-WICH complex positively regulates rRNA expression |
8 |
5.07e-06 |
2.59e-05 |
0.2740 |
0.11100 |
-0.010100 |
0.036500 |
-0.030900 |
-0.24600 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Developmental Biology |
157 |
5.07e-06 |
2.59e-05 |
0.1810 |
-0.05910 |
0.138000 |
-0.063800 |
-0.059700 |
0.04920 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Epigenetic regulation of gene expression |
14 |
5.07e-06 |
2.59e-05 |
0.2820 |
0.10500 |
-0.032700 |
0.089000 |
-0.030900 |
-0.24200 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Gene expression (Transcription) |
145 |
5.07e-06 |
2.59e-05 |
0.2070 |
0.07460 |
-0.030300 |
0.095100 |
-0.052700 |
-0.15700 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Generic Transcription Pathway |
110 |
5.07e-06 |
2.59e-05 |
0.1140 |
-0.00570 |
-0.026300 |
0.075800 |
-0.036200 |
-0.07280 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Positive epigenetic regulation of rRNA expression |
11 |
5.07e-06 |
2.59e-05 |
0.2520 |
0.11100 |
-0.010100 |
0.089000 |
-0.030900 |
-0.20500 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
RNA Polymerase II Transcription |
130 |
5.07e-06 |
2.59e-05 |
0.1620 |
0.04820 |
-0.030800 |
0.082900 |
-0.038100 |
-0.12100 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors |
9 |
5.07e-06 |
2.59e-05 |
0.3490 |
0.06980 |
-0.040500 |
0.133000 |
-0.131000 |
-0.28400 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
Transcriptional regulation of granulopoiesis |
7 |
5.07e-06 |
2.59e-05 |
0.4640 |
0.30400 |
0.015400 |
0.253000 |
-0.131000 |
-0.20300 |
0.9130 |
0.000207 |
0.044 |
0.3580 |
0.40000 |
IRE1alpha activates chaperones |
9 |
8.07e-02 |
3.09e-01 |
0.2290 |
0.07300 |
0.044100 |
0.101000 |
-0.097000 |
0.16000 |
0.2220 |
0.205000 |
0.415 |
0.2490 |
0.86300 |
Unfolded Protein Response (UPR) |
15 |
8.07e-02 |
3.09e-01 |
0.1890 |
0.06060 |
0.008810 |
0.141000 |
-0.097000 |
0.05110 |
0.2220 |
0.205000 |
0.415 |
0.2490 |
0.86300 |
XBP1(S) activates chaperone genes |
9 |
8.07e-02 |
3.09e-01 |
0.2290 |
0.07300 |
0.044100 |
0.101000 |
-0.097000 |
0.16000 |
0.2220 |
0.205000 |
0.415 |
0.2490 |
0.86300 |
Class A/1 (Rhodopsin-like receptors) |
5 |
1.26e-01 |
3.42e-01 |
0.3050 |
0.20000 |
0.098100 |
-0.118000 |
-0.146000 |
0.09070 |
0.0890 |
0.979000 |
0.148 |
0.7950 |
0.65700 |
G alpha (i) signalling events |
22 |
1.26e-01 |
3.42e-01 |
0.2890 |
-0.09680 |
0.079600 |
-0.090900 |
-0.081900 |
0.23000 |
0.0890 |
0.979000 |
0.148 |
0.7950 |
0.65700 |
GPCR downstream signalling |
30 |
1.26e-01 |
3.42e-01 |
0.2980 |
-0.10900 |
0.041500 |
-0.101000 |
-0.011800 |
0.25400 |
0.0890 |
0.979000 |
0.148 |
0.7950 |
0.65700 |
GPCR ligand binding |
11 |
1.26e-01 |
3.42e-01 |
0.3300 |
0.03010 |
0.098100 |
-0.152000 |
-0.073100 |
0.26400 |
0.0890 |
0.979000 |
0.148 |
0.7950 |
0.65700 |
Signaling by GPCR |
31 |
1.26e-01 |
3.42e-01 |
0.2950 |
-0.10900 |
0.041500 |
-0.101000 |
-0.011800 |
0.25100 |
0.0890 |
0.979000 |
0.148 |
0.7950 |
0.65700 |
Cellular responses to external stimuli |
112 |
2.32e-01 |
5.86e-01 |
0.2060 |
0.07990 |
0.097100 |
0.003180 |
-0.094400 |
-0.13400 |
0.1390 |
0.760000 |
0.163 |
0.5590 |
0.00453 |
Metabolism of proteins |
292 |
2.42e-01 |
5.86e-01 |
0.1040 |
0.01310 |
0.062700 |
0.010500 |
-0.044000 |
-0.06900 |
0.4290 |
0.859000 |
0.868 |
0.3250 |
0.10200 |
Post-translational protein modification |
153 |
4.00e-01 |
7.85e-01 |
0.0546 |
-0.03860 |
-0.012300 |
0.034800 |
-0.010200 |
0.00535 |
0.0544 |
0.485000 |
0.691 |
0.7560 |
0.07020 |
Post-translational protein phosphorylation |
25 |
4.00e-01 |
7.85e-01 |
0.5160 |
-0.29600 |
0.140000 |
-0.058100 |
0.023800 |
0.39400 |
0.0544 |
0.485000 |
0.691 |
0.7560 |
0.07020 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
28 |
4.00e-01 |
7.85e-01 |
0.5310 |
-0.28700 |
0.140000 |
-0.070400 |
-0.007020 |
0.41900 |
0.0544 |
0.485000 |
0.691 |
0.7560 |
0.07020 |
Cellular Senescence |
21 |
4.86e-01 |
7.85e-01 |
0.2270 |
0.07180 |
-0.073100 |
0.047500 |
-0.127000 |
-0.15000 |
0.2420 |
0.784000 |
0.884 |
0.7630 |
0.17200 |
Senescence-Associated Secretory Phenotype (SASP) |
13 |
4.86e-01 |
7.85e-01 |
0.1750 |
-0.03060 |
-0.054500 |
0.011400 |
-0.137000 |
-0.08790 |
0.2420 |
0.784000 |
0.884 |
0.7630 |
0.17200 |
Signal Transduction |
235 |
4.96e-01 |
7.85e-01 |
0.1350 |
-0.05540 |
-0.012500 |
0.002420 |
-0.020800 |
0.12100 |
0.8490 |
0.305000 |
0.135 |
0.3090 |
0.86000 |
Cellular responses to stress |
111 |
5.59e-01 |
7.85e-01 |
0.2180 |
0.08660 |
0.096700 |
0.009190 |
-0.095300 |
-0.14600 |
0.2080 |
0.775000 |
0.430 |
0.6070 |
0.03960 |
NR1H2 and NR1H3-mediated signaling |
6 |
6.04e-01 |
7.85e-01 |
0.2760 |
-0.17600 |
0.194000 |
0.035100 |
-0.044100 |
0.06340 |
0.1610 |
0.145000 |
0.574 |
0.0863 |
0.83900 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux |
5 |
6.04e-01 |
7.85e-01 |
0.3640 |
-0.22500 |
0.194000 |
0.035100 |
-0.044100 |
0.20300 |
0.1610 |
0.145000 |
0.574 |
0.0863 |
0.83900 |
SLC-mediated transmembrane transport |
21 |
6.04e-01 |
7.85e-01 |
0.2440 |
-0.05370 |
0.194000 |
-0.109000 |
0.066400 |
0.05090 |
0.1610 |
0.145000 |
0.574 |
0.0863 |
0.83900 |
Signaling by Nuclear Receptors |
46 |
6.04e-01 |
7.85e-01 |
0.0823 |
-0.02670 |
0.028000 |
0.010800 |
-0.036300 |
0.06190 |
0.1610 |
0.145000 |
0.574 |
0.0863 |
0.83900 |
Transport of small molecules |
76 |
6.04e-01 |
7.85e-01 |
0.2070 |
-0.10300 |
0.130000 |
0.009180 |
0.023400 |
0.12200 |
0.1610 |
0.145000 |
0.574 |
0.0863 |
0.83900 |
Transport of vitamins, nucleosides, and related molecules |
5 |
6.04e-01 |
7.85e-01 |
0.3450 |
-0.20100 |
0.194000 |
-0.098400 |
0.078400 |
-0.15900 |
0.1610 |
0.145000 |
0.574 |
0.0863 |
0.83900 |
Metabolism |
251 |
6.57e-01 |
7.85e-01 |
0.1720 |
0.04760 |
0.070500 |
-0.000650 |
-0.031000 |
-0.14600 |
0.1050 |
0.941000 |
0.799 |
0.7010 |
0.17500 |
Metabolism of amino acids and derivatives |
78 |
6.57e-01 |
7.85e-01 |
0.3210 |
0.10700 |
0.164000 |
-0.045900 |
-0.126000 |
-0.21600 |
0.1050 |
0.941000 |
0.799 |
0.7010 |
0.17500 |
Metabolism of polyamines |
9 |
6.57e-01 |
7.85e-01 |
0.3170 |
0.17400 |
0.026300 |
0.061900 |
0.027700 |
-0.25500 |
0.1050 |
0.941000 |
0.799 |
0.7010 |
0.17500 |
Regulation of ornithine decarboxylase (ODC) |
6 |
6.57e-01 |
7.85e-01 |
0.3570 |
0.23000 |
0.026300 |
0.147000 |
0.027700 |
-0.22600 |
0.1050 |
0.941000 |
0.799 |
0.7010 |
0.17500 |
Major pathway of rRNA processing in the nucleolus and cytosol |
79 |
6.82e-01 |
7.85e-01 |
0.4230 |
0.19400 |
0.165000 |
-0.034500 |
-0.148000 |
-0.30100 |
0.2110 |
0.879000 |
0.319 |
0.6400 |
0.19300 |
Metabolism of RNA |
161 |
6.82e-01 |
7.85e-01 |
0.3980 |
0.21200 |
0.065900 |
0.052300 |
-0.097200 |
-0.31100 |
0.2110 |
0.879000 |
0.319 |
0.6400 |
0.19300 |
rRNA processing |
82 |
6.82e-01 |
7.85e-01 |
0.4200 |
0.20000 |
0.161000 |
-0.030400 |
-0.137000 |
-0.30100 |
0.2110 |
0.879000 |
0.319 |
0.6400 |
0.19300 |
rRNA processing in the nucleus and cytosol |
82 |
6.82e-01 |
7.85e-01 |
0.4200 |
0.20000 |
0.161000 |
-0.030400 |
-0.137000 |
-0.30100 |
0.2110 |
0.879000 |
0.319 |
0.6400 |
0.19300 |
Cellular response to heat stress |
18 |
8.10e-01 |
8.49e-01 |
0.2550 |
0.18000 |
0.015300 |
0.081500 |
-0.061600 |
-0.14900 |
0.5990 |
0.908000 |
0.213 |
0.6910 |
0.19000 |
HSF1-dependent transactivation |
8 |
8.10e-01 |
8.49e-01 |
0.2170 |
0.13000 |
-0.001860 |
0.045200 |
-0.098100 |
-0.13700 |
0.5990 |
0.908000 |
0.213 |
0.6910 |
0.19000 |
Cytokine Signaling in Immune system |
97 |
8.49e-01 |
8.49e-01 |
0.1760 |
-0.09360 |
0.007000 |
0.024100 |
-0.067000 |
0.13000 |
0.5380 |
0.920000 |
0.263 |
0.8160 |
0.17000 |
Immune System |
228 |
8.49e-01 |
8.49e-01 |
0.1750 |
-0.10500 |
0.005730 |
-0.002130 |
-0.015000 |
0.13900 |
0.5380 |
0.920000 |
0.263 |
0.8160 |
0.17000 |
Interferon Signaling |
24 |
8.49e-01 |
8.49e-01 |
0.2860 |
-0.01620 |
0.074900 |
-0.126000 |
-0.109000 |
0.22000 |
0.5380 |
0.920000 |
0.263 |
0.8160 |
0.17000 |
Interferon gamma signaling |
14 |
8.49e-01 |
8.49e-01 |
0.4630 |
-0.10000 |
0.086700 |
-0.147000 |
-0.007240 |
0.41900 |
0.5380 |
0.920000 |
0.263 |
0.8160 |
0.17000 |
ABC transporter disorders |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
ABC-family proteins mediated transport |
10 |
NA |
NA |
0.1510 |
-0.00262 |
-0.019700 |
0.090800 |
-0.039500 |
-0.11300 |
NA |
NA |
NA |
NA |
NA |
ADORA2B mediated anti-inflammatory cytokines production |
5 |
NA |
NA |
0.6050 |
-0.25200 |
NaN |
-0.220000 |
0.073100 |
0.49900 |
NA |
NA |
NA |
NA |
NA |
APC-Cdc20 mediated degradation of Nek2A |
8 |
NA |
NA |
0.6430 |
0.27000 |
-0.161000 |
0.088200 |
-0.207000 |
-0.51400 |
NA |
NA |
NA |
NA |
NA |
APC/C-mediated degradation of cell cycle proteins |
20 |
NA |
NA |
0.4410 |
0.15600 |
-0.137000 |
0.153000 |
-0.039500 |
-0.35500 |
NA |
NA |
NA |
NA |
NA |
APC/C:Cdc20 mediated degradation of Cyclin B |
8 |
NA |
NA |
0.5490 |
0.20500 |
-0.154000 |
0.112000 |
-0.207000 |
-0.42400 |
NA |
NA |
NA |
NA |
NA |
APC/C:Cdc20 mediated degradation of Securin |
12 |
NA |
NA |
0.4130 |
0.12400 |
-0.138000 |
0.142000 |
-0.039500 |
-0.33900 |
NA |
NA |
NA |
NA |
NA |
APC/C:Cdc20 mediated degradation of mitotic proteins |
17 |
NA |
NA |
0.4880 |
0.23700 |
-0.146000 |
0.143000 |
-0.039500 |
-0.37200 |
NA |
NA |
NA |
NA |
NA |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
14 |
NA |
NA |
0.4130 |
0.16300 |
-0.125000 |
0.155000 |
-0.039500 |
-0.32100 |
NA |
NA |
NA |
NA |
NA |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint |
15 |
NA |
NA |
0.4470 |
0.23700 |
-0.136000 |
0.105000 |
-0.039500 |
-0.33500 |
NA |
NA |
NA |
NA |
NA |
AUF1 (hnRNP D0) binds and destabilizes mRNA |
11 |
NA |
NA |
0.2790 |
0.13500 |
-0.056600 |
0.033400 |
-0.039500 |
-0.23100 |
NA |
NA |
NA |
NA |
NA |
AURKA Activation by TPX2 |
13 |
NA |
NA |
0.3650 |
0.14700 |
-0.103000 |
0.166000 |
-0.110000 |
-0.24800 |
NA |
NA |
NA |
NA |
NA |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects |
6 |
NA |
NA |
0.1700 |
0.12700 |
0.060400 |
-0.071200 |
NaN |
0.06440 |
NA |
NA |
NA |
NA |
NA |
Aberrant regulation of mitotic cell cycle due to RB1 defects |
8 |
NA |
NA |
0.2300 |
0.14200 |
-0.096500 |
0.010300 |
NaN |
-0.15300 |
NA |
NA |
NA |
NA |
NA |
Abortive elongation of HIV-1 transcript in the absence of Tat |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Activated NOTCH1 Transmits Signal to the Nucleus |
6 |
NA |
NA |
0.3610 |
-0.22800 |
NaN |
-0.188000 |
-0.207000 |
0.00219 |
NA |
NA |
NA |
NA |
NA |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins |
18 |
NA |
NA |
0.4920 |
0.24300 |
-0.144000 |
0.154000 |
-0.039500 |
-0.37000 |
NA |
NA |
NA |
NA |
NA |
Activation of ATR in response to replication stress |
12 |
NA |
NA |
0.5580 |
0.38100 |
-0.092900 |
0.093100 |
NaN |
-0.38600 |
NA |
NA |
NA |
NA |
NA |
Activation of BH3-only proteins |
5 |
NA |
NA |
0.2500 |
0.01180 |
NaN |
0.245000 |
-0.008560 |
-0.04380 |
NA |
NA |
NA |
NA |
NA |
Activation of HOX genes during differentiation |
10 |
NA |
NA |
0.1060 |
0.01770 |
0.001980 |
0.046700 |
-0.072400 |
-0.05850 |
NA |
NA |
NA |
NA |
NA |
Activation of Matrix Metalloproteinases |
5 |
NA |
NA |
0.6690 |
-0.37500 |
0.162000 |
-0.063800 |
-0.194000 |
0.48900 |
NA |
NA |
NA |
NA |
NA |
Activation of NF-kappaB in B cells |
9 |
NA |
NA |
0.2850 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Activation of NMDA receptors and postsynaptic events |
5 |
NA |
NA |
0.2500 |
-0.16100 |
0.019700 |
-0.094500 |
NaN |
0.16400 |
NA |
NA |
NA |
NA |
NA |
Activation of anterior HOX genes in hindbrain development during early embryogenesis |
10 |
NA |
NA |
0.1060 |
0.01770 |
0.001980 |
0.046700 |
-0.072400 |
-0.05850 |
NA |
NA |
NA |
NA |
NA |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
27 |
NA |
NA |
0.4030 |
0.13300 |
0.159000 |
0.086600 |
-0.127000 |
-0.30900 |
NA |
NA |
NA |
NA |
NA |
Activation of the pre-replicative complex |
13 |
NA |
NA |
0.5370 |
0.36000 |
-0.097200 |
0.093100 |
NaN |
-0.37600 |
NA |
NA |
NA |
NA |
NA |
Adaptive Immune System |
72 |
NA |
NA |
0.2940 |
-0.17800 |
-0.056900 |
-0.018200 |
0.037700 |
0.22300 |
NA |
NA |
NA |
NA |
NA |
Adherens junctions interactions |
5 |
NA |
NA |
0.4570 |
-0.24200 |
NaN |
NaN |
NaN |
0.38800 |
NA |
NA |
NA |
NA |
NA |
Aggrephagy |
7 |
NA |
NA |
0.3610 |
0.04720 |
-0.063000 |
-0.188000 |
-0.207000 |
-0.21500 |
NA |
NA |
NA |
NA |
NA |
Amino acid transport across the plasma membrane |
6 |
NA |
NA |
0.3310 |
0.32700 |
NaN |
NaN |
NaN |
0.05390 |
NA |
NA |
NA |
NA |
NA |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal |
25 |
NA |
NA |
0.4690 |
0.21400 |
-0.111000 |
0.184000 |
-0.025000 |
-0.35700 |
NA |
NA |
NA |
NA |
NA |
Amplification of signal from the kinetochores |
25 |
NA |
NA |
0.4690 |
0.21400 |
-0.111000 |
0.184000 |
-0.025000 |
-0.35700 |
NA |
NA |
NA |
NA |
NA |
Amyloid fiber formation |
15 |
NA |
NA |
0.4510 |
-0.31100 |
0.180000 |
-0.165000 |
-0.031100 |
0.21500 |
NA |
NA |
NA |
NA |
NA |
Anchoring of the basal body to the plasma membrane |
11 |
NA |
NA |
0.2860 |
0.14700 |
-0.083300 |
0.099300 |
-0.093300 |
-0.18700 |
NA |
NA |
NA |
NA |
NA |
Anti-inflammatory response favouring Leishmania parasite infection |
9 |
NA |
NA |
0.5120 |
-0.27800 |
NaN |
-0.158000 |
0.073100 |
0.39300 |
NA |
NA |
NA |
NA |
NA |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
7 |
NA |
NA |
0.4950 |
-0.15400 |
NaN |
-0.214000 |
0.015800 |
0.41900 |
NA |
NA |
NA |
NA |
NA |
Antigen processing-Cross presentation |
19 |
NA |
NA |
0.3230 |
-0.17200 |
-0.019700 |
-0.112000 |
0.026000 |
0.24800 |
NA |
NA |
NA |
NA |
NA |
Antigen processing: Ubiquitination & Proteasome degradation |
24 |
NA |
NA |
0.1700 |
-0.05720 |
-0.128000 |
0.087400 |
-0.039500 |
-0.01400 |
NA |
NA |
NA |
NA |
NA |
Antiviral mechanism by IFN-stimulated genes |
10 |
NA |
NA |
0.2730 |
0.09540 |
0.021100 |
-0.078200 |
-0.207000 |
-0.12500 |
NA |
NA |
NA |
NA |
NA |
Apoptosis |
26 |
NA |
NA |
0.2130 |
-0.01000 |
-0.057300 |
0.148000 |
-0.061700 |
-0.12800 |
NA |
NA |
NA |
NA |
NA |
Apoptotic cleavage of cellular proteins |
8 |
NA |
NA |
0.4090 |
-0.31800 |
-0.045800 |
0.051900 |
-0.120000 |
0.21600 |
NA |
NA |
NA |
NA |
NA |
Apoptotic execution phase |
11 |
NA |
NA |
0.2560 |
-0.13200 |
-0.084500 |
0.163000 |
-0.120000 |
-0.01390 |
NA |
NA |
NA |
NA |
NA |
Aquaporin-mediated transport |
5 |
NA |
NA |
0.4840 |
-0.26700 |
NaN |
NaN |
-0.025000 |
0.40300 |
NA |
NA |
NA |
NA |
NA |
Arachidonic acid metabolism |
6 |
NA |
NA |
0.3330 |
-0.05650 |
-0.035600 |
-0.056500 |
NaN |
0.32100 |
NA |
NA |
NA |
NA |
NA |
Asparagine N-linked glycosylation |
21 |
NA |
NA |
0.2290 |
-0.18900 |
NaN |
-0.011000 |
-0.020200 |
0.12700 |
NA |
NA |
NA |
NA |
NA |
Assembly Of The HIV Virion |
6 |
NA |
NA |
0.4850 |
-0.46000 |
NaN |
-0.068500 |
-0.060600 |
0.12200 |
NA |
NA |
NA |
NA |
NA |
Assembly of collagen fibrils and other multimeric structures |
13 |
NA |
NA |
0.4330 |
-0.22100 |
0.093200 |
-0.114000 |
-0.081000 |
0.33300 |
NA |
NA |
NA |
NA |
NA |
Assembly of the pre-replicative complex |
16 |
NA |
NA |
0.4590 |
0.34400 |
-0.092400 |
0.061100 |
-0.039500 |
-0.28100 |
NA |
NA |
NA |
NA |
NA |
Association of TriC/CCT with target proteins during biosynthesis |
10 |
NA |
NA |
0.3730 |
0.25600 |
0.036900 |
0.089500 |
-0.143000 |
-0.20900 |
NA |
NA |
NA |
NA |
NA |
Asymmetric localization of PCP proteins |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Attenuation phase |
6 |
NA |
NA |
0.4820 |
0.20200 |
-0.024500 |
0.125000 |
-0.121000 |
-0.40100 |
NA |
NA |
NA |
NA |
NA |
Autodegradation of Cdh1 by Cdh1:APC/C |
10 |
NA |
NA |
0.3510 |
0.08530 |
-0.123000 |
0.088200 |
-0.039500 |
-0.30200 |
NA |
NA |
NA |
NA |
NA |
Autodegradation of the E3 ubiquitin ligase COP1 |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Autophagy |
19 |
NA |
NA |
0.2160 |
-0.05700 |
0.041000 |
-0.003300 |
-0.109000 |
-0.17200 |
NA |
NA |
NA |
NA |
NA |
Axon guidance |
120 |
NA |
NA |
0.2140 |
-0.06270 |
0.160000 |
-0.095000 |
-0.064200 |
0.05700 |
NA |
NA |
NA |
NA |
NA |
BBSome-mediated cargo-targeting to cilium |
7 |
NA |
NA |
0.4090 |
0.30700 |
0.018400 |
0.130000 |
-0.173000 |
-0.16100 |
NA |
NA |
NA |
NA |
NA |
Base Excision Repair |
10 |
NA |
NA |
0.4090 |
0.28400 |
-0.097500 |
0.018900 |
NaN |
-0.27600 |
NA |
NA |
NA |
NA |
NA |
Basigin interactions |
9 |
NA |
NA |
0.4070 |
-0.15100 |
0.109000 |
-0.036700 |
0.169000 |
0.31700 |
NA |
NA |
NA |
NA |
NA |
Beta-catenin independent WNT signaling |
21 |
NA |
NA |
0.1210 |
0.08120 |
0.063000 |
-0.058100 |
-0.025500 |
-0.00285 |
NA |
NA |
NA |
NA |
NA |
Binding and Uptake of Ligands by Scavenger Receptors |
10 |
NA |
NA |
0.3360 |
-0.18300 |
0.055900 |
-0.047200 |
NaN |
0.27200 |
NA |
NA |
NA |
NA |
NA |
Biological oxidations |
14 |
NA |
NA |
0.2420 |
0.03690 |
-0.165000 |
0.116000 |
-0.102000 |
-0.07950 |
NA |
NA |
NA |
NA |
NA |
Budding and maturation of HIV virion |
6 |
NA |
NA |
0.4650 |
-0.44700 |
NaN |
-0.068500 |
-0.060600 |
0.08980 |
NA |
NA |
NA |
NA |
NA |
C-type lectin receptors (CLRs) |
15 |
NA |
NA |
0.2800 |
-0.27000 |
0.063900 |
-0.002640 |
0.037400 |
-0.00610 |
NA |
NA |
NA |
NA |
NA |
CDK-mediated phosphorylation and removal of Cdc6 |
11 |
NA |
NA |
0.3970 |
0.17900 |
-0.132000 |
0.072800 |
-0.039500 |
-0.31800 |
NA |
NA |
NA |
NA |
NA |
CDT1 association with the CDC6:ORC:origin complex |
11 |
NA |
NA |
0.3690 |
0.28300 |
-0.097400 |
0.043400 |
-0.039500 |
-0.20800 |
NA |
NA |
NA |
NA |
NA |
CHL1 interactions |
5 |
NA |
NA |
0.4960 |
-0.15800 |
0.164000 |
-0.077800 |
-0.048400 |
0.43100 |
NA |
NA |
NA |
NA |
NA |
CLEC7A (Dectin-1) signaling |
13 |
NA |
NA |
0.2860 |
-0.27000 |
0.063900 |
-0.002640 |
-0.039500 |
-0.05740 |
NA |
NA |
NA |
NA |
NA |
COPI-dependent Golgi-to-ER retrograde traffic |
13 |
NA |
NA |
0.2060 |
0.04380 |
-0.072300 |
0.095300 |
0.037100 |
-0.15700 |
NA |
NA |
NA |
NA |
NA |
COPI-mediated anterograde transport |
9 |
NA |
NA |
0.1960 |
-0.14400 |
NaN |
-0.049900 |
0.041400 |
0.11700 |
NA |
NA |
NA |
NA |
NA |
Ca2+ pathway |
6 |
NA |
NA |
0.2440 |
0.00657 |
0.104000 |
-0.094500 |
-0.084900 |
0.18000 |
NA |
NA |
NA |
NA |
NA |
Cap-dependent Translation Initiation |
58 |
NA |
NA |
0.3920 |
0.13800 |
0.176000 |
-0.065400 |
-0.157000 |
-0.27300 |
NA |
NA |
NA |
NA |
NA |
Carboxyterminal post-translational modifications of tubulin |
8 |
NA |
NA |
0.5010 |
0.29700 |
-0.045100 |
0.182000 |
0.018500 |
-0.35700 |
NA |
NA |
NA |
NA |
NA |
Cardiac conduction |
10 |
NA |
NA |
0.4380 |
-0.22400 |
0.152000 |
-0.063100 |
0.090700 |
0.32600 |
NA |
NA |
NA |
NA |
NA |
Cargo recognition for clathrin-mediated endocytosis |
13 |
NA |
NA |
0.3090 |
-0.24800 |
NaN |
-0.092200 |
0.005550 |
0.15800 |
NA |
NA |
NA |
NA |
NA |
Cargo trafficking to the periciliary membrane |
8 |
NA |
NA |
0.3900 |
0.30700 |
0.018400 |
0.130000 |
-0.122000 |
-0.16100 |
NA |
NA |
NA |
NA |
NA |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A |
15 |
NA |
NA |
0.4470 |
0.23700 |
-0.136000 |
0.105000 |
-0.039500 |
-0.33500 |
NA |
NA |
NA |
NA |
NA |
Cell Cycle |
137 |
NA |
NA |
0.4520 |
0.20500 |
-0.123000 |
0.159000 |
-0.040400 |
-0.34700 |
NA |
NA |
NA |
NA |
NA |
Cell Cycle Checkpoints |
59 |
NA |
NA |
0.4780 |
0.22800 |
-0.123000 |
0.166000 |
0.001060 |
-0.36600 |
NA |
NA |
NA |
NA |
NA |
Cell Cycle, Mitotic |
115 |
NA |
NA |
0.4660 |
0.22500 |
-0.123000 |
0.161000 |
-0.068200 |
-0.34800 |
NA |
NA |
NA |
NA |
NA |
Cell death signalling via NRAGE, NRIF and NADE |
11 |
NA |
NA |
0.3240 |
-0.25700 |
-0.110000 |
-0.109000 |
-0.059300 |
0.10800 |
NA |
NA |
NA |
NA |
NA |
Cell junction organization |
10 |
NA |
NA |
0.5100 |
-0.27100 |
NaN |
-0.013200 |
-0.211000 |
0.37700 |
NA |
NA |
NA |
NA |
NA |
Cell surface interactions at the vascular wall |
22 |
NA |
NA |
0.4010 |
-0.15700 |
0.109000 |
-0.042600 |
-0.016900 |
0.34900 |
NA |
NA |
NA |
NA |
NA |
Cell-Cell communication |
13 |
NA |
NA |
0.4970 |
-0.24200 |
NaN |
-0.002640 |
-0.211000 |
0.38000 |
NA |
NA |
NA |
NA |
NA |
Cell-cell junction organization |
5 |
NA |
NA |
0.4570 |
-0.24200 |
NaN |
NaN |
NaN |
0.38800 |
NA |
NA |
NA |
NA |
NA |
Cellular response to hypoxia |
10 |
NA |
NA |
0.0657 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
0.02190 |
NA |
NA |
NA |
NA |
NA |
Centrosome maturation |
12 |
NA |
NA |
0.3190 |
0.15900 |
-0.080500 |
0.111000 |
-0.130000 |
-0.20100 |
NA |
NA |
NA |
NA |
NA |
Chaperone Mediated Autophagy |
8 |
NA |
NA |
0.4230 |
0.17400 |
0.069800 |
0.027600 |
-0.174000 |
-0.33600 |
NA |
NA |
NA |
NA |
NA |
Chaperonin-mediated protein folding |
22 |
NA |
NA |
0.2800 |
0.19100 |
-0.013600 |
0.127000 |
-0.024200 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Cholesterol biosynthesis |
5 |
NA |
NA |
0.3450 |
0.29100 |
-0.051200 |
0.124000 |
-0.097400 |
-0.08490 |
NA |
NA |
NA |
NA |
NA |
Chondroitin sulfate/dermatan sulfate metabolism |
5 |
NA |
NA |
0.2880 |
-0.25800 |
NaN |
-0.026800 |
0.051100 |
0.11300 |
NA |
NA |
NA |
NA |
NA |
Chromatin modifying enzymes |
15 |
NA |
NA |
0.3030 |
0.11100 |
-0.073500 |
0.138000 |
-0.196000 |
-0.12800 |
NA |
NA |
NA |
NA |
NA |
Chromatin organization |
15 |
NA |
NA |
0.3030 |
0.11100 |
-0.073500 |
0.138000 |
-0.196000 |
-0.12800 |
NA |
NA |
NA |
NA |
NA |
Chromosome Maintenance |
26 |
NA |
NA |
0.4100 |
0.20300 |
-0.084300 |
0.117000 |
0.026900 |
-0.32400 |
NA |
NA |
NA |
NA |
NA |
Cilium Assembly |
21 |
NA |
NA |
0.2580 |
0.12200 |
-0.066500 |
0.115000 |
-0.126000 |
-0.13400 |
NA |
NA |
NA |
NA |
NA |
Circadian Clock |
10 |
NA |
NA |
0.2520 |
-0.07990 |
NaN |
0.038000 |
-0.211000 |
0.10600 |
NA |
NA |
NA |
NA |
NA |
Class B/2 (Secretin family receptors) |
6 |
NA |
NA |
0.5530 |
-0.25200 |
NaN |
-0.220000 |
0.073100 |
0.43400 |
NA |
NA |
NA |
NA |
NA |
Class I MHC mediated antigen processing & presentation |
35 |
NA |
NA |
0.2270 |
-0.11200 |
-0.128000 |
-0.013700 |
0.026000 |
0.14700 |
NA |
NA |
NA |
NA |
NA |
Clathrin-mediated endocytosis |
16 |
NA |
NA |
0.2530 |
-0.21500 |
NaN |
-0.092200 |
0.005550 |
0.09780 |
NA |
NA |
NA |
NA |
NA |
Collagen biosynthesis and modifying enzymes |
12 |
NA |
NA |
0.3040 |
-0.19800 |
0.128000 |
-0.033400 |
-0.007040 |
0.18900 |
NA |
NA |
NA |
NA |
NA |
Collagen chain trimerization |
9 |
NA |
NA |
0.3880 |
-0.20300 |
0.144000 |
-0.087900 |
-0.081000 |
0.27200 |
NA |
NA |
NA |
NA |
NA |
Collagen degradation |
9 |
NA |
NA |
0.4940 |
-0.28200 |
0.093200 |
-0.063700 |
-0.194000 |
0.33800 |
NA |
NA |
NA |
NA |
NA |
Collagen formation |
18 |
NA |
NA |
0.3820 |
-0.21900 |
0.117000 |
-0.073000 |
-0.007040 |
0.28100 |
NA |
NA |
NA |
NA |
NA |
Complex I biogenesis |
11 |
NA |
NA |
0.2780 |
-0.06170 |
0.014400 |
-0.061700 |
0.050800 |
-0.25900 |
NA |
NA |
NA |
NA |
NA |
Condensation of Prometaphase Chromosomes |
7 |
NA |
NA |
0.4020 |
0.20100 |
-0.148000 |
0.178000 |
NaN |
-0.26000 |
NA |
NA |
NA |
NA |
NA |
Condensation of Prophase Chromosomes |
7 |
NA |
NA |
0.4420 |
0.25300 |
-0.112000 |
0.181000 |
-0.116000 |
-0.26900 |
NA |
NA |
NA |
NA |
NA |
Constitutive Signaling by Aberrant PI3K in Cancer |
8 |
NA |
NA |
0.3110 |
-0.27300 |
NaN |
0.018400 |
NaN |
0.14800 |
NA |
NA |
NA |
NA |
NA |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants |
5 |
NA |
NA |
0.4610 |
0.32100 |
-0.063000 |
-0.188000 |
-0.207000 |
-0.16600 |
NA |
NA |
NA |
NA |
NA |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants |
10 |
NA |
NA |
0.2250 |
-0.07270 |
0.085400 |
0.059300 |
-0.185000 |
-0.01530 |
NA |
NA |
NA |
NA |
NA |
Constitutive Signaling by NOTCH1 PEST Domain Mutants |
10 |
NA |
NA |
0.2250 |
-0.07270 |
0.085400 |
0.059300 |
-0.185000 |
-0.01530 |
NA |
NA |
NA |
NA |
NA |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding |
10 |
NA |
NA |
0.2040 |
0.00853 |
0.018400 |
0.145000 |
-0.087600 |
-0.11200 |
NA |
NA |
NA |
NA |
NA |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding |
18 |
NA |
NA |
0.3260 |
0.19500 |
-0.025100 |
0.170000 |
-0.022200 |
-0.19600 |
NA |
NA |
NA |
NA |
NA |
Costimulation by the CD28 family |
6 |
NA |
NA |
0.1740 |
NaN |
NaN |
0.018400 |
NaN |
0.17300 |
NA |
NA |
NA |
NA |
NA |
Cristae formation |
11 |
NA |
NA |
0.5350 |
-0.47500 |
NaN |
-0.021000 |
0.111000 |
-0.21900 |
NA |
NA |
NA |
NA |
NA |
Cross-presentation of soluble exogenous antigens (endosomes) |
6 |
NA |
NA |
0.3150 |
-0.00262 |
-0.019700 |
0.274000 |
0.129000 |
0.08470 |
NA |
NA |
NA |
NA |
NA |
Cyclin A/B1/B2 associated events during G2/M transition |
7 |
NA |
NA |
0.4760 |
0.29700 |
-0.146000 |
0.193000 |
NaN |
-0.28200 |
NA |
NA |
NA |
NA |
NA |
Cyclin A:Cdk2-associated events at S phase entry |
15 |
NA |
NA |
0.3320 |
0.16600 |
-0.072900 |
0.058300 |
-0.072600 |
-0.26200 |
NA |
NA |
NA |
NA |
NA |
Cyclin D associated events in G1 |
14 |
NA |
NA |
0.2270 |
-0.05610 |
-0.003080 |
-0.033600 |
-0.207000 |
-0.06410 |
NA |
NA |
NA |
NA |
NA |
Cyclin E associated events during G1/S transition |
15 |
NA |
NA |
0.3320 |
0.16600 |
-0.072900 |
0.058300 |
-0.072600 |
-0.26200 |
NA |
NA |
NA |
NA |
NA |
Cytosolic sensors of pathogen-associated DNA |
14 |
NA |
NA |
0.2640 |
0.12400 |
0.048900 |
-0.013500 |
-0.112000 |
-0.19800 |
NA |
NA |
NA |
NA |
NA |
DAP12 interactions |
8 |
NA |
NA |
0.4010 |
-0.12500 |
NaN |
-0.264000 |
0.044600 |
0.27100 |
NA |
NA |
NA |
NA |
NA |
DAP12 signaling |
6 |
NA |
NA |
0.3840 |
-0.09960 |
NaN |
-0.282000 |
0.044600 |
0.23700 |
NA |
NA |
NA |
NA |
NA |
DDX58/IFIH1-mediated induction of interferon-alpha/beta |
6 |
NA |
NA |
0.6100 |
-0.26500 |
-0.003950 |
0.028100 |
0.001980 |
-0.54900 |
NA |
NA |
NA |
NA |
NA |
DNA Damage Bypass |
10 |
NA |
NA |
0.4680 |
0.24800 |
-0.092600 |
-0.005920 |
-0.207000 |
-0.32500 |
NA |
NA |
NA |
NA |
NA |
DNA Damage Recognition in GG-NER |
9 |
NA |
NA |
0.4160 |
0.23700 |
-0.148000 |
0.041700 |
-0.064900 |
-0.29800 |
NA |
NA |
NA |
NA |
NA |
DNA Double Strand Break Response |
9 |
NA |
NA |
0.3530 |
0.14200 |
0.036900 |
-0.074300 |
-0.207000 |
-0.23300 |
NA |
NA |
NA |
NA |
NA |
DNA Double-Strand Break Repair |
22 |
NA |
NA |
0.4140 |
0.23700 |
-0.056300 |
0.058500 |
-0.207000 |
-0.25600 |
NA |
NA |
NA |
NA |
NA |
DNA Repair |
39 |
NA |
NA |
0.3470 |
0.22100 |
-0.070400 |
0.039600 |
-0.006440 |
-0.25500 |
NA |
NA |
NA |
NA |
NA |
DNA Replication |
30 |
NA |
NA |
0.4760 |
0.28500 |
-0.108000 |
0.081200 |
-0.039500 |
-0.35400 |
NA |
NA |
NA |
NA |
NA |
DNA Replication Pre-Initiation |
21 |
NA |
NA |
0.4640 |
0.32700 |
-0.089800 |
0.073600 |
-0.039500 |
-0.30500 |
NA |
NA |
NA |
NA |
NA |
DNA strand elongation |
12 |
NA |
NA |
0.5390 |
0.36500 |
-0.092300 |
0.136000 |
NaN |
-0.36200 |
NA |
NA |
NA |
NA |
NA |
Deactivation of the beta-catenin transactivating complex |
8 |
NA |
NA |
0.3780 |
-0.26900 |
0.122000 |
-0.188000 |
-0.060300 |
0.12900 |
NA |
NA |
NA |
NA |
NA |
Deadenylation-dependent mRNA decay |
11 |
NA |
NA |
0.4070 |
0.19600 |
-0.042800 |
0.145000 |
NaN |
-0.32300 |
NA |
NA |
NA |
NA |
NA |
Death Receptor Signalling |
14 |
NA |
NA |
0.3310 |
-0.27200 |
-0.110000 |
-0.033100 |
-0.059300 |
0.13800 |
NA |
NA |
NA |
NA |
NA |
Dectin-1 mediated noncanonical NF-kB signaling |
9 |
NA |
NA |
0.2850 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Defective CFTR causes cystic fibrosis |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) |
6 |
NA |
NA |
0.1700 |
0.12700 |
0.060400 |
-0.071200 |
NaN |
0.06440 |
NA |
NA |
NA |
NA |
NA |
Degradation of AXIN |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Degradation of DVL |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Degradation of GLI1 by the proteasome |
9 |
NA |
NA |
0.2850 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Degradation of GLI2 by the proteasome |
10 |
NA |
NA |
0.2390 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.03550 |
NA |
NA |
NA |
NA |
NA |
Degradation of beta-catenin by the destruction complex |
14 |
NA |
NA |
0.1130 |
-0.00263 |
0.063000 |
0.043400 |
-0.072600 |
-0.03970 |
NA |
NA |
NA |
NA |
NA |
Degradation of the extracellular matrix |
18 |
NA |
NA |
0.5500 |
-0.32500 |
0.143000 |
-0.079200 |
-0.000658 |
0.41300 |
NA |
NA |
NA |
NA |
NA |
Depolymerisation of the Nuclear Lamina |
5 |
NA |
NA |
0.5100 |
0.06440 |
-0.101000 |
0.227000 |
-0.080100 |
-0.43400 |
NA |
NA |
NA |
NA |
NA |
Deposition of new CENPA-containing nucleosomes at the centromere |
13 |
NA |
NA |
0.4790 |
0.12300 |
-0.109000 |
0.203000 |
-0.049900 |
-0.39800 |
NA |
NA |
NA |
NA |
NA |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models |
6 |
NA |
NA |
0.4040 |
-0.12700 |
0.000881 |
0.218000 |
-0.080100 |
-0.30600 |
NA |
NA |
NA |
NA |
NA |
Detoxification of Reactive Oxygen Species |
10 |
NA |
NA |
0.2720 |
0.03940 |
0.060600 |
-0.043500 |
0.021600 |
-0.25800 |
NA |
NA |
NA |
NA |
NA |
Deubiquitination |
28 |
NA |
NA |
0.2580 |
0.16000 |
-0.057800 |
0.070100 |
-0.040400 |
-0.17600 |
NA |
NA |
NA |
NA |
NA |
Disease |
207 |
NA |
NA |
0.1150 |
0.00171 |
0.071900 |
0.023000 |
-0.034300 |
-0.07950 |
NA |
NA |
NA |
NA |
NA |
Diseases associated with glycosaminoglycan metabolism |
5 |
NA |
NA |
0.3490 |
-0.31800 |
NaN |
-0.021500 |
0.077800 |
-0.11900 |
NA |
NA |
NA |
NA |
NA |
Diseases of carbohydrate metabolism |
6 |
NA |
NA |
0.5050 |
0.22900 |
NaN |
-0.188000 |
-0.207000 |
-0.35200 |
NA |
NA |
NA |
NA |
NA |
Diseases of glycosylation |
10 |
NA |
NA |
0.2950 |
-0.27800 |
NaN |
-0.021500 |
0.096700 |
0.00473 |
NA |
NA |
NA |
NA |
NA |
Diseases of metabolism |
19 |
NA |
NA |
0.1830 |
-0.11200 |
NaN |
-0.028100 |
0.058300 |
-0.12900 |
NA |
NA |
NA |
NA |
NA |
Diseases of mitotic cell cycle |
8 |
NA |
NA |
0.2300 |
0.14200 |
-0.096500 |
0.010300 |
NaN |
-0.15300 |
NA |
NA |
NA |
NA |
NA |
Diseases of programmed cell death |
7 |
NA |
NA |
0.4650 |
-0.00580 |
0.000881 |
0.218000 |
-0.084900 |
-0.40200 |
NA |
NA |
NA |
NA |
NA |
Diseases of signal transduction by growth factor receptors and second messengers |
48 |
NA |
NA |
0.1490 |
-0.07450 |
0.038800 |
0.085000 |
-0.084800 |
0.02630 |
NA |
NA |
NA |
NA |
NA |
Disorders of transmembrane transporters |
14 |
NA |
NA |
0.1190 |
0.07070 |
-0.019700 |
0.058000 |
0.026000 |
-0.06930 |
NA |
NA |
NA |
NA |
NA |
Downregulation of ERBB2 signaling |
5 |
NA |
NA |
0.6460 |
0.32100 |
-0.063000 |
-0.188000 |
-0.207000 |
-0.48100 |
NA |
NA |
NA |
NA |
NA |
Downregulation of SMAD2/3:SMAD4 transcriptional activity |
5 |
NA |
NA |
0.5480 |
0.17500 |
-0.148000 |
0.046100 |
-0.207000 |
-0.45000 |
NA |
NA |
NA |
NA |
NA |
Downregulation of TGF-beta receptor signaling |
10 |
NA |
NA |
0.2410 |
-0.00876 |
0.015800 |
-0.026800 |
-0.139000 |
-0.19400 |
NA |
NA |
NA |
NA |
NA |
Downstream TCR signaling |
12 |
NA |
NA |
0.2480 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.07260 |
NA |
NA |
NA |
NA |
NA |
Downstream signaling events of B Cell Receptor (BCR) |
13 |
NA |
NA |
0.2830 |
-0.27000 |
0.063900 |
0.042900 |
-0.008370 |
-0.02890 |
NA |
NA |
NA |
NA |
NA |
Dual Incision in GG-NER |
9 |
NA |
NA |
0.4890 |
0.26900 |
-0.097500 |
0.012300 |
-0.207000 |
-0.33800 |
NA |
NA |
NA |
NA |
NA |
Dual incision in TC-NER |
13 |
NA |
NA |
0.2700 |
0.14700 |
-0.040400 |
-0.065500 |
0.003960 |
-0.21300 |
NA |
NA |
NA |
NA |
NA |
E2F mediated regulation of DNA replication |
6 |
NA |
NA |
0.5460 |
0.37700 |
-0.153000 |
0.266000 |
NaN |
-0.24900 |
NA |
NA |
NA |
NA |
NA |
E3 ubiquitin ligases ubiquitinate target proteins |
8 |
NA |
NA |
0.2430 |
-0.01930 |
-0.105000 |
-0.182000 |
-0.115000 |
-0.03450 |
NA |
NA |
NA |
NA |
NA |
ECM proteoglycans |
10 |
NA |
NA |
0.3310 |
-0.21900 |
0.143000 |
-0.014600 |
0.007620 |
0.20100 |
NA |
NA |
NA |
NA |
NA |
EGR2 and SOX10-mediated initiation of Schwann cell myelination |
6 |
NA |
NA |
0.3450 |
-0.04330 |
NaN |
0.076900 |
0.045300 |
-0.33000 |
NA |
NA |
NA |
NA |
NA |
EML4 and NUDC in mitotic spindle formation |
25 |
NA |
NA |
0.4690 |
0.21400 |
-0.111000 |
0.184000 |
-0.025000 |
-0.35700 |
NA |
NA |
NA |
NA |
NA |
EPH-Ephrin signaling |
17 |
NA |
NA |
0.5050 |
-0.33300 |
NaN |
-0.168000 |
-0.036200 |
0.33800 |
NA |
NA |
NA |
NA |
NA |
EPH-ephrin mediated repulsion of cells |
9 |
NA |
NA |
0.4750 |
-0.27900 |
NaN |
-0.135000 |
-0.036200 |
0.35800 |
NA |
NA |
NA |
NA |
NA |
EPHB-mediated forward signaling |
6 |
NA |
NA |
0.3560 |
-0.35000 |
NaN |
NaN |
NaN |
0.06360 |
NA |
NA |
NA |
NA |
NA |
ER to Golgi Anterograde Transport |
12 |
NA |
NA |
0.1730 |
-0.13500 |
NaN |
-0.049900 |
-0.005630 |
0.09610 |
NA |
NA |
NA |
NA |
NA |
ER-Phagosome pathway |
16 |
NA |
NA |
0.2800 |
-0.17200 |
-0.019700 |
-0.112000 |
0.026000 |
0.18800 |
NA |
NA |
NA |
NA |
NA |
ESR-mediated signaling |
34 |
NA |
NA |
0.0714 |
0.00933 |
0.012200 |
0.004490 |
-0.067300 |
-0.01740 |
NA |
NA |
NA |
NA |
NA |
Early Phase of HIV Life Cycle |
6 |
NA |
NA |
0.5940 |
0.27500 |
0.014500 |
0.166000 |
-0.129000 |
-0.48300 |
NA |
NA |
NA |
NA |
NA |
Elastic fibre formation |
7 |
NA |
NA |
0.5460 |
-0.15300 |
NaN |
-0.106000 |
-0.159000 |
0.48800 |
NA |
NA |
NA |
NA |
NA |
Endosomal Sorting Complex Required For Transport (ESCRT) |
5 |
NA |
NA |
0.4980 |
-0.44700 |
NaN |
-0.192000 |
-0.060600 |
0.08980 |
NA |
NA |
NA |
NA |
NA |
Endosomal/Vacuolar pathway |
6 |
NA |
NA |
0.4800 |
-0.15400 |
NaN |
-0.214000 |
0.044600 |
0.39800 |
NA |
NA |
NA |
NA |
NA |
Estrogen-dependent gene expression |
24 |
NA |
NA |
0.2000 |
0.09720 |
0.002160 |
0.052800 |
-0.043400 |
-0.16100 |
NA |
NA |
NA |
NA |
NA |
Eukaryotic Translation Elongation |
52 |
NA |
NA |
0.4390 |
0.18700 |
0.186000 |
-0.131000 |
-0.148000 |
-0.28900 |
NA |
NA |
NA |
NA |
NA |
Eukaryotic Translation Initiation |
58 |
NA |
NA |
0.3920 |
0.13800 |
0.176000 |
-0.065400 |
-0.157000 |
-0.27300 |
NA |
NA |
NA |
NA |
NA |
Eukaryotic Translation Termination |
50 |
NA |
NA |
0.4210 |
0.16800 |
0.184000 |
-0.131000 |
-0.156000 |
-0.27200 |
NA |
NA |
NA |
NA |
NA |
Extension of Telomeres |
10 |
NA |
NA |
0.4570 |
0.31800 |
-0.066200 |
0.071600 |
0.068300 |
-0.30600 |
NA |
NA |
NA |
NA |
NA |
Extra-nuclear estrogen signaling |
13 |
NA |
NA |
0.2920 |
-0.14600 |
0.023100 |
-0.030100 |
-0.113000 |
0.22300 |
NA |
NA |
NA |
NA |
NA |
Extracellular matrix organization |
47 |
NA |
NA |
0.4620 |
-0.23100 |
0.144000 |
-0.076300 |
-0.039400 |
0.36300 |
NA |
NA |
NA |
NA |
NA |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis |
10 |
NA |
NA |
0.2930 |
-0.22800 |
-0.034900 |
0.076000 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
FCERI mediated MAPK activation |
5 |
NA |
NA |
0.1290 |
-0.06680 |
NaN |
NaN |
NaN |
0.11100 |
NA |
NA |
NA |
NA |
NA |
FCERI mediated NF-kB activation |
10 |
NA |
NA |
0.3100 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.20100 |
NA |
NA |
NA |
NA |
NA |
FCGR3A-mediated phagocytosis |
8 |
NA |
NA |
0.4290 |
-0.35000 |
NaN |
-0.235000 |
0.052500 |
0.06360 |
NA |
NA |
NA |
NA |
NA |
FGFR2 alternative splicing |
9 |
NA |
NA |
0.2630 |
0.12000 |
0.077500 |
-0.184000 |
0.061700 |
-0.10500 |
NA |
NA |
NA |
NA |
NA |
FGFR2 mutant receptor activation |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
FLT3 Signaling |
31 |
NA |
NA |
0.2290 |
-0.16200 |
-0.019700 |
0.046000 |
-0.058300 |
0.14300 |
NA |
NA |
NA |
NA |
NA |
FOXO-mediated transcription |
10 |
NA |
NA |
0.3370 |
-0.27500 |
0.146000 |
0.043600 |
0.024400 |
0.11900 |
NA |
NA |
NA |
NA |
NA |
Factors involved in megakaryocyte development and platelet production |
14 |
NA |
NA |
0.2380 |
0.15600 |
-0.068600 |
0.093800 |
0.025500 |
-0.13500 |
NA |
NA |
NA |
NA |
NA |
Fanconi Anemia Pathway |
8 |
NA |
NA |
0.5390 |
0.26400 |
-0.115000 |
0.032500 |
-0.207000 |
-0.40400 |
NA |
NA |
NA |
NA |
NA |
Fatty acid metabolism |
14 |
NA |
NA |
0.1480 |
-0.04470 |
-0.007490 |
-0.056500 |
0.016300 |
0.12800 |
NA |
NA |
NA |
NA |
NA |
Fc epsilon receptor (FCERI) signaling |
18 |
NA |
NA |
0.2350 |
-0.22000 |
0.063900 |
-0.002640 |
-0.039500 |
0.03320 |
NA |
NA |
NA |
NA |
NA |
Fcgamma receptor (FCGR) dependent phagocytosis |
12 |
NA |
NA |
0.1660 |
-0.14200 |
-0.063000 |
-0.045700 |
-0.030800 |
0.01890 |
NA |
NA |
NA |
NA |
NA |
Folding of actin by CCT/TriC |
8 |
NA |
NA |
0.2980 |
0.09310 |
0.018400 |
0.145000 |
-0.143000 |
-0.19600 |
NA |
NA |
NA |
NA |
NA |
Formation of ATP by chemiosmotic coupling |
9 |
NA |
NA |
0.5520 |
-0.47500 |
NaN |
-0.177000 |
0.111000 |
-0.19000 |
NA |
NA |
NA |
NA |
NA |
Formation of HIV elongation complex in the absence of HIV Tat |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Formation of HIV-1 elongation complex containing HIV-1 Tat |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Formation of Incision Complex in GG-NER |
8 |
NA |
NA |
0.4310 |
0.19800 |
-0.119000 |
0.012300 |
-0.207000 |
-0.29900 |
NA |
NA |
NA |
NA |
NA |
Formation of RNA Pol II elongation complex |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Formation of TC-NER Pre-Incision Complex |
10 |
NA |
NA |
0.1720 |
0.07050 |
0.077500 |
-0.036000 |
-0.021800 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Formation of a pool of free 40S subunits |
53 |
NA |
NA |
0.4130 |
0.15400 |
0.176000 |
-0.097300 |
-0.157000 |
-0.28600 |
NA |
NA |
NA |
NA |
NA |
Formation of the Early Elongation Complex |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Formation of the HIV-1 Early Elongation Complex |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Formation of the beta-catenin:TCF transactivating complex |
7 |
NA |
NA |
0.3650 |
0.31500 |
0.104000 |
NaN |
-0.138000 |
-0.06160 |
NA |
NA |
NA |
NA |
NA |
Formation of the ternary complex, and subsequently, the 43S complex |
24 |
NA |
NA |
0.4000 |
0.15200 |
0.159000 |
0.086600 |
-0.127000 |
-0.29600 |
NA |
NA |
NA |
NA |
NA |
Formation of tubulin folding intermediates by CCT/TriC |
15 |
NA |
NA |
0.4040 |
0.27700 |
-0.032500 |
0.153000 |
-0.022200 |
-0.24800 |
NA |
NA |
NA |
NA |
NA |
G alpha (12/13) signalling events |
6 |
NA |
NA |
0.5010 |
-0.13800 |
-0.110000 |
-0.078200 |
0.014100 |
0.46200 |
NA |
NA |
NA |
NA |
NA |
G alpha (q) signalling events |
6 |
NA |
NA |
0.3610 |
-0.06570 |
0.119000 |
-0.085300 |
0.027200 |
0.32200 |
NA |
NA |
NA |
NA |
NA |
G alpha (s) signalling events |
5 |
NA |
NA |
0.6050 |
-0.25200 |
NaN |
-0.220000 |
0.073100 |
0.49900 |
NA |
NA |
NA |
NA |
NA |
G0 and Early G1 |
7 |
NA |
NA |
0.5350 |
0.34500 |
-0.091900 |
0.072300 |
-0.138000 |
-0.36600 |
NA |
NA |
NA |
NA |
NA |
G1 Phase |
14 |
NA |
NA |
0.2270 |
-0.05610 |
-0.003080 |
-0.033600 |
-0.207000 |
-0.06410 |
NA |
NA |
NA |
NA |
NA |
G1/S DNA Damage Checkpoints |
11 |
NA |
NA |
0.2930 |
0.13500 |
-0.086900 |
0.055500 |
-0.039500 |
-0.23500 |
NA |
NA |
NA |
NA |
NA |
G1/S Transition |
37 |
NA |
NA |
0.4620 |
0.29300 |
-0.107000 |
0.099800 |
-0.072600 |
-0.31900 |
NA |
NA |
NA |
NA |
NA |
G1/S-Specific Transcription |
9 |
NA |
NA |
0.5190 |
0.33200 |
-0.116000 |
0.144000 |
NaN |
-0.35300 |
NA |
NA |
NA |
NA |
NA |
G2/M Checkpoints |
29 |
NA |
NA |
0.4450 |
0.23400 |
-0.106000 |
0.150000 |
0.018500 |
-0.33000 |
NA |
NA |
NA |
NA |
NA |
G2/M DNA damage checkpoint |
9 |
NA |
NA |
0.3970 |
0.00685 |
-0.102000 |
0.230000 |
0.134000 |
-0.27700 |
NA |
NA |
NA |
NA |
NA |
G2/M Transition |
34 |
NA |
NA |
0.3690 |
0.11600 |
-0.123000 |
0.169000 |
-0.089100 |
-0.26700 |
NA |
NA |
NA |
NA |
NA |
GLI3 is processed to GLI3R by the proteasome |
10 |
NA |
NA |
0.2390 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.03550 |
NA |
NA |
NA |
NA |
NA |
GTP hydrolysis and joining of the 60S ribosomal subunit |
56 |
NA |
NA |
0.3810 |
0.13800 |
0.176000 |
-0.065400 |
-0.157000 |
-0.25700 |
NA |
NA |
NA |
NA |
NA |
Gap-filling DNA repair synthesis and ligation in GG-NER |
8 |
NA |
NA |
0.4430 |
0.22300 |
-0.079700 |
-0.005920 |
-0.207000 |
-0.31200 |
NA |
NA |
NA |
NA |
NA |
Gap-filling DNA repair synthesis and ligation in TC-NER |
13 |
NA |
NA |
0.2700 |
0.14700 |
-0.040400 |
-0.065500 |
0.003960 |
-0.21300 |
NA |
NA |
NA |
NA |
NA |
Gene Silencing by RNA |
10 |
NA |
NA |
0.3430 |
0.17400 |
0.007250 |
0.112000 |
-0.060300 |
-0.26700 |
NA |
NA |
NA |
NA |
NA |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation |
14 |
NA |
NA |
0.4170 |
0.07700 |
-0.092800 |
0.200000 |
-0.098400 |
-0.33200 |
NA |
NA |
NA |
NA |
NA |
Global Genome Nucleotide Excision Repair (GG-NER) |
16 |
NA |
NA |
0.3720 |
0.22000 |
-0.097500 |
0.075600 |
-0.064900 |
-0.26500 |
NA |
NA |
NA |
NA |
NA |
Gluconeogenesis |
6 |
NA |
NA |
0.4380 |
0.26000 |
NaN |
0.146000 |
NaN |
-0.32100 |
NA |
NA |
NA |
NA |
NA |
Glucose metabolism |
12 |
NA |
NA |
0.3720 |
0.28900 |
0.021000 |
0.116000 |
NaN |
-0.20100 |
NA |
NA |
NA |
NA |
NA |
Glutamate binding, activation of AMPA receptors and synaptic plasticity |
6 |
NA |
NA |
0.5750 |
0.14200 |
NaN |
0.123000 |
0.151000 |
0.52200 |
NA |
NA |
NA |
NA |
NA |
Glutathione conjugation |
5 |
NA |
NA |
0.3340 |
0.18900 |
NaN |
0.085200 |
-0.193000 |
-0.17800 |
NA |
NA |
NA |
NA |
NA |
Glycerophospholipid biosynthesis |
7 |
NA |
NA |
0.1290 |
-0.04540 |
NaN |
0.053000 |
-0.053700 |
0.09390 |
NA |
NA |
NA |
NA |
NA |
Glycogen metabolism |
5 |
NA |
NA |
0.4610 |
-0.35300 |
NaN |
-0.141000 |
-0.207000 |
0.15900 |
NA |
NA |
NA |
NA |
NA |
Glycolysis |
10 |
NA |
NA |
0.3530 |
0.29400 |
0.021000 |
0.116000 |
NaN |
-0.15600 |
NA |
NA |
NA |
NA |
NA |
Glycosaminoglycan metabolism |
8 |
NA |
NA |
0.3290 |
-0.27600 |
-0.155000 |
0.033100 |
0.077800 |
0.02300 |
NA |
NA |
NA |
NA |
NA |
Golgi Cisternae Pericentriolar Stack Reorganization |
5 |
NA |
NA |
0.4840 |
0.13100 |
-0.143000 |
0.253000 |
NaN |
-0.36500 |
NA |
NA |
NA |
NA |
NA |
Golgi-to-ER retrograde transport |
15 |
NA |
NA |
0.1670 |
-0.06270 |
-0.072300 |
0.095300 |
0.037100 |
-0.09170 |
NA |
NA |
NA |
NA |
NA |
HCMV Early Events |
9 |
NA |
NA |
0.1870 |
0.02510 |
-0.109000 |
0.074600 |
-0.130000 |
-0.00702 |
NA |
NA |
NA |
NA |
NA |
HCMV Infection |
11 |
NA |
NA |
0.1760 |
-0.09380 |
-0.109000 |
0.020400 |
-0.057700 |
0.08220 |
NA |
NA |
NA |
NA |
NA |
HDR through Homologous Recombination (HRR) |
9 |
NA |
NA |
0.4220 |
0.22300 |
-0.073300 |
-0.005920 |
-0.207000 |
-0.28200 |
NA |
NA |
NA |
NA |
NA |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) |
15 |
NA |
NA |
0.4210 |
0.23800 |
-0.090300 |
-0.000439 |
-0.207000 |
-0.26400 |
NA |
NA |
NA |
NA |
NA |
HIV Infection |
44 |
NA |
NA |
0.1210 |
0.02790 |
-0.012900 |
0.058000 |
0.025500 |
-0.09810 |
NA |
NA |
NA |
NA |
NA |
HIV Life Cycle |
27 |
NA |
NA |
0.2230 |
0.12100 |
-0.017600 |
0.069700 |
-0.045800 |
-0.16600 |
NA |
NA |
NA |
NA |
NA |
HIV Transcription Elongation |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
HIV Transcription Initiation |
6 |
NA |
NA |
0.2330 |
0.07050 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
HIV elongation arrest and recovery |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
HSF1 activation |
7 |
NA |
NA |
0.5540 |
0.26000 |
0.002890 |
0.138000 |
-0.157000 |
-0.44200 |
NA |
NA |
NA |
NA |
NA |
HSP90 chaperone cycle for steroid hormone receptors (SHR) |
9 |
NA |
NA |
0.2830 |
0.06040 |
-0.053700 |
0.160000 |
-0.121000 |
-0.18200 |
NA |
NA |
NA |
NA |
NA |
Hedgehog 'off' state |
11 |
NA |
NA |
0.3170 |
-0.30500 |
-0.019700 |
0.043400 |
-0.039500 |
0.05970 |
NA |
NA |
NA |
NA |
NA |
Hedgehog 'on' state |
9 |
NA |
NA |
0.0714 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.03550 |
NA |
NA |
NA |
NA |
NA |
Hedgehog ligand biogenesis |
9 |
NA |
NA |
0.0743 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.04100 |
NA |
NA |
NA |
NA |
NA |
Hemostasis |
81 |
NA |
NA |
0.3560 |
-0.20400 |
0.054200 |
-0.072000 |
0.020800 |
0.27600 |
NA |
NA |
NA |
NA |
NA |
Hh mutants abrogate ligand secretion |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Homology Directed Repair |
17 |
NA |
NA |
0.4560 |
0.27300 |
-0.099300 |
0.011900 |
-0.207000 |
-0.28300 |
NA |
NA |
NA |
NA |
NA |
Host Interactions of HIV factors |
30 |
NA |
NA |
0.1630 |
0.04190 |
-0.052400 |
0.086700 |
0.012600 |
-0.12000 |
NA |
NA |
NA |
NA |
NA |
ISG15 antiviral mechanism |
10 |
NA |
NA |
0.2730 |
0.09540 |
0.021100 |
-0.078200 |
-0.207000 |
-0.12500 |
NA |
NA |
NA |
NA |
NA |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
11 |
NA |
NA |
0.5830 |
-0.21600 |
NaN |
-0.191000 |
0.044600 |
0.50500 |
NA |
NA |
NA |
NA |
NA |
Inactivation of APC/C via direct inhibition of the APC/C complex |
5 |
NA |
NA |
0.6380 |
0.27000 |
-0.161000 |
0.157000 |
NaN |
-0.53300 |
NA |
NA |
NA |
NA |
NA |
Infection with Mycobacterium tuberculosis |
8 |
NA |
NA |
0.2540 |
0.08920 |
0.033600 |
-0.032400 |
-0.081600 |
-0.21900 |
NA |
NA |
NA |
NA |
NA |
Infectious disease |
146 |
NA |
NA |
0.1380 |
0.02460 |
0.087400 |
0.004260 |
-0.049600 |
-0.09070 |
NA |
NA |
NA |
NA |
NA |
Influenza Infection |
63 |
NA |
NA |
0.3930 |
0.17400 |
0.146000 |
-0.069000 |
-0.135000 |
-0.28300 |
NA |
NA |
NA |
NA |
NA |
Influenza Viral RNA Transcription and Replication |
59 |
NA |
NA |
0.4010 |
0.19000 |
0.156000 |
-0.101000 |
-0.131000 |
-0.27000 |
NA |
NA |
NA |
NA |
NA |
Inhibition of DNA recombination at telomere |
5 |
NA |
NA |
0.2630 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.14400 |
NA |
NA |
NA |
NA |
NA |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
5 |
NA |
NA |
0.6380 |
0.27000 |
-0.161000 |
0.157000 |
NaN |
-0.53300 |
NA |
NA |
NA |
NA |
NA |
Initiation of Nuclear Envelope (NE) Reformation |
8 |
NA |
NA |
0.4630 |
0.11900 |
-0.089300 |
0.233000 |
-0.080100 |
-0.36200 |
NA |
NA |
NA |
NA |
NA |
Innate Immune System |
130 |
NA |
NA |
0.1730 |
-0.11300 |
0.043800 |
-0.042800 |
0.020100 |
0.11500 |
NA |
NA |
NA |
NA |
NA |
Integration of energy metabolism |
10 |
NA |
NA |
0.2220 |
-0.08260 |
NaN |
-0.015700 |
-0.122000 |
0.16500 |
NA |
NA |
NA |
NA |
NA |
Integration of provirus |
5 |
NA |
NA |
0.5800 |
0.24100 |
0.014500 |
0.166000 |
-0.129000 |
-0.48300 |
NA |
NA |
NA |
NA |
NA |
Integrin cell surface interactions |
9 |
NA |
NA |
0.5420 |
-0.20900 |
0.164000 |
-0.046000 |
-0.054600 |
0.46700 |
NA |
NA |
NA |
NA |
NA |
Interactions of Rev with host cellular proteins |
8 |
NA |
NA |
0.6360 |
0.20800 |
-0.077700 |
0.198000 |
-0.108000 |
-0.55100 |
NA |
NA |
NA |
NA |
NA |
Interactions of Vpr with host cellular proteins |
6 |
NA |
NA |
0.5570 |
0.22300 |
-0.032800 |
0.086600 |
0.013200 |
-0.50200 |
NA |
NA |
NA |
NA |
NA |
Interconversion of nucleotide di- and triphosphates |
12 |
NA |
NA |
0.4620 |
0.22100 |
-0.085000 |
-0.053500 |
-0.052500 |
-0.39000 |
NA |
NA |
NA |
NA |
NA |
Interferon alpha/beta signaling |
8 |
NA |
NA |
0.5490 |
-0.14000 |
0.168000 |
-0.119000 |
-0.209000 |
0.44200 |
NA |
NA |
NA |
NA |
NA |
Interleukin-1 family signaling |
14 |
NA |
NA |
0.3320 |
-0.24400 |
-0.009250 |
0.067000 |
0.044500 |
-0.21000 |
NA |
NA |
NA |
NA |
NA |
Interleukin-1 signaling |
13 |
NA |
NA |
0.3350 |
-0.24400 |
-0.009250 |
0.078900 |
0.044500 |
-0.21000 |
NA |
NA |
NA |
NA |
NA |
Interleukin-12 family signaling |
17 |
NA |
NA |
0.2450 |
0.06190 |
-0.092800 |
0.158000 |
-0.098400 |
-0.11300 |
NA |
NA |
NA |
NA |
NA |
Interleukin-12 signaling |
15 |
NA |
NA |
0.3180 |
0.06190 |
-0.092800 |
0.158000 |
-0.098400 |
-0.23200 |
NA |
NA |
NA |
NA |
NA |
Interleukin-17 signaling |
10 |
NA |
NA |
0.3360 |
-0.22300 |
NaN |
-0.124000 |
-0.207000 |
0.07150 |
NA |
NA |
NA |
NA |
NA |
Interleukin-3, Interleukin-5 and GM-CSF signaling |
5 |
NA |
NA |
0.5180 |
-0.23500 |
NaN |
-0.057200 |
0.134000 |
0.43800 |
NA |
NA |
NA |
NA |
NA |
Interleukin-4 and Interleukin-13 signaling |
22 |
NA |
NA |
0.3230 |
-0.09610 |
0.021300 |
-0.058000 |
-0.133000 |
0.27100 |
NA |
NA |
NA |
NA |
NA |
Interleukin-6 family signaling |
5 |
NA |
NA |
0.5720 |
-0.04460 |
NaN |
-0.057200 |
NaN |
0.56700 |
NA |
NA |
NA |
NA |
NA |
Intra-Golgi and retrograde Golgi-to-ER traffic |
19 |
NA |
NA |
0.1410 |
-0.09610 |
-0.032200 |
0.095300 |
0.022700 |
0.01160 |
NA |
NA |
NA |
NA |
NA |
Intracellular signaling by second messengers |
26 |
NA |
NA |
0.1560 |
-0.13600 |
-0.024700 |
0.037400 |
-0.039500 |
0.04760 |
NA |
NA |
NA |
NA |
NA |
Intrinsic Pathway for Apoptosis |
7 |
NA |
NA |
0.3960 |
0.11100 |
0.070900 |
0.215000 |
-0.035700 |
-0.30400 |
NA |
NA |
NA |
NA |
NA |
Ion channel transport |
17 |
NA |
NA |
0.4160 |
-0.22200 |
0.152000 |
-0.074400 |
-0.000532 |
0.30800 |
NA |
NA |
NA |
NA |
NA |
Ion homeostasis |
8 |
NA |
NA |
0.4780 |
-0.22400 |
0.152000 |
-0.063100 |
0.045400 |
0.38700 |
NA |
NA |
NA |
NA |
NA |
Ion transport by P-type ATPases |
9 |
NA |
NA |
0.4740 |
-0.22400 |
0.152000 |
0.005270 |
0.045400 |
0.38700 |
NA |
NA |
NA |
NA |
NA |
Iron uptake and transport |
9 |
NA |
NA |
0.2990 |
-0.23100 |
0.167000 |
-0.043100 |
-0.076200 |
0.02490 |
NA |
NA |
NA |
NA |
NA |
Josephin domain DUBs |
5 |
NA |
NA |
0.5450 |
-0.17100 |
NaN |
-0.188000 |
-0.207000 |
-0.43500 |
NA |
NA |
NA |
NA |
NA |
Kinesins |
9 |
NA |
NA |
0.3940 |
0.31800 |
-0.072300 |
0.095300 |
0.113000 |
-0.16400 |
NA |
NA |
NA |
NA |
NA |
L13a-mediated translational silencing of Ceruloplasmin expression |
56 |
NA |
NA |
0.3920 |
0.14300 |
0.176000 |
-0.065400 |
-0.157000 |
-0.27100 |
NA |
NA |
NA |
NA |
NA |
L1CAM interactions |
20 |
NA |
NA |
0.4040 |
-0.15900 |
0.164000 |
-0.084800 |
0.010400 |
0.32300 |
NA |
NA |
NA |
NA |
NA |
Lagging Strand Synthesis |
5 |
NA |
NA |
0.4560 |
0.30200 |
-0.079700 |
0.176000 |
NaN |
-0.28100 |
NA |
NA |
NA |
NA |
NA |
Laminin interactions |
5 |
NA |
NA |
0.5210 |
-0.20800 |
0.156000 |
-0.087400 |
0.010500 |
0.44300 |
NA |
NA |
NA |
NA |
NA |
Late Phase of HIV Life Cycle |
22 |
NA |
NA |
0.1570 |
0.07790 |
-0.033500 |
0.046300 |
-0.028700 |
-0.12000 |
NA |
NA |
NA |
NA |
NA |
Late endosomal microautophagy |
7 |
NA |
NA |
0.3550 |
-0.29000 |
NaN |
-0.192000 |
-0.060600 |
-0.04110 |
NA |
NA |
NA |
NA |
NA |
Leishmania infection |
20 |
NA |
NA |
0.3200 |
-0.25600 |
NaN |
-0.077300 |
0.019500 |
0.17400 |
NA |
NA |
NA |
NA |
NA |
Leishmania parasite growth and survival |
9 |
NA |
NA |
0.5120 |
-0.27800 |
NaN |
-0.158000 |
0.073100 |
0.39300 |
NA |
NA |
NA |
NA |
NA |
Leishmania phagocytosis |
8 |
NA |
NA |
0.4290 |
-0.35000 |
NaN |
-0.235000 |
0.052500 |
0.06360 |
NA |
NA |
NA |
NA |
NA |
Loss of Nlp from mitotic centrosomes |
10 |
NA |
NA |
0.3000 |
0.14700 |
-0.083300 |
0.099300 |
-0.130000 |
-0.18700 |
NA |
NA |
NA |
NA |
NA |
Loss of proteins required for interphase microtubule organization from the centrosome |
10 |
NA |
NA |
0.3000 |
0.14700 |
-0.083300 |
0.099300 |
-0.130000 |
-0.18700 |
NA |
NA |
NA |
NA |
NA |
Lysosome Vesicle Biogenesis |
5 |
NA |
NA |
0.3690 |
-0.26600 |
NaN |
-0.223000 |
0.108000 |
-0.06290 |
NA |
NA |
NA |
NA |
NA |
M Phase |
73 |
NA |
NA |
0.4510 |
0.18700 |
-0.111000 |
0.175000 |
-0.055500 |
-0.35100 |
NA |
NA |
NA |
NA |
NA |
MAP kinase activation |
10 |
NA |
NA |
0.3360 |
-0.22300 |
NaN |
-0.124000 |
-0.207000 |
0.07150 |
NA |
NA |
NA |
NA |
NA |
MAPK family signaling cascades |
38 |
NA |
NA |
0.1720 |
-0.08050 |
0.032200 |
0.031400 |
-0.095300 |
0.11000 |
NA |
NA |
NA |
NA |
NA |
MAPK targets/ Nuclear events mediated by MAP kinases |
5 |
NA |
NA |
0.2880 |
-0.10700 |
NaN |
-0.059000 |
NaN |
0.26000 |
NA |
NA |
NA |
NA |
NA |
MAPK1/MAPK3 signaling |
33 |
NA |
NA |
0.2120 |
-0.12500 |
-0.058000 |
0.046000 |
-0.058300 |
0.14300 |
NA |
NA |
NA |
NA |
NA |
MAPK6/MAPK4 signaling |
14 |
NA |
NA |
0.1990 |
0.09780 |
0.032200 |
-0.004390 |
-0.104000 |
-0.13500 |
NA |
NA |
NA |
NA |
NA |
MHC class II antigen presentation |
20 |
NA |
NA |
0.2540 |
-0.16900 |
-0.039100 |
-0.020500 |
0.024500 |
0.18300 |
NA |
NA |
NA |
NA |
NA |
Macroautophagy |
16 |
NA |
NA |
0.2970 |
-0.00595 |
-0.040200 |
-0.030200 |
-0.207000 |
-0.20700 |
NA |
NA |
NA |
NA |
NA |
Meiosis |
10 |
NA |
NA |
0.3470 |
0.15800 |
-0.069100 |
0.182000 |
-0.080100 |
-0.22600 |
NA |
NA |
NA |
NA |
NA |
Meiotic recombination |
5 |
NA |
NA |
0.5470 |
0.45500 |
-0.109000 |
0.176000 |
NaN |
-0.22200 |
NA |
NA |
NA |
NA |
NA |
Meiotic synapsis |
6 |
NA |
NA |
0.3030 |
0.00919 |
-0.037800 |
0.185000 |
-0.080100 |
-0.22300 |
NA |
NA |
NA |
NA |
NA |
Membrane Trafficking |
56 |
NA |
NA |
0.2530 |
-0.22800 |
0.001330 |
-0.022800 |
0.025600 |
0.10400 |
NA |
NA |
NA |
NA |
NA |
Metabolism of carbohydrates |
30 |
NA |
NA |
0.1790 |
0.08380 |
-0.037000 |
0.012900 |
-0.008890 |
-0.15300 |
NA |
NA |
NA |
NA |
NA |
Metabolism of fat-soluble vitamins |
7 |
NA |
NA |
0.5370 |
-0.34500 |
0.099800 |
-0.087400 |
-0.003940 |
0.38900 |
NA |
NA |
NA |
NA |
NA |
Metabolism of lipids |
43 |
NA |
NA |
0.1080 |
-0.06330 |
0.024100 |
0.062300 |
-0.049000 |
0.02830 |
NA |
NA |
NA |
NA |
NA |
Metabolism of non-coding RNA |
8 |
NA |
NA |
0.6830 |
0.38300 |
-0.089800 |
0.132000 |
NaN |
-0.54200 |
NA |
NA |
NA |
NA |
NA |
Metabolism of nucleotides |
25 |
NA |
NA |
0.4290 |
0.24800 |
-0.088700 |
-0.010300 |
-0.052500 |
-0.33400 |
NA |
NA |
NA |
NA |
NA |
Metabolism of steroids |
13 |
NA |
NA |
0.2370 |
0.13400 |
-0.014500 |
0.119000 |
-0.066600 |
-0.13900 |
NA |
NA |
NA |
NA |
NA |
Metabolism of vitamins and cofactors |
27 |
NA |
NA |
0.1230 |
-0.09610 |
-0.013700 |
0.004180 |
-0.044400 |
0.06140 |
NA |
NA |
NA |
NA |
NA |
Metabolism of water-soluble vitamins and cofactors |
17 |
NA |
NA |
0.2040 |
0.08520 |
-0.077500 |
0.129000 |
-0.057700 |
-0.09250 |
NA |
NA |
NA |
NA |
NA |
MicroRNA (miRNA) biogenesis |
5 |
NA |
NA |
0.2720 |
0.07900 |
0.077500 |
0.046000 |
-0.023000 |
-0.24400 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial biogenesis |
18 |
NA |
NA |
0.2230 |
-0.13500 |
0.007250 |
0.044700 |
0.070800 |
-0.15600 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial calcium ion transport |
9 |
NA |
NA |
0.4710 |
0.24700 |
NaN |
0.127000 |
-0.051400 |
-0.37600 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial protein import |
24 |
NA |
NA |
0.4190 |
0.18700 |
0.014100 |
0.077700 |
0.045700 |
-0.36400 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial translation |
26 |
NA |
NA |
0.2740 |
0.15900 |
0.030200 |
-0.065900 |
0.015000 |
-0.21000 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial translation elongation |
26 |
NA |
NA |
0.2740 |
0.15900 |
0.030200 |
-0.065900 |
0.015000 |
-0.21000 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial translation initiation |
25 |
NA |
NA |
0.2690 |
0.14400 |
0.030200 |
-0.065900 |
0.015000 |
-0.21500 |
NA |
NA |
NA |
NA |
NA |
Mitochondrial translation termination |
25 |
NA |
NA |
0.2690 |
0.14400 |
0.030200 |
-0.065900 |
0.015000 |
-0.21500 |
NA |
NA |
NA |
NA |
NA |
Mitophagy |
10 |
NA |
NA |
0.3350 |
0.06650 |
-0.017100 |
-0.030200 |
-0.207000 |
-0.25300 |
NA |
NA |
NA |
NA |
NA |
Mitotic Anaphase |
57 |
NA |
NA |
0.4640 |
0.18000 |
-0.108000 |
0.193000 |
-0.029800 |
-0.36500 |
NA |
NA |
NA |
NA |
NA |
Mitotic G1 phase and G1/S transition |
43 |
NA |
NA |
0.3920 |
0.24500 |
-0.094200 |
0.066900 |
-0.072600 |
-0.27400 |
NA |
NA |
NA |
NA |
NA |
Mitotic G2-G2/M phases |
34 |
NA |
NA |
0.3690 |
0.11600 |
-0.123000 |
0.169000 |
-0.089100 |
-0.26700 |
NA |
NA |
NA |
NA |
NA |
Mitotic Metaphase and Anaphase |
57 |
NA |
NA |
0.4640 |
0.18000 |
-0.108000 |
0.193000 |
-0.029800 |
-0.36500 |
NA |
NA |
NA |
NA |
NA |
Mitotic Prometaphase |
42 |
NA |
NA |
0.4510 |
0.20700 |
-0.115000 |
0.176000 |
-0.078200 |
-0.33200 |
NA |
NA |
NA |
NA |
NA |
Mitotic Prophase |
15 |
NA |
NA |
0.4140 |
0.16300 |
-0.109000 |
0.187000 |
-0.098100 |
-0.29700 |
NA |
NA |
NA |
NA |
NA |
Mitotic Spindle Checkpoint |
27 |
NA |
NA |
0.4850 |
0.21000 |
-0.119000 |
0.179000 |
-0.025000 |
-0.38000 |
NA |
NA |
NA |
NA |
NA |
Molecules associated with elastic fibres |
6 |
NA |
NA |
0.6140 |
-0.15300 |
NaN |
-0.106000 |
-0.159000 |
0.56300 |
NA |
NA |
NA |
NA |
NA |
Muscle contraction |
21 |
NA |
NA |
0.5140 |
-0.25600 |
0.118000 |
-0.133000 |
-0.027800 |
0.40800 |
NA |
NA |
NA |
NA |
NA |
MyD88 cascade initiated on plasma membrane |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
MyD88 dependent cascade initiated on endosome |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
MyD88-independent TLR4 cascade |
13 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.000265 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Myogenesis |
5 |
NA |
NA |
0.4190 |
-0.17600 |
NaN |
-0.059000 |
NaN |
0.37600 |
NA |
NA |
NA |
NA |
NA |
NCAM signaling for neurite out-growth |
7 |
NA |
NA |
0.4340 |
-0.26800 |
NaN |
-0.087900 |
-0.022300 |
0.32900 |
NA |
NA |
NA |
NA |
NA |
NF-kB is activated and signals survival |
5 |
NA |
NA |
0.3890 |
-0.27000 |
NaN |
-0.188000 |
-0.207000 |
0.01970 |
NA |
NA |
NA |
NA |
NA |
NGF-stimulated transcription |
8 |
NA |
NA |
0.4650 |
-0.20500 |
0.080400 |
-0.255000 |
-0.021100 |
0.32000 |
NA |
NA |
NA |
NA |
NA |
NIK-->noncanonical NF-kB signaling |
9 |
NA |
NA |
0.2850 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
NOTCH1 Intracellular Domain Regulates Transcription |
9 |
NA |
NA |
0.2140 |
-0.02060 |
0.085400 |
0.059300 |
-0.185000 |
-0.01710 |
NA |
NA |
NA |
NA |
NA |
NOTCH2 Activation and Transmission of Signal to the Nucleus |
6 |
NA |
NA |
0.3220 |
-0.15900 |
NaN |
-0.188000 |
-0.207000 |
0.00744 |
NA |
NA |
NA |
NA |
NA |
NOTCH3 Activation and Transmission of Signal to the Nucleus |
7 |
NA |
NA |
0.4670 |
0.21100 |
-0.121000 |
-0.188000 |
-0.207000 |
-0.28500 |
NA |
NA |
NA |
NA |
NA |
NRAGE signals death through JNK |
5 |
NA |
NA |
0.3490 |
-0.26000 |
-0.110000 |
0.090500 |
0.089300 |
0.16100 |
NA |
NA |
NA |
NA |
NA |
NRIF signals cell death from the nucleus |
6 |
NA |
NA |
0.3800 |
-0.25700 |
NaN |
-0.188000 |
-0.207000 |
0.01970 |
NA |
NA |
NA |
NA |
NA |
Neddylation |
28 |
NA |
NA |
0.1320 |
0.00332 |
-0.074900 |
0.078900 |
-0.075000 |
-0.00722 |
NA |
NA |
NA |
NA |
NA |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
5 |
NA |
NA |
0.6490 |
-0.23100 |
NaN |
-0.198000 |
0.086700 |
0.56700 |
NA |
NA |
NA |
NA |
NA |
Negative epigenetic regulation of rRNA expression |
7 |
NA |
NA |
0.1810 |
0.08750 |
0.009880 |
-0.048000 |
0.061700 |
-0.13800 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of FGFR1 signaling |
6 |
NA |
NA |
0.2420 |
-0.09040 |
NaN |
-0.084800 |
-0.207000 |
0.01230 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of FGFR2 signaling |
5 |
NA |
NA |
0.2550 |
NaN |
NaN |
-0.084800 |
-0.207000 |
-0.12100 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of FGFR3 signaling |
5 |
NA |
NA |
0.2550 |
NaN |
NaN |
-0.084800 |
-0.207000 |
-0.12100 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of FGFR4 signaling |
5 |
NA |
NA |
0.2550 |
NaN |
NaN |
-0.084800 |
-0.207000 |
-0.12100 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of MAPK pathway |
8 |
NA |
NA |
0.3990 |
-0.34900 |
NaN |
0.065900 |
-0.153000 |
-0.09980 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of NOTCH4 signaling |
11 |
NA |
NA |
0.2450 |
-0.12500 |
-0.070500 |
0.043400 |
0.018500 |
-0.19300 |
NA |
NA |
NA |
NA |
NA |
Negative regulation of the PI3K/AKT network |
9 |
NA |
NA |
0.3140 |
-0.27300 |
NaN |
0.018400 |
NaN |
0.15400 |
NA |
NA |
NA |
NA |
NA |
Nervous system development |
126 |
NA |
NA |
0.2020 |
-0.06210 |
0.160000 |
-0.083600 |
-0.055300 |
0.03550 |
NA |
NA |
NA |
NA |
NA |
Netrin-1 signaling |
7 |
NA |
NA |
0.1430 |
NaN |
NaN |
0.018400 |
0.019800 |
0.14000 |
NA |
NA |
NA |
NA |
NA |
Neurodegenerative Diseases |
6 |
NA |
NA |
0.4040 |
-0.12700 |
0.000881 |
0.218000 |
-0.080100 |
-0.30600 |
NA |
NA |
NA |
NA |
NA |
Neuronal System |
24 |
NA |
NA |
0.3270 |
-0.05210 |
0.076400 |
-0.096100 |
0.090700 |
0.28400 |
NA |
NA |
NA |
NA |
NA |
Neurotransmitter receptors and postsynaptic signal transmission |
13 |
NA |
NA |
0.3370 |
0.03220 |
0.019700 |
0.014500 |
0.090700 |
0.32200 |
NA |
NA |
NA |
NA |
NA |
Neurotransmitter release cycle |
6 |
NA |
NA |
0.4310 |
-0.15800 |
NaN |
-0.176000 |
NaN |
0.36000 |
NA |
NA |
NA |
NA |
NA |
Neutrophil degranulation |
77 |
NA |
NA |
0.1390 |
-0.09280 |
0.029700 |
-0.018600 |
-0.005770 |
0.09740 |
NA |
NA |
NA |
NA |
NA |
NoRC negatively regulates rRNA expression |
7 |
NA |
NA |
0.1810 |
0.08750 |
0.009880 |
-0.048000 |
0.061700 |
-0.13800 |
NA |
NA |
NA |
NA |
NA |
Non-integrin membrane-ECM interactions |
6 |
NA |
NA |
0.5020 |
-0.27500 |
0.156000 |
-0.108000 |
-0.053300 |
0.37100 |
NA |
NA |
NA |
NA |
NA |
Nonhomologous End-Joining (NHEJ) |
6 |
NA |
NA |
0.3580 |
0.23600 |
0.061700 |
0.159000 |
NaN |
-0.20800 |
NA |
NA |
NA |
NA |
NA |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
55 |
NA |
NA |
0.4200 |
0.19200 |
0.176000 |
-0.131000 |
-0.154000 |
-0.26000 |
NA |
NA |
NA |
NA |
NA |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
51 |
NA |
NA |
0.4230 |
0.16800 |
0.184000 |
-0.131000 |
-0.156000 |
-0.27400 |
NA |
NA |
NA |
NA |
NA |
Nonsense-Mediated Decay (NMD) |
55 |
NA |
NA |
0.4200 |
0.19200 |
0.176000 |
-0.131000 |
-0.154000 |
-0.26000 |
NA |
NA |
NA |
NA |
NA |
Nuclear Envelope (NE) Reassembly |
20 |
NA |
NA |
0.4630 |
0.16500 |
-0.075800 |
0.220000 |
-0.026800 |
-0.36400 |
NA |
NA |
NA |
NA |
NA |
Nuclear Envelope Breakdown |
9 |
NA |
NA |
0.5330 |
0.19700 |
-0.116000 |
0.211000 |
-0.080100 |
-0.42500 |
NA |
NA |
NA |
NA |
NA |
Nuclear Events (kinase and transcription factor activation) |
11 |
NA |
NA |
0.4120 |
-0.18600 |
0.080400 |
-0.157000 |
-0.021100 |
0.32200 |
NA |
NA |
NA |
NA |
NA |
Nuclear Pore Complex (NPC) Disassembly |
5 |
NA |
NA |
0.5500 |
0.31500 |
-0.148000 |
0.202000 |
NaN |
-0.37500 |
NA |
NA |
NA |
NA |
NA |
Nuclear import of Rev protein |
6 |
NA |
NA |
0.5970 |
0.20000 |
0.022300 |
0.197000 |
-0.108000 |
-0.51500 |
NA |
NA |
NA |
NA |
NA |
Nuclear signaling by ERBB4 |
7 |
NA |
NA |
0.4170 |
-0.25200 |
0.051500 |
-0.032700 |
0.002630 |
0.32700 |
NA |
NA |
NA |
NA |
NA |
Nucleobase biosynthesis |
6 |
NA |
NA |
0.4830 |
0.22500 |
-0.038100 |
NaN |
NaN |
-0.42600 |
NA |
NA |
NA |
NA |
NA |
Nucleosome assembly |
13 |
NA |
NA |
0.4790 |
0.12300 |
-0.109000 |
0.203000 |
-0.049900 |
-0.39800 |
NA |
NA |
NA |
NA |
NA |
Nucleotide Excision Repair |
21 |
NA |
NA |
0.2860 |
0.17600 |
-0.062500 |
0.023600 |
-0.006440 |
-0.21500 |
NA |
NA |
NA |
NA |
NA |
Oncogene Induced Senescence |
9 |
NA |
NA |
0.2110 |
0.02630 |
0.131000 |
-0.019200 |
-0.155000 |
0.04840 |
NA |
NA |
NA |
NA |
NA |
Oncogenic MAPK signaling |
11 |
NA |
NA |
0.2590 |
-0.17300 |
0.112000 |
0.112000 |
-0.110000 |
-0.01320 |
NA |
NA |
NA |
NA |
NA |
Opioid Signalling |
6 |
NA |
NA |
0.3120 |
-0.13300 |
0.019700 |
-0.094500 |
-0.031500 |
0.26300 |
NA |
NA |
NA |
NA |
NA |
Orc1 removal from chromatin |
17 |
NA |
NA |
0.4280 |
0.26700 |
-0.103000 |
0.048600 |
-0.039500 |
-0.31300 |
NA |
NA |
NA |
NA |
NA |
Organelle biogenesis and maintenance |
39 |
NA |
NA |
0.1740 |
0.01400 |
-0.048400 |
0.081100 |
-0.005550 |
-0.14500 |
NA |
NA |
NA |
NA |
NA |
Oxidative Stress Induced Senescence |
14 |
NA |
NA |
0.2370 |
0.02720 |
0.029000 |
-0.019200 |
-0.207000 |
-0.10700 |
NA |
NA |
NA |
NA |
NA |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
10 |
NA |
NA |
0.0657 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
0.02190 |
NA |
NA |
NA |
NA |
NA |
PCNA-Dependent Long Patch Base Excision Repair |
6 |
NA |
NA |
0.4240 |
0.25300 |
-0.079700 |
0.176000 |
NaN |
-0.28100 |
NA |
NA |
NA |
NA |
NA |
PCP/CE pathway |
15 |
NA |
NA |
0.2160 |
0.19200 |
-0.019700 |
-0.045700 |
0.014500 |
-0.08450 |
NA |
NA |
NA |
NA |
NA |
PERK regulates gene expression |
5 |
NA |
NA |
0.3620 |
0.27000 |
-0.061700 |
0.219000 |
NaN |
-0.08050 |
NA |
NA |
NA |
NA |
NA |
PI3K/AKT Signaling in Cancer |
9 |
NA |
NA |
0.3190 |
-0.27300 |
NaN |
0.071000 |
NaN |
0.14800 |
NA |
NA |
NA |
NA |
NA |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling |
9 |
NA |
NA |
0.3140 |
-0.27300 |
NaN |
0.018400 |
NaN |
0.15400 |
NA |
NA |
NA |
NA |
NA |
PINK1-PRKN Mediated Mitophagy |
10 |
NA |
NA |
0.3350 |
0.06650 |
-0.017100 |
-0.030200 |
-0.207000 |
-0.25300 |
NA |
NA |
NA |
NA |
NA |
PIP3 activates AKT signaling |
23 |
NA |
NA |
0.1550 |
-0.12500 |
-0.046800 |
0.063800 |
-0.039500 |
0.02270 |
NA |
NA |
NA |
NA |
NA |
PIWI-interacting RNA (piRNA) biogenesis |
6 |
NA |
NA |
0.2510 |
0.13400 |
0.007250 |
0.042100 |
-0.036200 |
-0.20500 |
NA |
NA |
NA |
NA |
NA |
PRC2 methylates histones and DNA |
5 |
NA |
NA |
0.2760 |
0.06160 |
-0.065900 |
NaN |
NaN |
-0.26100 |
NA |
NA |
NA |
NA |
NA |
PTEN Regulation |
13 |
NA |
NA |
0.1300 |
-0.02540 |
-0.046800 |
0.058400 |
-0.039500 |
-0.09470 |
NA |
NA |
NA |
NA |
NA |
Paradoxical activation of RAF signaling by kinase inactive BRAF |
6 |
NA |
NA |
0.2330 |
-0.20800 |
NaN |
0.097100 |
NaN |
0.03920 |
NA |
NA |
NA |
NA |
NA |
Parasite infection |
8 |
NA |
NA |
0.4290 |
-0.35000 |
NaN |
-0.235000 |
0.052500 |
0.06360 |
NA |
NA |
NA |
NA |
NA |
Pausing and recovery of HIV elongation |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Pausing and recovery of Tat-mediated HIV elongation |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Peptide chain elongation |
50 |
NA |
NA |
0.4240 |
0.17300 |
0.186000 |
-0.131000 |
-0.159000 |
-0.26900 |
NA |
NA |
NA |
NA |
NA |
Peptide hormone metabolism |
9 |
NA |
NA |
0.2430 |
-0.23300 |
-0.024900 |
NaN |
0.059000 |
0.02300 |
NA |
NA |
NA |
NA |
NA |
Phase II - Conjugation of compounds |
10 |
NA |
NA |
0.1820 |
0.04540 |
NaN |
0.092500 |
-0.096100 |
-0.11500 |
NA |
NA |
NA |
NA |
NA |
Phospholipid metabolism |
9 |
NA |
NA |
0.1700 |
-0.09570 |
NaN |
0.053000 |
-0.053700 |
0.11800 |
NA |
NA |
NA |
NA |
NA |
Phosphorylation of the APC/C |
5 |
NA |
NA |
0.5480 |
0.23100 |
-0.150000 |
0.193000 |
NaN |
-0.43200 |
NA |
NA |
NA |
NA |
NA |
Plasma lipoprotein assembly, remodeling, and clearance |
10 |
NA |
NA |
0.4020 |
-0.17300 |
0.138000 |
-0.060600 |
0.122000 |
0.30700 |
NA |
NA |
NA |
NA |
NA |
Plasma lipoprotein clearance |
7 |
NA |
NA |
0.3580 |
-0.12100 |
0.105000 |
-0.003290 |
0.122000 |
0.29600 |
NA |
NA |
NA |
NA |
NA |
Platelet activation, signaling and aggregation |
38 |
NA |
NA |
0.4590 |
-0.27400 |
0.167000 |
-0.084500 |
0.043600 |
0.31400 |
NA |
NA |
NA |
NA |
NA |
Platelet degranulation |
27 |
NA |
NA |
0.5290 |
-0.34000 |
0.167000 |
-0.097800 |
0.050600 |
0.35200 |
NA |
NA |
NA |
NA |
NA |
Platelet homeostasis |
10 |
NA |
NA |
0.5030 |
-0.25100 |
NaN |
-0.076900 |
-0.055300 |
0.42500 |
NA |
NA |
NA |
NA |
NA |
Polo-like kinase mediated events |
5 |
NA |
NA |
0.6340 |
0.25500 |
-0.162000 |
0.258000 |
NaN |
-0.49500 |
NA |
NA |
NA |
NA |
NA |
Post-chaperonin tubulin folding pathway |
7 |
NA |
NA |
0.5350 |
0.32200 |
-0.045100 |
0.182000 |
0.018500 |
-0.38200 |
NA |
NA |
NA |
NA |
NA |
Post-translational modification: synthesis of GPI-anchored proteins |
7 |
NA |
NA |
0.3710 |
-0.20100 |
0.185000 |
-0.156000 |
0.057300 |
0.18900 |
NA |
NA |
NA |
NA |
NA |
Postmitotic nuclear pore complex (NPC) reformation |
5 |
NA |
NA |
0.4000 |
0.19300 |
0.022300 |
0.198000 |
-0.108000 |
-0.26700 |
NA |
NA |
NA |
NA |
NA |
Potential therapeutics for SARS |
21 |
NA |
NA |
0.0880 |
0.04590 |
-0.026300 |
0.022000 |
0.056600 |
-0.03520 |
NA |
NA |
NA |
NA |
NA |
Pre-NOTCH Expression and Processing |
5 |
NA |
NA |
0.1860 |
0.18200 |
NaN |
-0.035400 |
NaN |
-0.02000 |
NA |
NA |
NA |
NA |
NA |
Prefoldin mediated transfer of substrate to CCT/TriC |
17 |
NA |
NA |
0.2770 |
0.15400 |
0.008250 |
0.166000 |
-0.022200 |
-0.15700 |
NA |
NA |
NA |
NA |
NA |
Processing of Capped Intron-Containing Pre-mRNA |
60 |
NA |
NA |
0.3970 |
0.21800 |
-0.038900 |
0.098300 |
-0.002920 |
-0.31400 |
NA |
NA |
NA |
NA |
NA |
Processing of Capped Intronless Pre-mRNA |
6 |
NA |
NA |
0.5730 |
0.35500 |
-0.062300 |
0.147000 |
NaN |
-0.42000 |
NA |
NA |
NA |
NA |
NA |
Processing of DNA double-strand break ends |
11 |
NA |
NA |
0.4400 |
0.27200 |
-0.094800 |
-0.000439 |
-0.207000 |
-0.26000 |
NA |
NA |
NA |
NA |
NA |
Processing of SMDT1 |
5 |
NA |
NA |
0.5650 |
0.27300 |
NaN |
NaN |
-0.051400 |
-0.49200 |
NA |
NA |
NA |
NA |
NA |
Programmed Cell Death |
29 |
NA |
NA |
0.1910 |
-0.02760 |
-0.038900 |
0.148000 |
-0.061700 |
-0.09260 |
NA |
NA |
NA |
NA |
NA |
Protein folding |
22 |
NA |
NA |
0.2800 |
0.19100 |
-0.013600 |
0.127000 |
-0.024200 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Protein localization |
30 |
NA |
NA |
0.3550 |
0.13700 |
0.014100 |
0.005330 |
0.025300 |
-0.32700 |
NA |
NA |
NA |
NA |
NA |
Protein methylation |
8 |
NA |
NA |
0.2900 |
0.12600 |
0.202000 |
-0.121000 |
-0.111000 |
-0.02500 |
NA |
NA |
NA |
NA |
NA |
Protein ubiquitination |
12 |
NA |
NA |
0.2750 |
0.04790 |
-0.162000 |
-0.056700 |
-0.115000 |
-0.17600 |
NA |
NA |
NA |
NA |
NA |
Protein-protein interactions at synapses |
5 |
NA |
NA |
0.4670 |
-0.25100 |
0.133000 |
-0.095800 |
NaN |
0.35800 |
NA |
NA |
NA |
NA |
NA |
Purine ribonucleoside monophosphate biosynthesis |
5 |
NA |
NA |
0.4840 |
0.22600 |
-0.038100 |
NaN |
NaN |
-0.42600 |
NA |
NA |
NA |
NA |
NA |
Pyruvate metabolism |
5 |
NA |
NA |
0.3660 |
0.18200 |
NaN |
0.127000 |
NaN |
-0.29100 |
NA |
NA |
NA |
NA |
NA |
Pyruvate metabolism and Citric Acid (TCA) cycle |
9 |
NA |
NA |
0.3660 |
0.15000 |
-0.056500 |
0.127000 |
NaN |
-0.30400 |
NA |
NA |
NA |
NA |
NA |
RAB GEFs exchange GTP for GDP on RABs |
6 |
NA |
NA |
0.2430 |
-0.17000 |
NaN |
NaN |
NaN |
0.17400 |
NA |
NA |
NA |
NA |
NA |
RAB geranylgeranylation |
5 |
NA |
NA |
0.3570 |
-0.30200 |
NaN |
NaN |
-0.018400 |
0.19000 |
NA |
NA |
NA |
NA |
NA |
RAF activation |
7 |
NA |
NA |
0.1960 |
-0.17200 |
NaN |
0.074300 |
-0.053800 |
0.01890 |
NA |
NA |
NA |
NA |
NA |
RAF-independent MAPK1/3 activation |
7 |
NA |
NA |
0.3670 |
0.09780 |
-0.095900 |
-0.057200 |
-0.098500 |
0.32100 |
NA |
NA |
NA |
NA |
NA |
RAF/MAP kinase cascade |
30 |
NA |
NA |
0.2300 |
-0.16200 |
-0.019700 |
0.049300 |
-0.058300 |
0.14300 |
NA |
NA |
NA |
NA |
NA |
RET signaling |
5 |
NA |
NA |
0.2360 |
NaN |
NaN |
-0.046700 |
NaN |
0.23100 |
NA |
NA |
NA |
NA |
NA |
RHO GTPase Effectors |
48 |
NA |
NA |
0.2090 |
-0.05730 |
-0.107000 |
0.106000 |
0.017200 |
-0.13100 |
NA |
NA |
NA |
NA |
NA |
RHO GTPases Activate Formins |
32 |
NA |
NA |
0.3300 |
0.12000 |
-0.111000 |
0.139000 |
-0.022000 |
-0.25000 |
NA |
NA |
NA |
NA |
NA |
RHO GTPases Activate WASPs and WAVEs |
6 |
NA |
NA |
0.4220 |
-0.35000 |
NaN |
-0.235000 |
NaN |
-0.00854 |
NA |
NA |
NA |
NA |
NA |
RHO GTPases activate CIT |
5 |
NA |
NA |
0.4520 |
-0.35100 |
NaN |
-0.061900 |
-0.015800 |
0.27700 |
NA |
NA |
NA |
NA |
NA |
RHO GTPases activate PKNs |
8 |
NA |
NA |
0.3330 |
-0.30700 |
NaN |
-0.050500 |
0.059300 |
0.10300 |
NA |
NA |
NA |
NA |
NA |
RIPK1-mediated regulated necrosis |
6 |
NA |
NA |
0.3000 |
-0.10200 |
0.034900 |
-0.188000 |
-0.207000 |
-0.01740 |
NA |
NA |
NA |
NA |
NA |
RMTs methylate histone arginines |
8 |
NA |
NA |
0.3280 |
0.16100 |
NaN |
0.092700 |
-0.185000 |
-0.19700 |
NA |
NA |
NA |
NA |
NA |
RNA Pol II CTD phosphorylation and interaction with CE |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase I Promoter Clearance |
8 |
NA |
NA |
0.2040 |
0.09380 |
0.077500 |
0.049600 |
0.061700 |
-0.14400 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase I Promoter Escape |
6 |
NA |
NA |
0.2450 |
0.09380 |
0.077500 |
0.030200 |
0.061700 |
-0.20200 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase I Transcription |
8 |
NA |
NA |
0.2040 |
0.09380 |
0.077500 |
0.049600 |
0.061700 |
-0.14400 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase I Transcription Initiation |
6 |
NA |
NA |
0.1730 |
0.09380 |
0.077500 |
-0.048000 |
0.061700 |
-0.09420 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II HIV Promoter Escape |
6 |
NA |
NA |
0.2330 |
0.07050 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Pre-transcription Events |
9 |
NA |
NA |
0.2340 |
0.11500 |
0.015000 |
-0.184000 |
0.043500 |
-0.07540 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Promoter Escape |
6 |
NA |
NA |
0.2330 |
0.07050 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Transcription Elongation |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Transcription Initiation |
6 |
NA |
NA |
0.2330 |
0.07050 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Transcription Initiation And Promoter Clearance |
6 |
NA |
NA |
0.2330 |
0.07050 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
6 |
NA |
NA |
0.2330 |
0.07050 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase II Transcription Termination |
18 |
NA |
NA |
0.4650 |
0.25700 |
-0.040400 |
0.122000 |
-0.122000 |
-0.34500 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Abortive And Retractive Initiation |
7 |
NA |
NA |
0.3680 |
0.16400 |
0.042200 |
0.035600 |
-0.036900 |
-0.32300 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Chain Elongation |
5 |
NA |
NA |
0.3870 |
0.16400 |
0.042200 |
-0.184000 |
0.061700 |
-0.28900 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Transcription |
7 |
NA |
NA |
0.3680 |
0.16400 |
0.042200 |
0.035600 |
-0.036900 |
-0.32300 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Transcription Initiation |
6 |
NA |
NA |
0.3810 |
0.16400 |
0.042200 |
-0.015100 |
-0.036900 |
-0.33800 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Transcription Initiation From Type 1 Promoter |
6 |
NA |
NA |
0.3810 |
0.16400 |
0.042200 |
-0.015100 |
-0.036900 |
-0.33800 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Transcription Initiation From Type 2 Promoter |
5 |
NA |
NA |
0.3870 |
0.16400 |
0.042200 |
-0.184000 |
0.061700 |
-0.28900 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Transcription Initiation From Type 3 Promoter |
5 |
NA |
NA |
0.3870 |
0.16400 |
0.042200 |
-0.184000 |
0.061700 |
-0.28900 |
NA |
NA |
NA |
NA |
NA |
RNA Polymerase III Transcription Termination |
6 |
NA |
NA |
0.3330 |
0.16400 |
0.042200 |
-0.023700 |
0.061700 |
-0.27900 |
NA |
NA |
NA |
NA |
NA |
RNA polymerase II transcribes snRNA genes |
7 |
NA |
NA |
0.2270 |
0.04770 |
0.038200 |
-0.184000 |
0.043500 |
-0.11000 |
NA |
NA |
NA |
NA |
NA |
RUNX1 regulates transcription of genes involved in differentiation of HSCs |
10 |
NA |
NA |
0.1300 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.11400 |
NA |
NA |
NA |
NA |
NA |
Rab regulation of trafficking |
8 |
NA |
NA |
0.2170 |
-0.17000 |
NaN |
NaN |
-0.087600 |
0.10300 |
NA |
NA |
NA |
NA |
NA |
Recognition of DNA damage by PCNA-containing replication complex |
9 |
NA |
NA |
0.4020 |
0.19800 |
-0.071600 |
-0.005920 |
-0.207000 |
-0.27200 |
NA |
NA |
NA |
NA |
NA |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks |
8 |
NA |
NA |
0.3610 |
0.18000 |
0.053800 |
-0.074300 |
-0.207000 |
-0.21600 |
NA |
NA |
NA |
NA |
NA |
Recruitment of NuMA to mitotic centrosomes |
12 |
NA |
NA |
0.3190 |
0.15900 |
-0.080500 |
0.111000 |
-0.130000 |
-0.20100 |
NA |
NA |
NA |
NA |
NA |
Recruitment of mitotic centrosome proteins and complexes |
12 |
NA |
NA |
0.3190 |
0.15900 |
-0.080500 |
0.111000 |
-0.130000 |
-0.20100 |
NA |
NA |
NA |
NA |
NA |
Recycling pathway of L1 |
5 |
NA |
NA |
0.3920 |
NaN |
NaN |
NaN |
0.012300 |
0.39100 |
NA |
NA |
NA |
NA |
NA |
Regulated Necrosis |
6 |
NA |
NA |
0.3000 |
-0.10200 |
0.034900 |
-0.188000 |
-0.207000 |
-0.01740 |
NA |
NA |
NA |
NA |
NA |
Regulation of APC/C activators between G1/S and early anaphase |
18 |
NA |
NA |
0.4330 |
0.15600 |
-0.140000 |
0.139000 |
-0.039500 |
-0.35000 |
NA |
NA |
NA |
NA |
NA |
Regulation of Apoptosis |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Regulation of HSF1-mediated heat shock response |
12 |
NA |
NA |
0.3600 |
0.24100 |
0.014500 |
0.100000 |
0.143000 |
-0.20300 |
NA |
NA |
NA |
NA |
NA |
Regulation of MECP2 expression and activity |
6 |
NA |
NA |
0.3340 |
-0.20500 |
-0.051200 |
0.125000 |
-0.206000 |
0.09520 |
NA |
NA |
NA |
NA |
NA |
Regulation of PLK1 Activity at G2/M Transition |
17 |
NA |
NA |
0.3560 |
0.10200 |
-0.103000 |
0.111000 |
-0.157000 |
-0.26200 |
NA |
NA |
NA |
NA |
NA |
Regulation of PTEN gene transcription |
5 |
NA |
NA |
0.1280 |
-0.03670 |
-0.073500 |
0.087900 |
NaN |
-0.04230 |
NA |
NA |
NA |
NA |
NA |
Regulation of PTEN stability and activity |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Regulation of RAS by GAPs |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Regulation of RUNX1 Expression and Activity |
5 |
NA |
NA |
0.2510 |
-0.17700 |
0.060400 |
-0.048900 |
NaN |
0.16100 |
NA |
NA |
NA |
NA |
NA |
Regulation of RUNX2 expression and activity |
11 |
NA |
NA |
0.2370 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.02020 |
NA |
NA |
NA |
NA |
NA |
Regulation of RUNX3 expression and activity |
11 |
NA |
NA |
0.1510 |
-0.00262 |
-0.019700 |
0.070300 |
-0.090300 |
-0.09700 |
NA |
NA |
NA |
NA |
NA |
Regulation of TP53 Activity |
19 |
NA |
NA |
0.3490 |
0.23300 |
-0.095600 |
0.084900 |
-0.138000 |
-0.18000 |
NA |
NA |
NA |
NA |
NA |
Regulation of TP53 Activity through Phosphorylation |
14 |
NA |
NA |
0.4300 |
0.23100 |
-0.095000 |
0.084000 |
-0.138000 |
-0.31100 |
NA |
NA |
NA |
NA |
NA |
Regulation of TP53 Degradation |
8 |
NA |
NA |
0.4050 |
0.30300 |
-0.125000 |
-0.018000 |
-0.207000 |
-0.11500 |
NA |
NA |
NA |
NA |
NA |
Regulation of TP53 Expression and Degradation |
8 |
NA |
NA |
0.4050 |
0.30300 |
-0.125000 |
-0.018000 |
-0.207000 |
-0.11500 |
NA |
NA |
NA |
NA |
NA |
Regulation of actin dynamics for phagocytic cup formation |
9 |
NA |
NA |
0.1720 |
-0.01440 |
-0.063000 |
0.003950 |
-0.034200 |
-0.15600 |
NA |
NA |
NA |
NA |
NA |
Regulation of activated PAK-2p34 by proteasome mediated degradation |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Regulation of cholesterol biosynthesis by SREBP (SREBF) |
5 |
NA |
NA |
0.4710 |
0.07490 |
0.022300 |
0.276000 |
-0.106000 |
-0.35800 |
NA |
NA |
NA |
NA |
NA |
Regulation of expression of SLITs and ROBOs |
63 |
NA |
NA |
0.3620 |
0.18000 |
0.168000 |
-0.096700 |
-0.137000 |
-0.20600 |
NA |
NA |
NA |
NA |
NA |
Regulation of insulin secretion |
6 |
NA |
NA |
0.3770 |
-0.10800 |
NaN |
-0.015700 |
-0.106000 |
0.34500 |
NA |
NA |
NA |
NA |
NA |
Regulation of mRNA stability by proteins that bind AU-rich elements |
19 |
NA |
NA |
0.2500 |
0.09380 |
-0.035100 |
0.086900 |
-0.015200 |
-0.21200 |
NA |
NA |
NA |
NA |
NA |
Regulation of mitotic cell cycle |
20 |
NA |
NA |
0.4410 |
0.15600 |
-0.137000 |
0.153000 |
-0.039500 |
-0.35500 |
NA |
NA |
NA |
NA |
NA |
Regulation of necroptotic cell death |
6 |
NA |
NA |
0.3000 |
-0.10200 |
0.034900 |
-0.188000 |
-0.207000 |
-0.01740 |
NA |
NA |
NA |
NA |
NA |
Reproduction |
11 |
NA |
NA |
0.2770 |
0.05030 |
-0.069100 |
0.133000 |
-0.023000 |
-0.22600 |
NA |
NA |
NA |
NA |
NA |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
7 |
NA |
NA |
0.4520 |
0.28400 |
-0.097500 |
0.112000 |
NaN |
-0.31800 |
NA |
NA |
NA |
NA |
NA |
Resolution of Abasic Sites (AP sites) |
9 |
NA |
NA |
0.4170 |
0.28400 |
-0.097500 |
0.018900 |
NaN |
-0.28900 |
NA |
NA |
NA |
NA |
NA |
Resolution of Sister Chromatid Cohesion |
30 |
NA |
NA |
0.4820 |
0.22500 |
-0.114000 |
0.194000 |
-0.025000 |
-0.36100 |
NA |
NA |
NA |
NA |
NA |
Respiratory electron transport |
25 |
NA |
NA |
0.3830 |
-0.05310 |
0.042800 |
-0.056100 |
0.095300 |
-0.36100 |
NA |
NA |
NA |
NA |
NA |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
34 |
NA |
NA |
0.3690 |
-0.11500 |
0.042800 |
-0.080800 |
0.104000 |
-0.32200 |
NA |
NA |
NA |
NA |
NA |
Response of EIF2AK4 (GCN2) to amino acid deficiency |
51 |
NA |
NA |
0.3930 |
0.15200 |
0.184000 |
-0.092200 |
-0.156000 |
-0.25400 |
NA |
NA |
NA |
NA |
NA |
Response of Mtb to phagocytosis |
7 |
NA |
NA |
0.4480 |
0.15200 |
0.033600 |
0.051400 |
-0.207000 |
-0.36200 |
NA |
NA |
NA |
NA |
NA |
Response to elevated platelet cytosolic Ca2+ |
27 |
NA |
NA |
0.5290 |
-0.34000 |
0.167000 |
-0.097800 |
0.050600 |
0.35200 |
NA |
NA |
NA |
NA |
NA |
Retinoid metabolism and transport |
7 |
NA |
NA |
0.5370 |
-0.34500 |
0.099800 |
-0.087400 |
-0.003940 |
0.38900 |
NA |
NA |
NA |
NA |
NA |
Rev-mediated nuclear export of HIV RNA |
6 |
NA |
NA |
0.7900 |
0.29300 |
-0.177000 |
0.190000 |
-0.108000 |
-0.67700 |
NA |
NA |
NA |
NA |
NA |
Rho GTPase cycle |
9 |
NA |
NA |
0.2170 |
-0.02940 |
0.030300 |
-0.111000 |
0.036900 |
0.17800 |
NA |
NA |
NA |
NA |
NA |
Ribosomal scanning and start codon recognition |
26 |
NA |
NA |
0.3700 |
0.12600 |
0.159000 |
0.086600 |
-0.127000 |
-0.26800 |
NA |
NA |
NA |
NA |
NA |
S Phase |
34 |
NA |
NA |
0.4830 |
0.28900 |
-0.102000 |
0.099600 |
-0.072600 |
-0.35200 |
NA |
NA |
NA |
NA |
NA |
SARS-CoV Infections |
29 |
NA |
NA |
0.0509 |
-0.02870 |
-0.026300 |
0.019200 |
0.020400 |
-0.01700 |
NA |
NA |
NA |
NA |
NA |
SARS-CoV-1 Infection |
6 |
NA |
NA |
0.3170 |
-0.14000 |
NaN |
-0.188000 |
-0.207000 |
-0.05210 |
NA |
NA |
NA |
NA |
NA |
SARS-CoV-2 Infection |
9 |
NA |
NA |
0.2840 |
-0.26700 |
NaN |
0.008550 |
-0.052000 |
0.08180 |
NA |
NA |
NA |
NA |
NA |
SCF(Skp2)-mediated degradation of p27/p21 |
13 |
NA |
NA |
0.2690 |
0.02830 |
-0.126000 |
0.058300 |
-0.039500 |
-0.22500 |
NA |
NA |
NA |
NA |
NA |
SCF-beta-TrCP mediated degradation of Emi1 |
10 |
NA |
NA |
0.2440 |
-0.08540 |
-0.079700 |
0.101000 |
-0.039500 |
-0.18400 |
NA |
NA |
NA |
NA |
NA |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
5 |
NA |
NA |
0.4100 |
-0.32200 |
NaN |
-0.074800 |
NaN |
0.24300 |
NA |
NA |
NA |
NA |
NA |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
6 |
NA |
NA |
0.5730 |
0.35500 |
-0.062300 |
0.147000 |
NaN |
-0.42000 |
NA |
NA |
NA |
NA |
NA |
SLBP independent Processing of Histone Pre-mRNAs |
5 |
NA |
NA |
0.6480 |
0.35700 |
-0.086300 |
0.147000 |
NaN |
-0.51300 |
NA |
NA |
NA |
NA |
NA |
SLC transporter disorders |
6 |
NA |
NA |
0.2090 |
0.09510 |
NaN |
0.086600 |
0.156000 |
0.05120 |
NA |
NA |
NA |
NA |
NA |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
7 |
NA |
NA |
0.3290 |
0.19900 |
0.109000 |
-0.107000 |
-0.173000 |
-0.12400 |
NA |
NA |
NA |
NA |
NA |
SRP-dependent cotranslational protein targeting to membrane |
57 |
NA |
NA |
0.3640 |
0.03160 |
0.184000 |
-0.074200 |
-0.085300 |
-0.29100 |
NA |
NA |
NA |
NA |
NA |
SUMO E3 ligases SUMOylate target proteins |
23 |
NA |
NA |
0.4320 |
0.22100 |
-0.102000 |
0.139000 |
-0.217000 |
-0.24600 |
NA |
NA |
NA |
NA |
NA |
SUMOylation |
25 |
NA |
NA |
0.4240 |
0.22100 |
-0.100000 |
0.131000 |
-0.217000 |
-0.23800 |
NA |
NA |
NA |
NA |
NA |
SUMOylation of DNA damage response and repair proteins |
6 |
NA |
NA |
0.4050 |
0.32100 |
-0.084100 |
0.095800 |
NaN |
-0.21100 |
NA |
NA |
NA |
NA |
NA |
SUMOylation of DNA replication proteins |
9 |
NA |
NA |
0.4500 |
0.28000 |
-0.124000 |
0.161000 |
NaN |
-0.28800 |
NA |
NA |
NA |
NA |
NA |
SUMOylation of RNA binding proteins |
5 |
NA |
NA |
0.3730 |
0.31800 |
NaN |
0.086600 |
NaN |
-0.17400 |
NA |
NA |
NA |
NA |
NA |
SUMOylation of transcription cofactors |
6 |
NA |
NA |
0.3750 |
0.04600 |
NaN |
0.133000 |
-0.217000 |
-0.27100 |
NA |
NA |
NA |
NA |
NA |
Scavenging by Class A Receptors |
5 |
NA |
NA |
0.6330 |
-0.35400 |
0.167000 |
-0.073500 |
NaN |
0.49200 |
NA |
NA |
NA |
NA |
NA |
Sealing of the nuclear envelope (NE) by ESCRT-III |
8 |
NA |
NA |
0.4600 |
0.17100 |
-0.045100 |
0.182000 |
0.018500 |
-0.38200 |
NA |
NA |
NA |
NA |
NA |
Selective autophagy |
15 |
NA |
NA |
0.3020 |
0.05550 |
-0.040200 |
-0.030200 |
-0.207000 |
-0.20700 |
NA |
NA |
NA |
NA |
NA |
Selenoamino acid metabolism |
51 |
NA |
NA |
0.3940 |
0.16200 |
0.184000 |
-0.093100 |
-0.156000 |
-0.25000 |
NA |
NA |
NA |
NA |
NA |
Selenocysteine synthesis |
48 |
NA |
NA |
0.4290 |
0.16200 |
0.184000 |
-0.131000 |
-0.156000 |
-0.28600 |
NA |
NA |
NA |
NA |
NA |
Sema4D in semaphorin signaling |
5 |
NA |
NA |
0.5230 |
-0.34400 |
NaN |
-0.158000 |
-0.015800 |
0.36000 |
NA |
NA |
NA |
NA |
NA |
Semaphorin interactions |
16 |
NA |
NA |
0.3550 |
-0.23200 |
-0.063000 |
-0.061300 |
0.022100 |
0.25300 |
NA |
NA |
NA |
NA |
NA |
Separation of Sister Chromatids |
38 |
NA |
NA |
0.4560 |
0.19100 |
-0.114000 |
0.172000 |
-0.032500 |
-0.35700 |
NA |
NA |
NA |
NA |
NA |
Signaling by BRAF and RAF fusions |
8 |
NA |
NA |
0.4050 |
-0.26300 |
0.112000 |
0.131000 |
-0.137000 |
0.21600 |
NA |
NA |
NA |
NA |
NA |
Signaling by EGFR |
8 |
NA |
NA |
0.3090 |
NaN |
NaN |
-0.084800 |
-0.207000 |
0.21300 |
NA |
NA |
NA |
NA |
NA |
Signaling by EGFR in Cancer |
5 |
NA |
NA |
0.4610 |
0.32100 |
-0.063000 |
-0.188000 |
-0.207000 |
-0.16600 |
NA |
NA |
NA |
NA |
NA |
Signaling by ERBB2 |
7 |
NA |
NA |
0.4590 |
0.32100 |
-0.063000 |
-0.188000 |
-0.207000 |
-0.16000 |
NA |
NA |
NA |
NA |
NA |
Signaling by ERBB4 |
12 |
NA |
NA |
0.2810 |
-0.25200 |
0.051500 |
-0.055300 |
-0.067800 |
0.07400 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR |
16 |
NA |
NA |
0.1840 |
0.08510 |
0.077500 |
-0.118000 |
-0.073100 |
-0.03640 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR in disease |
7 |
NA |
NA |
0.2200 |
0.02980 |
0.077500 |
-0.184000 |
0.061700 |
-0.06190 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR1 |
7 |
NA |
NA |
0.2560 |
-0.09040 |
NaN |
-0.084800 |
-0.207000 |
0.08310 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR2 |
15 |
NA |
NA |
0.2110 |
0.12000 |
0.077500 |
-0.118000 |
-0.073100 |
-0.06800 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR2 IIIa TM |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR2 in disease |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR3 |
6 |
NA |
NA |
0.2250 |
NaN |
NaN |
-0.084800 |
-0.207000 |
0.01790 |
NA |
NA |
NA |
NA |
NA |
Signaling by FGFR4 |
6 |
NA |
NA |
0.2250 |
NaN |
NaN |
-0.084800 |
-0.207000 |
0.01790 |
NA |
NA |
NA |
NA |
NA |
Signaling by Hedgehog |
12 |
NA |
NA |
0.3310 |
-0.30500 |
-0.019700 |
0.043400 |
-0.039500 |
0.11300 |
NA |
NA |
NA |
NA |
NA |
Signaling by Insulin receptor |
6 |
NA |
NA |
0.4130 |
-0.15000 |
NaN |
-0.089400 |
0.152000 |
0.34300 |
NA |
NA |
NA |
NA |
NA |
Signaling by Interleukins |
62 |
NA |
NA |
0.1500 |
-0.09230 |
-0.025100 |
0.059000 |
-0.059200 |
0.08030 |
NA |
NA |
NA |
NA |
NA |
Signaling by Ligand-Responsive EGFR Variants in Cancer |
5 |
NA |
NA |
0.4610 |
0.32100 |
-0.063000 |
-0.188000 |
-0.207000 |
-0.16600 |
NA |
NA |
NA |
NA |
NA |
Signaling by MET |
10 |
NA |
NA |
0.3410 |
-0.23800 |
0.156000 |
-0.101000 |
-0.061900 |
0.14400 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH |
29 |
NA |
NA |
0.1480 |
0.02150 |
-0.013600 |
0.115000 |
-0.058500 |
-0.06780 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH1 |
12 |
NA |
NA |
0.2300 |
-0.07270 |
0.085400 |
0.059300 |
-0.185000 |
0.05120 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer |
10 |
NA |
NA |
0.2250 |
-0.07270 |
0.085400 |
0.059300 |
-0.185000 |
-0.01530 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH1 PEST Domain Mutants in Cancer |
10 |
NA |
NA |
0.2250 |
-0.07270 |
0.085400 |
0.059300 |
-0.185000 |
-0.01530 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH1 in Cancer |
10 |
NA |
NA |
0.2250 |
-0.07270 |
0.085400 |
0.059300 |
-0.185000 |
-0.01530 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH2 |
6 |
NA |
NA |
0.3220 |
-0.15900 |
NaN |
-0.188000 |
-0.207000 |
0.00744 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH3 |
11 |
NA |
NA |
0.2870 |
0.11800 |
-0.044500 |
0.063700 |
-0.207000 |
-0.14000 |
NA |
NA |
NA |
NA |
NA |
Signaling by NOTCH4 |
14 |
NA |
NA |
0.1690 |
-0.14600 |
-0.070500 |
0.043400 |
0.018500 |
-0.01340 |
NA |
NA |
NA |
NA |
NA |
Signaling by NTRK1 (TRKA) |
17 |
NA |
NA |
0.4130 |
-0.22700 |
0.080400 |
-0.022800 |
0.026900 |
0.33300 |
NA |
NA |
NA |
NA |
NA |
Signaling by NTRKs |
21 |
NA |
NA |
0.3850 |
-0.22700 |
0.080400 |
-0.012600 |
0.026900 |
0.29900 |
NA |
NA |
NA |
NA |
NA |
Signaling by Non-Receptor Tyrosine Kinases |
11 |
NA |
NA |
0.2440 |
0.11700 |
0.044600 |
-0.009230 |
-0.207000 |
-0.02950 |
NA |
NA |
NA |
NA |
NA |
Signaling by PDGF |
11 |
NA |
NA |
0.4890 |
-0.29600 |
0.118000 |
-0.073400 |
-0.022300 |
0.36200 |
NA |
NA |
NA |
NA |
NA |
Signaling by PTK6 |
11 |
NA |
NA |
0.2440 |
0.11700 |
0.044600 |
-0.009230 |
-0.207000 |
-0.02950 |
NA |
NA |
NA |
NA |
NA |
Signaling by RAS mutants |
6 |
NA |
NA |
0.2330 |
-0.20800 |
NaN |
0.097100 |
NaN |
0.03920 |
NA |
NA |
NA |
NA |
NA |
Signaling by ROBO receptors |
68 |
NA |
NA |
0.3360 |
0.15400 |
0.168000 |
-0.090400 |
-0.129000 |
-0.19100 |
NA |
NA |
NA |
NA |
NA |
Signaling by Receptor Tyrosine Kinases |
69 |
NA |
NA |
0.3340 |
-0.18400 |
0.073300 |
-0.088600 |
0.015800 |
0.25400 |
NA |
NA |
NA |
NA |
NA |
Signaling by Retinoic Acid |
7 |
NA |
NA |
0.4330 |
0.00832 |
NaN |
NaN |
0.167000 |
0.39900 |
NA |
NA |
NA |
NA |
NA |
Signaling by Rho GTPases |
55 |
NA |
NA |
0.1660 |
-0.04700 |
-0.095900 |
0.093700 |
0.031900 |
-0.08040 |
NA |
NA |
NA |
NA |
NA |
Signaling by TGF-beta Receptor Complex |
18 |
NA |
NA |
0.2160 |
0.11600 |
0.021200 |
0.036900 |
-0.119000 |
-0.13100 |
NA |
NA |
NA |
NA |
NA |
Signaling by TGFB family members |
22 |
NA |
NA |
0.1660 |
0.09920 |
0.034100 |
0.016900 |
-0.119000 |
0.04680 |
NA |
NA |
NA |
NA |
NA |
Signaling by VEGF |
11 |
NA |
NA |
0.2970 |
-0.14900 |
0.023100 |
-0.139000 |
NaN |
0.21500 |
NA |
NA |
NA |
NA |
NA |
Signaling by WNT |
35 |
NA |
NA |
0.1450 |
-0.01230 |
0.074900 |
-0.082300 |
-0.040100 |
0.08290 |
NA |
NA |
NA |
NA |
NA |
Signaling by moderate kinase activity BRAF mutants |
6 |
NA |
NA |
0.2330 |
-0.20800 |
NaN |
0.097100 |
NaN |
0.03920 |
NA |
NA |
NA |
NA |
NA |
Signaling by the B Cell Receptor (BCR) |
15 |
NA |
NA |
0.2850 |
-0.27000 |
0.063900 |
0.042900 |
-0.008370 |
0.04540 |
NA |
NA |
NA |
NA |
NA |
Signaling downstream of RAS mutants |
6 |
NA |
NA |
0.2330 |
-0.20800 |
NaN |
0.097100 |
NaN |
0.03920 |
NA |
NA |
NA |
NA |
NA |
Smooth Muscle Contraction |
11 |
NA |
NA |
0.5620 |
-0.27000 |
0.100000 |
-0.150000 |
-0.064700 |
0.45500 |
NA |
NA |
NA |
NA |
NA |
Spry regulation of FGF signaling |
5 |
NA |
NA |
0.2550 |
NaN |
NaN |
-0.084800 |
-0.207000 |
-0.12100 |
NA |
NA |
NA |
NA |
NA |
Stabilization of p53 |
9 |
NA |
NA |
0.1800 |
-0.00262 |
-0.019700 |
0.070300 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Stimuli-sensing channels |
8 |
NA |
NA |
0.4230 |
-0.35300 |
NaN |
-0.141000 |
-0.123000 |
0.13900 |
NA |
NA |
NA |
NA |
NA |
Switching of origins to a post-replicative state |
19 |
NA |
NA |
0.4670 |
0.25900 |
-0.120000 |
0.077000 |
-0.039500 |
-0.36000 |
NA |
NA |
NA |
NA |
NA |
Synthesis of DNA |
27 |
NA |
NA |
0.4730 |
0.27300 |
-0.113000 |
0.091600 |
-0.039500 |
-0.35600 |
NA |
NA |
NA |
NA |
NA |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes |
7 |
NA |
NA |
0.4740 |
0.11500 |
-0.180000 |
0.025500 |
-0.207000 |
-0.36800 |
NA |
NA |
NA |
NA |
NA |
TCF dependent signaling in response to WNT |
24 |
NA |
NA |
0.1330 |
0.04420 |
0.074900 |
-0.042900 |
-0.068400 |
0.06060 |
NA |
NA |
NA |
NA |
NA |
TCR signaling |
14 |
NA |
NA |
0.2370 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
0.00103 |
NA |
NA |
NA |
NA |
NA |
TGF-beta receptor signaling activates SMADs |
12 |
NA |
NA |
0.1620 |
-0.00876 |
0.015800 |
-0.026800 |
-0.091100 |
-0.13100 |
NA |
NA |
NA |
NA |
NA |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
5 |
NA |
NA |
0.4880 |
NaN |
NaN |
-0.188000 |
-0.115000 |
-0.43500 |
NA |
NA |
NA |
NA |
NA |
TNFR2 non-canonical NF-kB pathway |
11 |
NA |
NA |
0.2140 |
-0.12300 |
0.043500 |
0.006150 |
-0.058600 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
TP53 Regulates Metabolic Genes |
11 |
NA |
NA |
0.5360 |
-0.17900 |
0.060600 |
0.215000 |
0.156000 |
-0.42600 |
NA |
NA |
NA |
NA |
NA |
TP53 Regulates Transcription of Cell Cycle Genes |
10 |
NA |
NA |
0.4050 |
0.18600 |
-0.117000 |
0.134000 |
NaN |
-0.31300 |
NA |
NA |
NA |
NA |
NA |
TP53 Regulates Transcription of Cell Death Genes |
7 |
NA |
NA |
0.2020 |
0.05490 |
-0.000659 |
0.050900 |
-0.151000 |
-0.11200 |
NA |
NA |
NA |
NA |
NA |
TP53 Regulates Transcription of DNA Repair Genes |
11 |
NA |
NA |
0.1450 |
0.08470 |
-0.029100 |
-0.037500 |
0.061700 |
-0.08910 |
NA |
NA |
NA |
NA |
NA |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest |
7 |
NA |
NA |
0.3730 |
0.22900 |
-0.107000 |
0.140000 |
NaN |
-0.23500 |
NA |
NA |
NA |
NA |
NA |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
TRIF(TICAM1)-mediated TLR4 signaling |
13 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.000265 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Tat-mediated HIV elongation arrest and recovery |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Tat-mediated elongation of the HIV-1 transcript |
8 |
NA |
NA |
0.2410 |
0.11500 |
0.023100 |
-0.184000 |
0.061700 |
-0.08340 |
NA |
NA |
NA |
NA |
NA |
Telomere C-strand (Lagging Strand) Synthesis |
5 |
NA |
NA |
0.4560 |
0.30200 |
-0.079700 |
0.176000 |
NaN |
-0.28100 |
NA |
NA |
NA |
NA |
NA |
Telomere Extension By Telomerase |
5 |
NA |
NA |
0.4750 |
0.33100 |
-0.044800 |
0.019100 |
0.068300 |
-0.33000 |
NA |
NA |
NA |
NA |
NA |
Telomere Maintenance |
15 |
NA |
NA |
0.3490 |
0.23600 |
-0.042300 |
0.007600 |
0.065200 |
-0.24500 |
NA |
NA |
NA |
NA |
NA |
Termination of translesion DNA synthesis |
9 |
NA |
NA |
0.5170 |
0.27900 |
-0.104000 |
-0.005920 |
-0.207000 |
-0.36800 |
NA |
NA |
NA |
NA |
NA |
The citric acid (TCA) cycle and respiratory electron transport |
42 |
NA |
NA |
0.3610 |
-0.06770 |
0.009690 |
-0.046000 |
0.104000 |
-0.33600 |
NA |
NA |
NA |
NA |
NA |
The role of GTSE1 in G2/M progression after G2 checkpoint |
16 |
NA |
NA |
0.4510 |
0.23800 |
-0.116000 |
0.168000 |
-0.066900 |
-0.31700 |
NA |
NA |
NA |
NA |
NA |
The role of Nef in HIV-1 replication and disease pathogenesis |
7 |
NA |
NA |
0.4910 |
-0.23100 |
NaN |
-0.198000 |
0.086700 |
0.37600 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 10 (TLR10) Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 2 (TLR2) Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 3 (TLR3) Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 4 (TLR4) Cascade |
14 |
NA |
NA |
0.2300 |
-0.23000 |
-0.003950 |
-0.000265 |
0.001980 |
-0.00616 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 5 (TLR5) Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 7/8 (TLR7/8) Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor 9 (TLR9) Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor TLR1:TLR2 Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll Like Receptor TLR6:TLR2 Cascade |
12 |
NA |
NA |
0.2310 |
-0.23000 |
-0.003950 |
-0.004950 |
0.001980 |
-0.02060 |
NA |
NA |
NA |
NA |
NA |
Toll-like Receptor Cascades |
19 |
NA |
NA |
0.2480 |
-0.23500 |
0.028600 |
-0.042300 |
0.014100 |
0.05920 |
NA |
NA |
NA |
NA |
NA |
Trafficking of AMPA receptors |
6 |
NA |
NA |
0.5750 |
0.14200 |
NaN |
0.123000 |
0.151000 |
0.52200 |
NA |
NA |
NA |
NA |
NA |
Transcription of the HIV genome |
9 |
NA |
NA |
0.2340 |
0.11500 |
0.015000 |
-0.184000 |
0.043500 |
-0.07540 |
NA |
NA |
NA |
NA |
NA |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) |
15 |
NA |
NA |
0.2420 |
0.14700 |
-0.040400 |
0.017200 |
-0.021800 |
-0.18600 |
NA |
NA |
NA |
NA |
NA |
Transcriptional Regulation by E2F6 |
5 |
NA |
NA |
0.5390 |
0.40300 |
-0.092900 |
0.244000 |
NaN |
-0.24500 |
NA |
NA |
NA |
NA |
NA |
Transcriptional Regulation by MECP2 |
9 |
NA |
NA |
0.3450 |
-0.18600 |
-0.051200 |
0.087900 |
-0.206000 |
0.17800 |
NA |
NA |
NA |
NA |
NA |
Transcriptional Regulation by TP53 |
53 |
NA |
NA |
0.2440 |
0.04770 |
-0.060900 |
0.097700 |
0.032500 |
-0.20700 |
NA |
NA |
NA |
NA |
NA |
Transcriptional Regulation by VENTX |
5 |
NA |
NA |
0.3800 |
0.17300 |
-0.075800 |
0.076400 |
NaN |
-0.32100 |
NA |
NA |
NA |
NA |
NA |
Transcriptional activation of mitochondrial biogenesis |
8 |
NA |
NA |
0.2400 |
-0.02020 |
0.007250 |
0.077300 |
-0.206000 |
-0.09390 |
NA |
NA |
NA |
NA |
NA |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
9 |
NA |
NA |
0.3230 |
0.19000 |
0.022900 |
0.028100 |
-0.185000 |
-0.18100 |
NA |
NA |
NA |
NA |
NA |
Transcriptional regulation by RUNX1 |
23 |
NA |
NA |
0.0815 |
-0.02660 |
0.063000 |
-0.014700 |
-0.039500 |
-0.01370 |
NA |
NA |
NA |
NA |
NA |
Transcriptional regulation by RUNX2 |
19 |
NA |
NA |
0.2000 |
-0.13000 |
-0.097400 |
0.048700 |
-0.039500 |
0.09780 |
NA |
NA |
NA |
NA |
NA |
Transcriptional regulation by RUNX3 |
17 |
NA |
NA |
0.1330 |
0.01580 |
0.076900 |
0.030200 |
-0.103000 |
-0.00469 |
NA |
NA |
NA |
NA |
NA |
Transcriptional regulation by small RNAs |
8 |
NA |
NA |
0.2950 |
0.14400 |
0.077500 |
0.059800 |
-0.023000 |
-0.23600 |
NA |
NA |
NA |
NA |
NA |
Transcriptional regulation of white adipocyte differentiation |
5 |
NA |
NA |
0.3600 |
-0.05640 |
NaN |
0.277000 |
-0.199000 |
0.10200 |
NA |
NA |
NA |
NA |
NA |
Translation |
101 |
NA |
NA |
0.3500 |
0.12300 |
0.173000 |
-0.033700 |
-0.077800 |
-0.26500 |
NA |
NA |
NA |
NA |
NA |
Translation initiation complex formation |
26 |
NA |
NA |
0.3880 |
0.13300 |
0.159000 |
0.086600 |
-0.127000 |
-0.29000 |
NA |
NA |
NA |
NA |
NA |
Translesion Synthesis by POLH |
6 |
NA |
NA |
0.4640 |
0.28200 |
-0.079700 |
-0.005920 |
-0.207000 |
-0.29400 |
NA |
NA |
NA |
NA |
NA |
Translesion synthesis by POLI |
6 |
NA |
NA |
0.4640 |
0.28200 |
-0.079700 |
-0.005920 |
-0.207000 |
-0.29400 |
NA |
NA |
NA |
NA |
NA |
Translesion synthesis by POLK |
6 |
NA |
NA |
0.4640 |
0.28200 |
-0.079700 |
-0.005920 |
-0.207000 |
-0.29400 |
NA |
NA |
NA |
NA |
NA |
Translesion synthesis by REV1 |
6 |
NA |
NA |
0.4640 |
0.28200 |
-0.079700 |
-0.005920 |
-0.207000 |
-0.29400 |
NA |
NA |
NA |
NA |
NA |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template |
9 |
NA |
NA |
0.5170 |
0.27900 |
-0.104000 |
-0.005920 |
-0.207000 |
-0.36800 |
NA |
NA |
NA |
NA |
NA |
Translocation of SLC2A4 (GLUT4) to the plasma membrane |
7 |
NA |
NA |
0.4840 |
-0.35900 |
NaN |
0.075600 |
0.057900 |
0.31100 |
NA |
NA |
NA |
NA |
NA |
Transmission across Chemical Synapses |
19 |
NA |
NA |
0.3190 |
0.00162 |
0.019700 |
-0.081300 |
0.090700 |
0.29400 |
NA |
NA |
NA |
NA |
NA |
Transport of Mature Transcript to Cytoplasm |
15 |
NA |
NA |
0.3950 |
0.25200 |
-0.019700 |
0.083900 |
-0.122000 |
-0.26400 |
NA |
NA |
NA |
NA |
NA |
Transport of Mature mRNA derived from an Intron-Containing Transcript |
14 |
NA |
NA |
0.4110 |
0.24200 |
-0.024700 |
0.083900 |
-0.122000 |
-0.29500 |
NA |
NA |
NA |
NA |
NA |
Transport of bile salts and organic acids, metal ions and amine compounds |
5 |
NA |
NA |
0.1520 |
-0.14300 |
NaN |
-0.011800 |
0.001320 |
0.05080 |
NA |
NA |
NA |
NA |
NA |
Transport of inorganic cations/anions and amino acids/oligopeptides |
12 |
NA |
NA |
0.2800 |
0.05980 |
NaN |
-0.162000 |
0.156000 |
0.15500 |
NA |
NA |
NA |
NA |
NA |
Transport to the Golgi and subsequent modification |
13 |
NA |
NA |
0.2100 |
-0.13500 |
NaN |
-0.049900 |
-0.005630 |
0.15200 |
NA |
NA |
NA |
NA |
NA |
UCH proteinases |
14 |
NA |
NA |
0.2420 |
0.17000 |
-0.001980 |
0.003080 |
-0.020500 |
-0.17100 |
NA |
NA |
NA |
NA |
NA |
Ub-specific processing proteases |
20 |
NA |
NA |
0.3470 |
0.25700 |
-0.064100 |
0.094700 |
-0.072600 |
-0.18900 |
NA |
NA |
NA |
NA |
NA |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
Ubiquitin-dependent degradation of Cyclin D |
10 |
NA |
NA |
0.1260 |
-0.00262 |
-0.019700 |
0.017100 |
-0.039500 |
-0.11700 |
NA |
NA |
NA |
NA |
NA |
Unwinding of DNA |
7 |
NA |
NA |
0.5940 |
0.39300 |
-0.096800 |
0.095800 |
NaN |
-0.42400 |
NA |
NA |
NA |
NA |
NA |
Uptake and actions of bacterial toxins |
8 |
NA |
NA |
0.1420 |
-0.06720 |
-0.063000 |
0.008920 |
-0.043500 |
0.09900 |
NA |
NA |
NA |
NA |
NA |
VEGFA-VEGFR2 Pathway |
10 |
NA |
NA |
0.3120 |
-0.16000 |
0.023100 |
-0.139000 |
NaN |
0.22800 |
NA |
NA |
NA |
NA |
NA |
VEGFR2 mediated vascular permeability |
6 |
NA |
NA |
0.2430 |
-0.15800 |
0.023100 |
-0.092700 |
NaN |
0.15800 |
NA |
NA |
NA |
NA |
NA |
Vasopressin regulates renal water homeostasis via Aquaporins |
5 |
NA |
NA |
0.4840 |
-0.26700 |
NaN |
NaN |
-0.025000 |
0.40300 |
NA |
NA |
NA |
NA |
NA |
Vesicle-mediated transport |
65 |
NA |
NA |
0.2570 |
-0.21300 |
0.001010 |
-0.029400 |
0.025600 |
0.13800 |
NA |
NA |
NA |
NA |
NA |
Vif-mediated degradation of APOBEC3G |
9 |
NA |
NA |
0.0722 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.03710 |
NA |
NA |
NA |
NA |
NA |
Viral Messenger RNA Synthesis |
7 |
NA |
NA |
0.2300 |
0.15400 |
0.077500 |
-0.048700 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
Viral mRNA Translation |
49 |
NA |
NA |
0.4240 |
0.16200 |
0.184000 |
-0.131000 |
-0.144000 |
-0.28600 |
NA |
NA |
NA |
NA |
NA |
Visual phototransduction |
11 |
NA |
NA |
0.4620 |
-0.34800 |
0.099800 |
-0.079200 |
0.023000 |
0.27500 |
NA |
NA |
NA |
NA |
NA |
Vpu mediated degradation of CD4 |
9 |
NA |
NA |
0.2850 |
-0.22800 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
mRNA 3'-end processing |
12 |
NA |
NA |
0.4000 |
0.22600 |
-0.024700 |
0.082200 |
-0.122000 |
-0.29500 |
NA |
NA |
NA |
NA |
NA |
mRNA Capping |
5 |
NA |
NA |
0.2560 |
0.07050 |
0.077500 |
-0.184000 |
0.061700 |
-0.13000 |
NA |
NA |
NA |
NA |
NA |
mRNA Splicing |
55 |
NA |
NA |
0.4040 |
0.21300 |
-0.039200 |
0.098600 |
-0.002920 |
-0.32700 |
NA |
NA |
NA |
NA |
NA |
mRNA Splicing - Major Pathway |
54 |
NA |
NA |
0.4060 |
0.21700 |
-0.039200 |
0.098600 |
-0.002920 |
-0.32700 |
NA |
NA |
NA |
NA |
NA |
mRNA Splicing - Minor Pathway |
19 |
NA |
NA |
0.4990 |
0.24400 |
-0.037100 |
0.053500 |
0.061700 |
-0.42600 |
NA |
NA |
NA |
NA |
NA |
mRNA decay by 5' to 3' exoribonuclease |
6 |
NA |
NA |
0.5540 |
0.21400 |
-0.037800 |
0.145000 |
NaN |
-0.48800 |
NA |
NA |
NA |
NA |
NA |
p53-Dependent G1 DNA Damage Response |
11 |
NA |
NA |
0.2930 |
0.13500 |
-0.086900 |
0.055500 |
-0.039500 |
-0.23500 |
NA |
NA |
NA |
NA |
NA |
p53-Dependent G1/S DNA damage checkpoint |
11 |
NA |
NA |
0.2930 |
0.13500 |
-0.086900 |
0.055500 |
-0.039500 |
-0.23500 |
NA |
NA |
NA |
NA |
NA |
p53-Independent DNA Damage Response |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
p53-Independent G1/S DNA damage checkpoint |
8 |
NA |
NA |
0.1710 |
-0.00262 |
-0.019700 |
0.043400 |
-0.039500 |
-0.15900 |
NA |
NA |
NA |
NA |
NA |
p75 NTR receptor-mediated signalling |
13 |
NA |
NA |
0.3230 |
-0.25700 |
-0.110000 |
-0.059500 |
-0.059300 |
0.13800 |
NA |
NA |
NA |
NA |
NA |
p75NTR recruits signalling complexes |
5 |
NA |
NA |
0.3890 |
-0.27000 |
NaN |
-0.188000 |
-0.207000 |
0.01970 |
NA |
NA |
NA |
NA |
NA |
p75NTR signals via NF-kB |
5 |
NA |
NA |
0.3890 |
-0.27000 |
NaN |
-0.188000 |
-0.207000 |
0.01970 |
NA |
NA |
NA |
NA |
NA |
rRNA modification in the nucleus and cytosol |
19 |
NA |
NA |
0.4160 |
0.21900 |
0.116000 |
0.094900 |
-0.112000 |
-0.30000 |
NA |
NA |
NA |
NA |
NA |
snRNP Assembly |
8 |
NA |
NA |
0.6830 |
0.38300 |
-0.089800 |
0.132000 |
NaN |
-0.54200 |
NA |
NA |
NA |
NA |
NA |
tRNA processing |
5 |
NA |
NA |
0.5820 |
0.28100 |
0.047300 |
0.181000 |
-0.108000 |
-0.46100 |
NA |
NA |
NA |
NA |
NA |
tRNA processing in the nucleus |
5 |
NA |
NA |
0.5820 |
0.28100 |
0.047300 |
0.181000 |
-0.108000 |
-0.46100 |
NA |
NA |
NA |
NA |
NA |
trans-Golgi Network Vesicle Budding |
6 |
NA |
NA |
0.4310 |
-0.30400 |
0.167000 |
-0.223000 |
0.108000 |
-0.06290 |
NA |
NA |
NA |
NA |
NA |
Detailed Gene set reports
B-WICH complex positively regulates rRNA expression
B-WICH complex positively regulates rRNA expression
setSize |
8 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.274 |
s.clus_0 |
0.111 |
s.clus_1 |
-0.0101 |
s.clus_2 |
0.0365 |
s.clus_3 |
-0.0309 |
s.clus_4 |
-0.246 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 18 rows containing non-finite values (stat_ydensity).
Warning: Removed 18 rows containing non-finite values (stat_boxplot).
Top 20 genes
POLR2F |
-615 |
302 |
DDX21 |
-437 |
187 |
POLR2H |
-284 |
140 |
BAZ1B |
-170 |
139 |
DEK |
-419 |
50 |
Click HERE to show all gene set members
All member genes
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
DDX21 |
187 |
NA |
NA |
NA |
-437 |
POLR1E |
149 |
NA |
NA |
NA |
NA |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
BAZ1B |
139 |
-36 |
27 |
NA |
-170 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
Developmental Biology
Developmental Biology
setSize |
157 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.181 |
s.clus_0 |
-0.0591 |
s.clus_1 |
0.138 |
s.clus_2 |
-0.0638 |
s.clus_3 |
-0.0597 |
s.clus_4 |
0.0492 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 99 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 149 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 137 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 139 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 114 rows containing missing values
Warning: Removed 149 rows containing non-finite values (stat_density2d).
Warning: Removed 127 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 153 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 149 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 147 rows containing missing values
Warning: Removed 137 rows containing non-finite values (stat_density2d).
Warning: Removed 153 rows containing non-finite values (stat_density2d).
Warning: Removed 122 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 145 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 135 rows containing missing values
Warning: Removed 139 rows containing non-finite values (stat_density2d).
Warning: Removed 149 rows containing non-finite values (stat_density2d).
Warning: Removed 145 rows containing non-finite values (stat_density2d).
Warning: Removed 115 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 138 rows containing missing values
Warning: Removed 114 rows containing non-finite values (stat_density2d).
Warning: Removed 147 rows containing non-finite values (stat_density2d).
Warning: Removed 135 rows containing non-finite values (stat_density2d).
Warning: Removed 138 rows containing non-finite values (stat_density2d).
Warning: Removed 56 rows containing non-finite values (stat_bin).
Warning: Removed 99 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 149 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 137 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 139 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 114 rows containing missing values
Warning: Removed 149 rows containing missing values (geom_point).
Warning: Removed 127 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 153 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 149 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 147 rows containing missing values
Warning: Removed 137 rows containing missing values (geom_point).
Warning: Removed 153 rows containing missing values (geom_point).
Warning: Removed 122 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 145 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 135 rows containing missing values
Warning: Removed 139 rows containing missing values (geom_point).
Warning: Removed 149 rows containing missing values (geom_point).
Warning: Removed 145 rows containing missing values (geom_point).
Warning: Removed 115 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 138 rows containing missing values
Warning: Removed 114 rows containing missing values (geom_point).
Warning: Removed 147 rows containing missing values (geom_point).
Warning: Removed 135 rows containing missing values (geom_point).
Warning: Removed 138 rows containing missing values (geom_point).
Warning: Removed 56 rows containing non-finite values (stat_bin).
Warning in grid.Call.graphics(C_points, x$x, x$y, x$pch, x$size): semi-
transparency is not supported on this device: reported only once per page
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 519 rows containing non-finite values (stat_ydensity).
Warning: Removed 519 rows containing non-finite values (stat_boxplot).
Top 20 genes
RPL32 |
74 |
-201 |
ITGA10 |
48 |
-77 |
TSC22D1 |
45 |
-6 |
Click HERE to show all gene set members
All member genes
MYL6 |
-342 |
NA |
-117 |
NA |
439 |
RNPS1 |
368 |
NA |
NA |
-48 |
-217 |
MYC |
367 |
-12 |
NA |
-60 |
-492 |
TFDP1 |
353 |
NA |
NA |
NA |
-254 |
RPS2 |
322 |
NA |
NA |
-96 |
-397 |
RPL12 |
316 |
NA |
NA |
NA |
-273 |
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
RPS6 |
301 |
41 |
NA |
-97 |
-19 |
RPSA |
292 |
NA |
NA |
-69 |
-530 |
RPL9 |
272 |
NA |
NA |
NA |
NA |
HSP90AA1 |
270 |
-125 |
NA |
NA |
-351 |
RPL4 |
257 |
NA |
NA |
NA |
-280 |
COL6A2 |
-312 |
NA |
-133 |
NA |
403 |
MAGOHB |
219 |
-71 |
NA |
NA |
-475 |
RPL30 |
-307 |
NA |
NA |
NA |
NA |
SMARCA4 |
198 |
NA |
NA |
NA |
-54 |
GSPT1 |
195 |
NA |
NA |
NA |
-120 |
RPLP0 |
186 |
NA |
NA |
-75 |
-474 |
RBM8A |
177 |
NA |
NA |
NA |
-33 |
RPS21 |
-296 |
NA |
177 |
NA |
-6 |
COL6A1 |
-290 |
NA |
-157 |
28 |
236 |
KRT10 |
-289 |
NA |
NA |
NA |
NA |
TSC22D1 |
-287 |
45 |
-6 |
NA |
304 |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
RPL22L1 |
126 |
NA |
-34 |
NA |
-16 |
ITGB1 |
-282 |
NA |
-85 |
NA |
420 |
PFN2 |
115 |
NA |
NA |
NA |
NA |
MAGOH |
105 |
NA |
NA |
NA |
-88 |
MYL12B |
-257 |
NA |
NA |
NA |
174 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
HSPA8 |
45 |
NA |
NA |
NA |
-126 |
CAPNS1 |
-250 |
NA |
NA |
NA |
NA |
ARPC3 |
-242 |
NA |
NA |
NA |
NA |
PSMA3 |
23 |
NA |
NA |
NA |
-105 |
MMP9 |
-226 |
NA |
-39 |
NA |
419 |
RRAS |
-221 |
NA |
-60 |
NA |
383 |
MBP |
-214 |
NA |
NA |
127 |
NA |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
SDCBP |
-205 |
NA |
NA |
NA |
275 |
MYL12A |
-168 |
NA |
-192 |
NA |
393 |
GPC1 |
-156 |
NA |
-21 |
42 |
NA |
NRCAM |
-155 |
NA |
NA |
NA |
262 |
PSENEN |
-149 |
NA |
NA |
NA |
NA |
CTNNA1 |
-131 |
NA |
NA |
NA |
NA |
CHL1 |
-129 |
NA |
NA |
18 |
NA |
RHOC |
-127 |
NA |
-191 |
33 |
NA |
KCNQ2 |
-119 |
NA |
NA |
NA |
NA |
ITGAV |
-103 |
NA |
NA |
NA |
336 |
ITGA1 |
-93 |
NA |
-24 |
-3 |
457 |
MEF2C |
-87 |
NA |
-48 |
NA |
351 |
GAP43 |
-80 |
NA |
-108 |
36 |
101 |
SPTBN1 |
-69 |
NA |
NA |
NA |
242 |
NRP2 |
-45 |
NA |
NA |
NA |
6 |
FGFR1 |
-44 |
NA |
NA |
NA |
134 |
JUN |
-26 |
NA |
NA |
NA |
47 |
ANK2 |
-21 |
NA |
-41 |
198 |
-22 |
NCOR1 |
-18 |
NA |
208 |
-112 |
NA |
ITGA10 |
-16 |
48 |
-77 |
10 |
NA |
RPS18 |
NA |
78 |
NA |
-118 |
NA |
RPL6 |
NA |
76 |
NA |
NA |
NA |
RPL3 |
NA |
75 |
NA |
NA |
NA |
RPL32 |
NA |
74 |
-201 |
NA |
NA |
RPS4X |
NA |
72 |
NA |
NA |
NA |
RPL28 |
NA |
70 |
NA |
NA |
NA |
RPL18A |
NA |
68 |
NA |
-117 |
NA |
RPL10 |
NA |
66 |
NA |
NA |
NA |
RPS14 |
NA |
65 |
NA |
NA |
NA |
EZH2 |
NA |
-133 |
NA |
NA |
-277 |
RPL10A |
NA |
63 |
NA |
-56 |
NA |
RPL27A |
NA |
61 |
NA |
NA |
NA |
RPL15 |
NA |
59 |
NA |
NA |
NA |
RPS12 |
NA |
58 |
NA |
-87 |
-417 |
RPL13 |
NA |
57 |
NA |
NA |
NA |
RPL7A |
NA |
55 |
NA |
NA |
NA |
PSMB2 |
NA |
-92 |
NA |
NA |
NA |
RPL39L |
NA |
-85 |
NA |
NA |
-223 |
RPS27 |
NA |
49 |
NA |
NA |
NA |
RPL23 |
NA |
47 |
NA |
NA |
NA |
RPL26 |
NA |
44 |
NA |
NA |
NA |
LEF1 |
NA |
16 |
NA |
NA |
NA |
PSMA7 |
NA |
NA |
206 |
NA |
-189 |
HSP90AB1 |
NA |
NA |
182 |
-47 |
-489 |
RPL34 |
NA |
NA |
-217 |
NA |
NA |
COL9A3 |
NA |
NA |
81 |
NA |
-11 |
RPL29 |
NA |
NA |
-194 |
NA |
NA |
RPS3A |
NA |
NA |
-190 |
NA |
NA |
HDAC2 |
NA |
NA |
64 |
NA |
-51 |
RPL41 |
NA |
NA |
-184 |
NA |
NA |
MPZ |
NA |
NA |
47 |
1 |
-605 |
RPS20 |
NA |
NA |
31 |
NA |
NA |
CLTB |
NA |
NA |
-173 |
NA |
NA |
PTPN11 |
NA |
NA |
11 |
NA |
NA |
UBC |
NA |
NA |
-146 |
NA |
NA |
PDLIM7 |
NA |
NA |
-88 |
NA |
42 |
UBA52 |
NA |
NA |
NA |
-113 |
NA |
RPS26 |
NA |
NA |
NA |
186 |
NA |
CACNG8 |
NA |
NA |
NA |
182 |
339 |
CRMP1 |
NA |
NA |
NA |
170 |
NA |
RPL23A |
NA |
NA |
NA |
-105 |
-216 |
MMP2 |
NA |
NA |
NA |
-103 |
NA |
TGFB1 |
NA |
NA |
NA |
-100 |
NA |
SEMA5A |
NA |
NA |
NA |
155 |
NA |
PSMB4 |
NA |
NA |
NA |
143 |
NA |
AP2S1 |
NA |
NA |
NA |
138 |
NA |
RPL14 |
NA |
NA |
NA |
-89 |
-203 |
RPL21 |
NA |
NA |
NA |
-84 |
-100 |
TRIO |
NA |
NA |
NA |
113 |
NA |
SCD5 |
NA |
NA |
NA |
110 |
NA |
MYO10 |
NA |
NA |
NA |
85 |
NA |
RPS10 |
NA |
NA |
NA |
-46 |
NA |
SHTN1 |
NA |
NA |
NA |
43 |
NA |
EZR |
NA |
NA |
NA |
-18 |
NA |
SOX10 |
NA |
NA |
NA |
NA |
-608 |
RPS19 |
NA |
NA |
NA |
NA |
-533 |
AP2M1 |
NA |
NA |
NA |
NA |
407 |
RPS16 |
NA |
NA |
NA |
NA |
-413 |
RPS27A |
NA |
NA |
NA |
NA |
-410 |
RPS23 |
NA |
NA |
NA |
NA |
-379 |
RPL8 |
NA |
NA |
NA |
NA |
-361 |
RPLP2 |
NA |
NA |
NA |
NA |
-322 |
PABPC1 |
NA |
NA |
NA |
NA |
-318 |
RPLP1 |
NA |
NA |
NA |
NA |
-312 |
PFN1 |
NA |
NA |
NA |
NA |
-289 |
RPS25 |
NA |
NA |
NA |
NA |
-259 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
RAC1 |
NA |
NA |
NA |
NA |
-213 |
TLN1 |
NA |
NA |
NA |
NA |
319 |
ARPC1A |
NA |
NA |
NA |
NA |
-205 |
ETF1 |
NA |
NA |
NA |
NA |
-202 |
TCF4 |
NA |
NA |
NA |
NA |
312 |
FARP2 |
NA |
NA |
NA |
NA |
-146 |
POLR2I |
NA |
NA |
NA |
NA |
-111 |
RBBP7 |
NA |
NA |
NA |
NA |
-101 |
PSMB3 |
NA |
NA |
NA |
NA |
-93 |
ELOB |
NA |
NA |
NA |
NA |
266 |
ARPC1B |
NA |
NA |
NA |
NA |
-72 |
SEMA6A |
NA |
NA |
NA |
NA |
254 |
CDK4 |
NA |
NA |
NA |
NA |
-37 |
ENAH |
NA |
NA |
NA |
NA |
232 |
FOXP1 |
NA |
NA |
NA |
NA |
230 |
FYN |
NA |
NA |
NA |
NA |
190 |
ADAM10 |
NA |
NA |
NA |
NA |
170 |
PBX1 |
NA |
NA |
NA |
NA |
167 |
ACTG1 |
NA |
NA |
NA |
NA |
152 |
SHC1 |
NA |
NA |
NA |
NA |
147 |
DOK5 |
NA |
NA |
NA |
NA |
129 |
ROBO1 |
NA |
NA |
NA |
NA |
109 |
MEF2A |
NA |
NA |
NA |
NA |
87 |
CTNNB1 |
NA |
NA |
NA |
NA |
82 |
IRS2 |
NA |
NA |
NA |
NA |
74 |
FURIN |
NA |
NA |
NA |
NA |
64 |
CBFB |
NA |
NA |
NA |
NA |
38 |
SOX2 |
NA |
NA |
NA |
NA |
35 |
DPYSL2 |
NA |
NA |
NA |
NA |
34 |
NR2F2 |
NA |
NA |
NA |
NA |
32 |
COL4A1 |
NA |
NA |
NA |
NA |
10 |
LPL |
NA |
NA |
NA |
NA |
4 |
Epigenetic regulation of gene expression
Epigenetic regulation of gene expression
setSize |
14 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.282 |
s.clus_0 |
0.105 |
s.clus_1 |
-0.0327 |
s.clus_2 |
0.089 |
s.clus_3 |
-0.0309 |
s.clus_4 |
-0.242 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 37 rows containing non-finite values (stat_ydensity).
Warning: Removed 37 rows containing non-finite values (stat_boxplot).
Top 20 genes
POLR2F |
-615 |
302 |
DDX21 |
-437 |
187 |
POLR2H |
-284 |
140 |
BAZ1B |
-170 |
139 |
DEK |
-419 |
50 |
DNMT1 |
-219 |
72 |
Click HERE to show all gene set members
All member genes
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
DDX21 |
187 |
NA |
NA |
NA |
-437 |
POLR1E |
149 |
NA |
NA |
NA |
NA |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
BAZ1B |
139 |
-36 |
27 |
NA |
-170 |
DNMT1 |
72 |
-121 |
NA |
NA |
-219 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
EZH2 |
NA |
-133 |
NA |
NA |
-277 |
CBX3 |
NA |
NA |
183 |
NA |
-331 |
HDAC2 |
NA |
NA |
64 |
NA |
-51 |
PHF19 |
NA |
NA |
NA |
NA |
-554 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
RBBP7 |
NA |
NA |
NA |
NA |
-101 |
Gene expression (Transcription)
Gene expression (Transcription)
setSize |
145 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.207 |
s.clus_0 |
0.0746 |
s.clus_1 |
-0.0303 |
s.clus_2 |
0.0951 |
s.clus_3 |
-0.0527 |
s.clus_4 |
-0.157 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 67 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 110 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 116 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 133 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 84 rows containing missing values
Warning: Removed 110 rows containing non-finite values (stat_density2d).
Warning: Removed 94 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 122 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 140 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 101 rows containing missing values
Warning: Removed 116 rows containing non-finite values (stat_density2d).
Warning: Removed 122 rows containing non-finite values (stat_density2d).
Warning: Removed 91 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 138 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 102 rows containing missing values
Warning: Removed 133 rows containing non-finite values (stat_density2d).
Warning: Removed 140 rows containing non-finite values (stat_density2d).
Warning: Removed 138 rows containing non-finite values (stat_density2d).
Warning: Removed 125 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 135 rows containing missing values
Warning: Removed 84 rows containing non-finite values (stat_density2d).
Warning: Removed 101 rows containing non-finite values (stat_density2d).
Warning: Removed 102 rows containing non-finite values (stat_density2d).
Warning: Removed 135 rows containing non-finite values (stat_density2d).
Warning: Removed 32 rows containing non-finite values (stat_bin).
Warning: Removed 67 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 110 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 116 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 133 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 84 rows containing missing values
Warning: Removed 110 rows containing missing values (geom_point).
Warning: Removed 94 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 122 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 140 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 101 rows containing missing values
Warning: Removed 116 rows containing missing values (geom_point).
Warning: Removed 122 rows containing missing values (geom_point).
Warning: Removed 91 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 138 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 102 rows containing missing values
Warning: Removed 133 rows containing missing values (geom_point).
Warning: Removed 140 rows containing missing values (geom_point).
Warning: Removed 138 rows containing missing values (geom_point).
Warning: Removed 125 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 135 rows containing missing values
Warning: Removed 84 rows containing missing values (geom_point).
Warning: Removed 101 rows containing missing values (geom_point).
Warning: Removed 102 rows containing missing values (geom_point).
Warning: Removed 135 rows containing missing values (geom_point).
Warning: Removed 32 rows containing non-finite values (stat_bin).
Warning in grid.Call.graphics(C_points, x$x, x$y, x$pch, x$size): semi-
transparency is not supported on this device: reported only once per page
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 409 rows containing non-finite values (stat_ydensity).
Warning: Removed 409 rows containing non-finite values (stat_boxplot).
Top 20 genes
RAN |
-609 |
207 |
HSPD1 |
-610 |
189 |
UBE2S |
-584 |
194 |
TPX2 |
-537 |
210 |
NPM1 |
-611 |
169 |
BIRC5 |
-569 |
179 |
SNRPF |
-548 |
180 |
CCNB1 |
-454 |
200 |
PRMT1 |
-547 |
165 |
CYCS |
-607 |
137 |
DEK |
-419 |
190 |
PLD6 |
-345 |
201 |
CBX3 |
-331 |
183 |
GTF3A |
-523 |
114 |
SRSF3 |
-549 |
98 |
FANCI |
-561 |
80 |
PRELID1 |
-606 |
74 |
SNRPE |
-576 |
69 |
PSMA7 |
-189 |
206 |
SNRPD3 |
-497 |
77 |
Click HERE to show all gene set members
All member genes
SNRPB |
381 |
-166 |
NA |
NA |
-495 |
RNPS1 |
368 |
NA |
NA |
-48 |
-217 |
MYC |
367 |
-12 |
NA |
-60 |
-492 |
NDUFA4 |
-340 |
NA |
NA |
153 |
NA |
SRSF2 |
359 |
-57 |
NA |
NA |
-565 |
COX6C |
-337 |
NA |
NA |
175 |
NA |
TFDP1 |
353 |
NA |
NA |
NA |
-254 |
PARP1 |
335 |
-190 |
34 |
NA |
-433 |
NUP210 |
332 |
NA |
NA |
NA |
NA |
BID |
323 |
NA |
NA |
-70 |
-317 |
RRM2 |
311 |
-162 |
NA |
NA |
-358 |
CCNA2 |
304 |
-194 |
5 |
NA |
-392 |
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
HSPD1 |
298 |
-77 |
189 |
NA |
-610 |
SLBP |
291 |
-69 |
NA |
NA |
-42 |
SRSF7 |
290 |
-79 |
21 |
NA |
-585 |
POLR3K |
287 |
-72 |
NA |
NA |
-416 |
RFC4 |
278 |
-111 |
NA |
NA |
-211 |
BIRC5 |
277 |
-228 |
179 |
NA |
-569 |
HSP90AA1 |
270 |
-125 |
NA |
NA |
-351 |
SKP1 |
-321 |
NA |
NA |
NA |
NA |
SSRP1 |
251 |
NA |
NA |
NA |
-385 |
COX5A |
250 |
NA |
NA |
NA |
-570 |
POLR3G |
224 |
NA |
NA |
NA |
-476 |
MAGOHB |
219 |
-71 |
NA |
NA |
-475 |
SNRPD3 |
213 |
NA |
77 |
NA |
-497 |
CDK1 |
208 |
-150 |
NA |
NA |
-195 |
PCNA |
202 |
-157 |
NA |
NA |
-303 |
SMARCA4 |
198 |
NA |
NA |
NA |
-54 |
TFAM |
188 |
NA |
NA |
NA |
-229 |
DDX21 |
187 |
NA |
NA |
NA |
-437 |
RBM8A |
177 |
NA |
NA |
NA |
-33 |
APOE |
-302 |
NA |
-59 |
NA |
448 |
YWHAZ |
-299 |
NA |
NA |
147 |
NA |
UBE2S |
157 |
-223 |
194 |
NA |
-584 |
SRSF3 |
151 |
-100 |
98 |
NA |
-549 |
POLR1E |
149 |
NA |
NA |
NA |
NA |
UBE2I |
141 |
NA |
NA |
NA |
-45 |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
BAZ1B |
139 |
-36 |
27 |
NA |
-170 |
SRSF11 |
137 |
NA |
NA |
NA |
NA |
CYCS |
129 |
-23 |
137 |
NA |
-607 |
ALYREF |
113 |
-134 |
NA |
NA |
-163 |
NR2F6 |
112 |
NA |
NA |
-77 |
NA |
MAGOH |
105 |
NA |
NA |
NA |
-88 |
RAN |
104 |
NA |
207 |
-37 |
-609 |
NOC2L |
94 |
NA |
NA |
NA |
NA |
CAV1 |
-274 |
6 |
-72 |
NA |
396 |
SUPT16H |
74 |
-101 |
NA |
NA |
-127 |
DNMT1 |
72 |
-121 |
NA |
NA |
-219 |
PRDX2 |
67 |
-39 |
NA |
NA |
NA |
PCBP4 |
56 |
NA |
NA |
NA |
-350 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
SMARCC1 |
35 |
NA |
NA |
NA |
-226 |
TRIM28 |
34 |
NA |
28 |
NA |
-194 |
PRMT1 |
33 |
NA |
165 |
NA |
-547 |
DDX39A |
31 |
-132 |
NA |
NA |
NA |
CALM1 |
-244 |
NA |
-75 |
NA |
297 |
PSMA3 |
23 |
NA |
NA |
NA |
-105 |
YWHAB |
-241 |
NA |
184 |
NA |
NA |
IGFBP3 |
-228 |
73 |
-4 |
NA |
0 |
SSU72 |
9 |
NA |
NA |
NA |
NA |
NPM1 |
5 |
NA |
169 |
NA |
-611 |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
ZKSCAN1 |
-197 |
40 |
NA |
NA |
NA |
CDKN2B |
-190 |
23 |
-23 |
NA |
131 |
BTG1 |
-162 |
62 |
NA |
-20 |
NA |
SPP1 |
-151 |
NA |
-22 |
NA |
421 |
LGALS3 |
-150 |
NA |
-61 |
NA |
299 |
MAF |
-128 |
NA |
NA |
NA |
290 |
CCND2 |
-110 |
-31 |
-149 |
NA |
51 |
TMEM219 |
-105 |
NA |
-107 |
NA |
NA |
CTGF |
-91 |
12 |
NA |
NA |
14 |
MEF2C |
-87 |
NA |
-48 |
NA |
351 |
NR2F1 |
-54 |
NA |
NA |
NA |
294 |
JUN |
-26 |
NA |
NA |
NA |
47 |
NCOR1 |
-18 |
NA |
208 |
-112 |
NA |
CITED1 |
-14 |
1 |
-2 |
NA |
-104 |
TPX2 |
NA |
-224 |
210 |
-6 |
-537 |
CCNB1 |
NA |
-210 |
200 |
NA |
-454 |
UBE2C |
NA |
-196 |
1 |
NA |
-465 |
MYBL2 |
NA |
-180 |
NA |
NA |
-482 |
FANCI |
NA |
-178 |
80 |
NA |
-561 |
ATAD2 |
NA |
-176 |
NA |
NA |
-324 |
RPA3 |
NA |
-144 |
131 |
NA |
-283 |
SNRPG |
NA |
-143 |
NA |
NA |
-225 |
EZH2 |
NA |
-133 |
NA |
NA |
-277 |
SNRPE |
NA |
-118 |
69 |
NA |
-576 |
LBR |
NA |
-116 |
168 |
NA |
-207 |
AURKA |
NA |
-115 |
104 |
NA |
-196 |
PSMB2 |
NA |
-92 |
NA |
NA |
NA |
GTF2A2 |
NA |
-78 |
NA |
64 |
-86 |
NFATC2 |
NA |
35 |
NA |
NA |
NA |
LEF1 |
NA |
16 |
NA |
NA |
NA |
PSMA7 |
NA |
NA |
206 |
NA |
-189 |
PLD6 |
NA |
NA |
201 |
-57 |
-345 |
CBX3 |
NA |
NA |
183 |
NA |
-331 |
SNRPF |
NA |
NA |
180 |
NA |
-548 |
GTF3A |
NA |
NA |
114 |
-58 |
-523 |
SSB |
NA |
NA |
101 |
NA |
-252 |
MDM2 |
NA |
NA |
91 |
NA |
NA |
PRELID1 |
NA |
NA |
74 |
NA |
-606 |
HDAC2 |
NA |
NA |
64 |
NA |
-51 |
RAE1 |
NA |
NA |
63 |
NA |
NA |
DYRK2 |
NA |
NA |
26 |
NA |
NA |
PTPN11 |
NA |
NA |
11 |
NA |
NA |
CDK6 |
NA |
NA |
8 |
NA |
NA |
UBC |
NA |
NA |
-146 |
NA |
NA |
RSPO3 |
NA |
NA |
-130 |
NA |
NA |
GADD45A |
NA |
NA |
-56 |
NA |
156 |
CCND1 |
NA |
NA |
-30 |
NA |
NA |
UBA52 |
NA |
NA |
NA |
-113 |
NA |
COX7C |
NA |
NA |
NA |
176 |
NA |
TGFB1 |
NA |
NA |
NA |
-100 |
NA |
PSMB4 |
NA |
NA |
NA |
143 |
NA |
PHF19 |
NA |
NA |
NA |
NA |
-554 |
PRDX1 |
NA |
NA |
NA |
NA |
-511 |
SOCS3 |
NA |
NA |
NA |
NA |
406 |
TXN |
NA |
NA |
NA |
NA |
-503 |
RPS27A |
NA |
NA |
NA |
NA |
-410 |
HIPK2 |
NA |
NA |
NA |
NA |
-279 |
HEY1 |
NA |
NA |
NA |
NA |
335 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
SRSF9 |
NA |
NA |
NA |
NA |
-180 |
GTF2F2 |
NA |
NA |
NA |
NA |
-177 |
THOC7 |
NA |
NA |
NA |
NA |
-160 |
BNIP3L |
NA |
NA |
NA |
NA |
277 |
POLR2I |
NA |
NA |
NA |
NA |
-111 |
RBBP7 |
NA |
NA |
NA |
NA |
-101 |
PSMB3 |
NA |
NA |
NA |
NA |
-93 |
SMAD1 |
NA |
NA |
NA |
NA |
268 |
ELOB |
NA |
NA |
NA |
NA |
266 |
CDK4 |
NA |
NA |
NA |
NA |
-37 |
BBC3 |
NA |
NA |
NA |
NA |
237 |
CAMK2D |
NA |
NA |
NA |
NA |
212 |
NR3C1 |
NA |
NA |
NA |
NA |
199 |
SESN3 |
NA |
NA |
NA |
NA |
182 |
JUNB |
NA |
NA |
NA |
NA |
165 |
CTSL |
NA |
NA |
NA |
NA |
102 |
SGK1 |
NA |
NA |
NA |
NA |
100 |
CTNNB1 |
NA |
NA |
NA |
NA |
82 |
PPP2CB |
NA |
NA |
NA |
NA |
70 |
FOS |
NA |
NA |
NA |
NA |
45 |
CBFB |
NA |
NA |
NA |
NA |
38 |
SOX2 |
NA |
NA |
NA |
NA |
35 |
Generic Transcription Pathway
Generic Transcription Pathway
setSize |
110 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.114 |
s.clus_0 |
-0.0057 |
s.clus_1 |
-0.0263 |
s.clus_2 |
0.0758 |
s.clus_3 |
-0.0362 |
s.clus_4 |
-0.0728 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 56 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 87 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 86 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 100 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 68 rows containing missing values
Warning: Removed 87 rows containing non-finite values (stat_density2d).
Warning: Removed 74 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 91 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 106 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 80 rows containing missing values
Warning: Removed 86 rows containing non-finite values (stat_density2d).
Warning: Removed 91 rows containing non-finite values (stat_density2d).
Warning: Removed 67 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 106 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 77 rows containing missing values
Warning: Removed 100 rows containing non-finite values (stat_density2d).
Warning: Removed 106 rows containing non-finite values (stat_density2d).
Warning: Removed 106 rows containing non-finite values (stat_density2d).
Warning: Removed 95 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 105 rows containing missing values
Warning: Removed 68 rows containing non-finite values (stat_density2d).
Warning: Removed 80 rows containing non-finite values (stat_density2d).
Warning: Removed 77 rows containing non-finite values (stat_density2d).
Warning: Removed 105 rows containing non-finite values (stat_density2d).
Warning: Removed 26 rows containing non-finite values (stat_bin).
Warning: Removed 56 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 87 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 86 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 100 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 68 rows containing missing values
Warning: Removed 87 rows containing missing values (geom_point).
Warning: Removed 74 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 91 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 106 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 80 rows containing missing values
Warning: Removed 86 rows containing missing values (geom_point).
Warning: Removed 91 rows containing missing values (geom_point).
Warning: Removed 67 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 106 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 77 rows containing missing values
Warning: Removed 100 rows containing missing values (geom_point).
Warning: Removed 106 rows containing missing values (geom_point).
Warning: Removed 106 rows containing missing values (geom_point).
Warning: Removed 95 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 105 rows containing missing values
Warning: Removed 68 rows containing missing values (geom_point).
Warning: Removed 80 rows containing missing values (geom_point).
Warning: Removed 77 rows containing missing values (geom_point).
Warning: Removed 105 rows containing missing values (geom_point).
Warning: Removed 26 rows containing non-finite values (stat_bin).
Warning in grid.Call.graphics(C_points, x$x, x$y, x$pch, x$size): semi-
transparency is not supported on this device: reported only once per page
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 318 rows containing non-finite values (stat_ydensity).
Warning: Removed 318 rows containing non-finite values (stat_boxplot).
Top 20 genes
HSPD1 |
189 |
-610 |
UBE2S |
194 |
-584 |
TPX2 |
210 |
-537 |
NPM1 |
169 |
-611 |
BIRC5 |
179 |
-569 |
CCNB1 |
200 |
-454 |
PRMT1 |
165 |
-547 |
CYCS |
137 |
-607 |
DEK |
190 |
-419 |
CBX3 |
183 |
-331 |
FANCI |
80 |
-561 |
PRELID1 |
74 |
-606 |
PSMA7 |
206 |
-189 |
RPA3 |
131 |
-283 |
LBR |
168 |
-207 |
AURKA |
104 |
-196 |
PARP1 |
34 |
-433 |
TRIM28 |
28 |
-194 |
HDAC2 |
64 |
-51 |
CCNA2 |
5 |
-392 |
Click HERE to show all gene set members
All member genes
MYC |
367 |
-12 |
NA |
-60 |
-492 |
NDUFA4 |
-340 |
NA |
NA |
153 |
NA |
COX6C |
-337 |
NA |
NA |
175 |
NA |
TFDP1 |
353 |
NA |
NA |
NA |
-254 |
PARP1 |
335 |
-190 |
34 |
NA |
-433 |
BID |
323 |
NA |
NA |
-70 |
-317 |
RRM2 |
311 |
-162 |
NA |
NA |
-358 |
CCNA2 |
304 |
-194 |
5 |
NA |
-392 |
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
HSPD1 |
298 |
-77 |
189 |
NA |
-610 |
RFC4 |
278 |
-111 |
NA |
NA |
-211 |
BIRC5 |
277 |
-228 |
179 |
NA |
-569 |
SKP1 |
-321 |
NA |
NA |
NA |
NA |
SSRP1 |
251 |
NA |
NA |
NA |
-385 |
COX5A |
250 |
NA |
NA |
NA |
-570 |
CDK1 |
208 |
-150 |
NA |
NA |
-195 |
PCNA |
202 |
-157 |
NA |
NA |
-303 |
SMARCA4 |
198 |
NA |
NA |
NA |
-54 |
APOE |
-302 |
NA |
-59 |
NA |
448 |
YWHAZ |
-299 |
NA |
NA |
147 |
NA |
UBE2S |
157 |
-223 |
194 |
NA |
-584 |
UBE2I |
141 |
NA |
NA |
NA |
-45 |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
CYCS |
129 |
-23 |
137 |
NA |
-607 |
NR2F6 |
112 |
NA |
NA |
-77 |
NA |
NOC2L |
94 |
NA |
NA |
NA |
NA |
CAV1 |
-274 |
6 |
-72 |
NA |
396 |
SUPT16H |
74 |
-101 |
NA |
NA |
-127 |
PRDX2 |
67 |
-39 |
NA |
NA |
NA |
PCBP4 |
56 |
NA |
NA |
NA |
-350 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
SMARCC1 |
35 |
NA |
NA |
NA |
-226 |
TRIM28 |
34 |
NA |
28 |
NA |
-194 |
PRMT1 |
33 |
NA |
165 |
NA |
-547 |
CALM1 |
-244 |
NA |
-75 |
NA |
297 |
PSMA3 |
23 |
NA |
NA |
NA |
-105 |
YWHAB |
-241 |
NA |
184 |
NA |
NA |
IGFBP3 |
-228 |
73 |
-4 |
NA |
0 |
NPM1 |
5 |
NA |
169 |
NA |
-611 |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
ZKSCAN1 |
-197 |
40 |
NA |
NA |
NA |
CDKN2B |
-190 |
23 |
-23 |
NA |
131 |
BTG1 |
-162 |
62 |
NA |
-20 |
NA |
SPP1 |
-151 |
NA |
-22 |
NA |
421 |
LGALS3 |
-150 |
NA |
-61 |
NA |
299 |
MAF |
-128 |
NA |
NA |
NA |
290 |
CCND2 |
-110 |
-31 |
-149 |
NA |
51 |
TMEM219 |
-105 |
NA |
-107 |
NA |
NA |
CTGF |
-91 |
12 |
NA |
NA |
14 |
MEF2C |
-87 |
NA |
-48 |
NA |
351 |
NR2F1 |
-54 |
NA |
NA |
NA |
294 |
JUN |
-26 |
NA |
NA |
NA |
47 |
NCOR1 |
-18 |
NA |
208 |
-112 |
NA |
CITED1 |
-14 |
1 |
-2 |
NA |
-104 |
TPX2 |
NA |
-224 |
210 |
-6 |
-537 |
CCNB1 |
NA |
-210 |
200 |
NA |
-454 |
UBE2C |
NA |
-196 |
1 |
NA |
-465 |
MYBL2 |
NA |
-180 |
NA |
NA |
-482 |
FANCI |
NA |
-178 |
80 |
NA |
-561 |
ATAD2 |
NA |
-176 |
NA |
NA |
-324 |
RPA3 |
NA |
-144 |
131 |
NA |
-283 |
EZH2 |
NA |
-133 |
NA |
NA |
-277 |
LBR |
NA |
-116 |
168 |
NA |
-207 |
AURKA |
NA |
-115 |
104 |
NA |
-196 |
PSMB2 |
NA |
-92 |
NA |
NA |
NA |
NFATC2 |
NA |
35 |
NA |
NA |
NA |
LEF1 |
NA |
16 |
NA |
NA |
NA |
PSMA7 |
NA |
NA |
206 |
NA |
-189 |
CBX3 |
NA |
NA |
183 |
NA |
-331 |
MDM2 |
NA |
NA |
91 |
NA |
NA |
PRELID1 |
NA |
NA |
74 |
NA |
-606 |
HDAC2 |
NA |
NA |
64 |
NA |
-51 |
DYRK2 |
NA |
NA |
26 |
NA |
NA |
PTPN11 |
NA |
NA |
11 |
NA |
NA |
CDK6 |
NA |
NA |
8 |
NA |
NA |
UBC |
NA |
NA |
-146 |
NA |
NA |
RSPO3 |
NA |
NA |
-130 |
NA |
NA |
GADD45A |
NA |
NA |
-56 |
NA |
156 |
CCND1 |
NA |
NA |
-30 |
NA |
NA |
UBA52 |
NA |
NA |
NA |
-113 |
NA |
COX7C |
NA |
NA |
NA |
176 |
NA |
TGFB1 |
NA |
NA |
NA |
-100 |
NA |
PSMB4 |
NA |
NA |
NA |
143 |
NA |
PRDX1 |
NA |
NA |
NA |
NA |
-511 |
SOCS3 |
NA |
NA |
NA |
NA |
406 |
TXN |
NA |
NA |
NA |
NA |
-503 |
RPS27A |
NA |
NA |
NA |
NA |
-410 |
HIPK2 |
NA |
NA |
NA |
NA |
-279 |
HEY1 |
NA |
NA |
NA |
NA |
335 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
GTF2F2 |
NA |
NA |
NA |
NA |
-177 |
BNIP3L |
NA |
NA |
NA |
NA |
277 |
POLR2I |
NA |
NA |
NA |
NA |
-111 |
RBBP7 |
NA |
NA |
NA |
NA |
-101 |
PSMB3 |
NA |
NA |
NA |
NA |
-93 |
SMAD1 |
NA |
NA |
NA |
NA |
268 |
ELOB |
NA |
NA |
NA |
NA |
266 |
CDK4 |
NA |
NA |
NA |
NA |
-37 |
BBC3 |
NA |
NA |
NA |
NA |
237 |
CAMK2D |
NA |
NA |
NA |
NA |
212 |
NR3C1 |
NA |
NA |
NA |
NA |
199 |
SESN3 |
NA |
NA |
NA |
NA |
182 |
JUNB |
NA |
NA |
NA |
NA |
165 |
CTSL |
NA |
NA |
NA |
NA |
102 |
SGK1 |
NA |
NA |
NA |
NA |
100 |
CTNNB1 |
NA |
NA |
NA |
NA |
82 |
PPP2CB |
NA |
NA |
NA |
NA |
70 |
FOS |
NA |
NA |
NA |
NA |
45 |
CBFB |
NA |
NA |
NA |
NA |
38 |
SOX2 |
NA |
NA |
NA |
NA |
35 |
Positive epigenetic regulation of rRNA expression
Positive epigenetic regulation of rRNA expression
setSize |
11 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.252 |
s.clus_0 |
0.111 |
s.clus_1 |
-0.0101 |
s.clus_2 |
0.089 |
s.clus_3 |
-0.0309 |
s.clus_4 |
-0.205 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 28 rows containing non-finite values (stat_ydensity).
Warning: Removed 28 rows containing non-finite values (stat_boxplot).
Top 20 genes
POLR2F |
-615 |
302 |
DDX21 |
-437 |
187 |
POLR2H |
-284 |
140 |
BAZ1B |
-170 |
139 |
DEK |
-419 |
50 |
Click HERE to show all gene set members
All member genes
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
DDX21 |
187 |
NA |
NA |
NA |
-437 |
POLR1E |
149 |
NA |
NA |
NA |
NA |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
BAZ1B |
139 |
-36 |
27 |
NA |
-170 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
CBX3 |
NA |
NA |
183 |
NA |
-331 |
HDAC2 |
NA |
NA |
64 |
NA |
-51 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
RBBP7 |
NA |
NA |
NA |
NA |
-101 |
RNA Polymerase II Transcription
RNA Polymerase II Transcription
setSize |
130 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.162 |
s.clus_0 |
0.0482 |
s.clus_1 |
-0.0308 |
s.clus_2 |
0.0829 |
s.clus_3 |
-0.0381 |
s.clus_4 |
-0.121 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 62 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 99 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 103 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 119 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 77 rows containing missing values
Warning: Removed 99 rows containing non-finite values (stat_density2d).
Warning: Removed 83 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 108 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 125 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 90 rows containing missing values
Warning: Removed 103 rows containing non-finite values (stat_density2d).
Warning: Removed 108 rows containing non-finite values (stat_density2d).
Warning: Removed 82 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 126 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 92 rows containing missing values
Warning: Removed 119 rows containing non-finite values (stat_density2d).
Warning: Removed 125 rows containing non-finite values (stat_density2d).
Warning: Removed 126 rows containing non-finite values (stat_density2d).
Warning: Removed 113 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 123 rows containing missing values
Warning: Removed 77 rows containing non-finite values (stat_density2d).
Warning: Removed 90 rows containing non-finite values (stat_density2d).
Warning: Removed 92 rows containing non-finite values (stat_density2d).
Warning: Removed 123 rows containing non-finite values (stat_density2d).
Warning: Removed 29 rows containing non-finite values (stat_bin).
Warning: Removed 62 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 99 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 103 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 119 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 77 rows containing missing values
Warning: Removed 99 rows containing missing values (geom_point).
Warning: Removed 83 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 108 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 125 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 90 rows containing missing values
Warning: Removed 103 rows containing missing values (geom_point).
Warning: Removed 108 rows containing missing values (geom_point).
Warning: Removed 82 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 126 rows containing missing values
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 92 rows containing missing values
Warning: Removed 119 rows containing missing values (geom_point).
Warning: Removed 125 rows containing missing values (geom_point).
Warning: Removed 126 rows containing missing values (geom_point).
Warning: Removed 113 rows containing non-finite values (stat_bin).
Warning in ggally_statistic(data = data, mapping = mapping, na.rm = na.rm, :
Removed 123 rows containing missing values
Warning: Removed 77 rows containing missing values (geom_point).
Warning: Removed 90 rows containing missing values (geom_point).
Warning: Removed 92 rows containing missing values (geom_point).
Warning: Removed 123 rows containing missing values (geom_point).
Warning: Removed 29 rows containing non-finite values (stat_bin).
Warning in grid.Call.graphics(C_points, x$x, x$y, x$pch, x$size): semi-
transparency is not supported on this device: reported only once per page
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 369 rows containing non-finite values (stat_ydensity).
Warning: Removed 369 rows containing non-finite values (stat_boxplot).
Top 20 genes
HSPD1 |
-610 |
189 |
UBE2S |
-584 |
194 |
TPX2 |
-537 |
210 |
NPM1 |
-611 |
169 |
BIRC5 |
-569 |
179 |
SNRPF |
-548 |
180 |
CCNB1 |
-454 |
200 |
PRMT1 |
-547 |
165 |
CYCS |
-607 |
137 |
DEK |
-419 |
190 |
CBX3 |
-331 |
183 |
SRSF3 |
-549 |
98 |
FANCI |
-561 |
80 |
PRELID1 |
-606 |
74 |
SNRPE |
-576 |
69 |
PSMA7 |
-189 |
206 |
SNRPD3 |
-497 |
77 |
RPA3 |
-283 |
131 |
LBR |
-207 |
168 |
AURKA |
-196 |
104 |
Click HERE to show all gene set members
All member genes
SNRPB |
381 |
-166 |
NA |
NA |
-495 |
RNPS1 |
368 |
NA |
NA |
-48 |
-217 |
MYC |
367 |
-12 |
NA |
-60 |
-492 |
NDUFA4 |
-340 |
NA |
NA |
153 |
NA |
SRSF2 |
359 |
-57 |
NA |
NA |
-565 |
COX6C |
-337 |
NA |
NA |
175 |
NA |
TFDP1 |
353 |
NA |
NA |
NA |
-254 |
PARP1 |
335 |
-190 |
34 |
NA |
-433 |
BID |
323 |
NA |
NA |
-70 |
-317 |
RRM2 |
311 |
-162 |
NA |
NA |
-358 |
CCNA2 |
304 |
-194 |
5 |
NA |
-392 |
POLR2F |
302 |
-18 |
NA |
NA |
-615 |
HSPD1 |
298 |
-77 |
189 |
NA |
-610 |
SLBP |
291 |
-69 |
NA |
NA |
-42 |
SRSF7 |
290 |
-79 |
21 |
NA |
-585 |
RFC4 |
278 |
-111 |
NA |
NA |
-211 |
BIRC5 |
277 |
-228 |
179 |
NA |
-569 |
SKP1 |
-321 |
NA |
NA |
NA |
NA |
SSRP1 |
251 |
NA |
NA |
NA |
-385 |
COX5A |
250 |
NA |
NA |
NA |
-570 |
MAGOHB |
219 |
-71 |
NA |
NA |
-475 |
SNRPD3 |
213 |
NA |
77 |
NA |
-497 |
CDK1 |
208 |
-150 |
NA |
NA |
-195 |
PCNA |
202 |
-157 |
NA |
NA |
-303 |
SMARCA4 |
198 |
NA |
NA |
NA |
-54 |
RBM8A |
177 |
NA |
NA |
NA |
-33 |
APOE |
-302 |
NA |
-59 |
NA |
448 |
YWHAZ |
-299 |
NA |
NA |
147 |
NA |
UBE2S |
157 |
-223 |
194 |
NA |
-584 |
SRSF3 |
151 |
-100 |
98 |
NA |
-549 |
UBE2I |
141 |
NA |
NA |
NA |
-45 |
POLR2H |
140 |
NA |
NA |
NA |
-284 |
SRSF11 |
137 |
NA |
NA |
NA |
NA |
CYCS |
129 |
-23 |
137 |
NA |
-607 |
ALYREF |
113 |
-134 |
NA |
NA |
-163 |
NR2F6 |
112 |
NA |
NA |
-77 |
NA |
MAGOH |
105 |
NA |
NA |
NA |
-88 |
NOC2L |
94 |
NA |
NA |
NA |
NA |
CAV1 |
-274 |
6 |
-72 |
NA |
396 |
SUPT16H |
74 |
-101 |
NA |
NA |
-127 |
PRDX2 |
67 |
-39 |
NA |
NA |
NA |
PCBP4 |
56 |
NA |
NA |
NA |
-350 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
SMARCC1 |
35 |
NA |
NA |
NA |
-226 |
TRIM28 |
34 |
NA |
28 |
NA |
-194 |
PRMT1 |
33 |
NA |
165 |
NA |
-547 |
DDX39A |
31 |
-132 |
NA |
NA |
NA |
CALM1 |
-244 |
NA |
-75 |
NA |
297 |
PSMA3 |
23 |
NA |
NA |
NA |
-105 |
YWHAB |
-241 |
NA |
184 |
NA |
NA |
IGFBP3 |
-228 |
73 |
-4 |
NA |
0 |
SSU72 |
9 |
NA |
NA |
NA |
NA |
NPM1 |
5 |
NA |
169 |
NA |
-611 |
POLR2L |
-206 |
NA |
-143 |
92 |
303 |
ZKSCAN1 |
-197 |
40 |
NA |
NA |
NA |
CDKN2B |
-190 |
23 |
-23 |
NA |
131 |
BTG1 |
-162 |
62 |
NA |
-20 |
NA |
SPP1 |
-151 |
NA |
-22 |
NA |
421 |
LGALS3 |
-150 |
NA |
-61 |
NA |
299 |
MAF |
-128 |
NA |
NA |
NA |
290 |
CCND2 |
-110 |
-31 |
-149 |
NA |
51 |
TMEM219 |
-105 |
NA |
-107 |
NA |
NA |
CTGF |
-91 |
12 |
NA |
NA |
14 |
MEF2C |
-87 |
NA |
-48 |
NA |
351 |
NR2F1 |
-54 |
NA |
NA |
NA |
294 |
JUN |
-26 |
NA |
NA |
NA |
47 |
NCOR1 |
-18 |
NA |
208 |
-112 |
NA |
CITED1 |
-14 |
1 |
-2 |
NA |
-104 |
TPX2 |
NA |
-224 |
210 |
-6 |
-537 |
CCNB1 |
NA |
-210 |
200 |
NA |
-454 |
UBE2C |
NA |
-196 |
1 |
NA |
-465 |
MYBL2 |
NA |
-180 |
NA |
NA |
-482 |
FANCI |
NA |
-178 |
80 |
NA |
-561 |
ATAD2 |
NA |
-176 |
NA |
NA |
-324 |
RPA3 |
NA |
-144 |
131 |
NA |
-283 |
SNRPG |
NA |
-143 |
NA |
NA |
-225 |
EZH2 |
NA |
-133 |
NA |
NA |
-277 |
SNRPE |
NA |
-118 |
69 |
NA |
-576 |
LBR |
NA |
-116 |
168 |
NA |
-207 |
AURKA |
NA |
-115 |
104 |
NA |
-196 |
PSMB2 |
NA |
-92 |
NA |
NA |
NA |
GTF2A2 |
NA |
-78 |
NA |
64 |
-86 |
NFATC2 |
NA |
35 |
NA |
NA |
NA |
LEF1 |
NA |
16 |
NA |
NA |
NA |
PSMA7 |
NA |
NA |
206 |
NA |
-189 |
CBX3 |
NA |
NA |
183 |
NA |
-331 |
SNRPF |
NA |
NA |
180 |
NA |
-548 |
MDM2 |
NA |
NA |
91 |
NA |
NA |
PRELID1 |
NA |
NA |
74 |
NA |
-606 |
HDAC2 |
NA |
NA |
64 |
NA |
-51 |
DYRK2 |
NA |
NA |
26 |
NA |
NA |
PTPN11 |
NA |
NA |
11 |
NA |
NA |
CDK6 |
NA |
NA |
8 |
NA |
NA |
UBC |
NA |
NA |
-146 |
NA |
NA |
RSPO3 |
NA |
NA |
-130 |
NA |
NA |
GADD45A |
NA |
NA |
-56 |
NA |
156 |
CCND1 |
NA |
NA |
-30 |
NA |
NA |
UBA52 |
NA |
NA |
NA |
-113 |
NA |
COX7C |
NA |
NA |
NA |
176 |
NA |
TGFB1 |
NA |
NA |
NA |
-100 |
NA |
PSMB4 |
NA |
NA |
NA |
143 |
NA |
PRDX1 |
NA |
NA |
NA |
NA |
-511 |
SOCS3 |
NA |
NA |
NA |
NA |
406 |
TXN |
NA |
NA |
NA |
NA |
-503 |
RPS27A |
NA |
NA |
NA |
NA |
-410 |
HIPK2 |
NA |
NA |
NA |
NA |
-279 |
HEY1 |
NA |
NA |
NA |
NA |
335 |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
SRSF9 |
NA |
NA |
NA |
NA |
-180 |
GTF2F2 |
NA |
NA |
NA |
NA |
-177 |
THOC7 |
NA |
NA |
NA |
NA |
-160 |
BNIP3L |
NA |
NA |
NA |
NA |
277 |
POLR2I |
NA |
NA |
NA |
NA |
-111 |
RBBP7 |
NA |
NA |
NA |
NA |
-101 |
PSMB3 |
NA |
NA |
NA |
NA |
-93 |
SMAD1 |
NA |
NA |
NA |
NA |
268 |
ELOB |
NA |
NA |
NA |
NA |
266 |
CDK4 |
NA |
NA |
NA |
NA |
-37 |
BBC3 |
NA |
NA |
NA |
NA |
237 |
CAMK2D |
NA |
NA |
NA |
NA |
212 |
NR3C1 |
NA |
NA |
NA |
NA |
199 |
SESN3 |
NA |
NA |
NA |
NA |
182 |
JUNB |
NA |
NA |
NA |
NA |
165 |
CTSL |
NA |
NA |
NA |
NA |
102 |
SGK1 |
NA |
NA |
NA |
NA |
100 |
CTNNB1 |
NA |
NA |
NA |
NA |
82 |
PPP2CB |
NA |
NA |
NA |
NA |
70 |
FOS |
NA |
NA |
NA |
NA |
45 |
CBFB |
NA |
NA |
NA |
NA |
38 |
SOX2 |
NA |
NA |
NA |
NA |
35 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
setSize |
9 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.349 |
s.clus_0 |
0.0698 |
s.clus_1 |
-0.0405 |
s.clus_2 |
0.133 |
s.clus_3 |
-0.131 |
s.clus_4 |
-0.284 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 16 rows containing non-finite values (stat_ydensity).
Warning: Removed 16 rows containing non-finite values (stat_boxplot).
Top 20 genes
HSPD1 |
-610 |
189 |
NPM1 |
-611 |
169 |
DEK |
-419 |
190 |
Click HERE to show all gene set members
All member genes
MYC |
367 |
-12 |
NA |
-60 |
-492 |
HSPD1 |
298 |
-77 |
189 |
NA |
-610 |
APOE |
-302 |
NA |
-59 |
NA |
448 |
UBE2I |
141 |
NA |
NA |
NA |
-45 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
NPM1 |
5 |
NA |
169 |
NA |
-611 |
CITED1 |
-14 |
1 |
-2 |
NA |
-104 |
MYBL2 |
NA |
-180 |
NA |
NA |
-482 |
ATAD2 |
NA |
-176 |
NA |
NA |
-324 |
Transcriptional regulation of granulopoiesis
Transcriptional regulation of granulopoiesis
setSize |
7 |
pMANOVA |
5.07e-06 |
p.adjustMANOVA |
2.59e-05 |
s.dist |
0.464 |
s.clus_0 |
0.304 |
s.clus_1 |
0.0154 |
s.clus_2 |
0.253 |
s.clus_3 |
-0.131 |
s.clus_4 |
-0.203 |
p.clus_0 |
0.913 |
p.clus_1 |
0.000207 |
p.clus_2 |
0.044 |
p.clus_3 |
0.358 |
p.clus_4 |
0.4 |
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 20 rows containing non-finite values (stat_ydensity).
Warning: Removed 20 rows containing non-finite values (stat_boxplot).
Click HERE to show all gene set members
All member genes
MYC |
367 |
-12 |
NA |
-60 |
-492 |
TFDP1 |
353 |
NA |
NA |
NA |
-254 |
DEK |
50 |
-200 |
190 |
-49 |
-419 |
LEF1 |
NA |
16 |
NA |
NA |
NA |
H2AFX |
NA |
NA |
NA |
NA |
-230 |
CDK4 |
NA |
NA |
NA |
NA |
-37 |
CBFB |
NA |
NA |
NA |
NA |
38 |
IRE1alpha activates chaperones
IRE1alpha activates chaperones
setSize |
9 |
pMANOVA |
0.0807 |
p.adjustMANOVA |
0.309 |
s.dist |
0.229 |
s.clus_0 |
0.073 |
s.clus_1 |
0.0441 |
s.clus_2 |
0.101 |
s.clus_3 |
-0.097 |
s.clus_4 |
0.16 |
p.clus_0 |
0.222 |
p.clus_1 |
0.205 |
p.clus_2 |
0.415 |
p.clus_3 |
0.249 |
p.clus_4 |
0.863 |
Warning: Removed 4751 rows containing non-finite values (stat_ydensity).
Warning: Removed 4751 rows containing non-finite values (stat_boxplot).
Warning: Removed 27 rows containing non-finite values (stat_ydensity).
Warning: Removed 27 rows containing non-finite values (stat_boxplot).
Click HERE to show all gene set members
All member genes
HDGF |
297 |
-95 |
73 |
-65 |
-13 |
KDELR3 |
175 |
NA |
NA |
-99 |
-457 |
LMNA |
-77 |
8 |
NA |
-16 |
NA |
ACADVL |
-73 |
NA |
NA |
NA |
183 |
SSR1 |
NA |
NA |
75 |
NA |
NA |
DNAJC3 |
NA |
NA |
NA |
67 |
NA |
TLN1 |
NA |
NA |
NA |
NA |
319 |
SHC1 |
NA |
NA |
NA |
NA |
147 |
ADD1 |
NA |
NA |
NA |
NA |
84 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.0 (2020-04-24)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /mnt/md0/app/R-4.0.0/lib/libRblas.so
## LAPACK: /mnt/md0/app/R-4.0.0/lib/libRlapack.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel grid stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] mitch_1.1.8 plyr_1.8.6 pbmcapply_1.5.0 knitr_1.30
## [5] rmarkdown_2.4 pkgload_1.1.0 beeswarm_0.2.3 gtools_3.8.2
## [9] tibble_3.0.3 dplyr_1.0.2 echarts4r_0.3.2 magrittr_1.5
## [13] reshape2_1.4.4 MASS_7.3-53 gplots_3.1.0 gridExtra_2.3
## [17] GGally_2.0.0 ggplot2_3.3.2
##
## loaded via a namespace (and not attached):
## [1] Rcpp_1.0.5 prettyunits_1.1.1 assertthat_0.2.1 rprojroot_1.3-2
## [5] digest_0.6.25 mime_0.9 R6_2.4.1 backports_1.1.10
## [9] evaluate_0.14 highr_0.8 pillar_1.4.6 rlang_0.4.7
## [13] progress_1.2.2 desc_1.2.0 labeling_0.3 stringr_1.4.0
## [17] htmlwidgets_1.5.2 munsell_0.5.0 shiny_1.5.0 compiler_4.0.0
## [21] httpuv_1.5.4 xfun_0.18 pkgconfig_2.0.3 htmltools_0.5.0
## [25] tidyselect_1.1.0 reshape_0.8.8 crayon_1.3.4 withr_2.3.0
## [29] later_1.1.0.1 bitops_1.0-6 jsonlite_1.7.1 xtable_1.8-4
## [33] gtable_0.3.0 lifecycle_0.2.0 scales_1.1.1 KernSmooth_2.23-17
## [37] stringi_1.5.3 farver_2.0.3 promises_1.1.1 testthat_2.3.2
## [41] ellipsis_0.3.1 generics_0.0.2 vctrs_0.3.4 RColorBrewer_1.1-2
## [45] tools_4.0.0 glue_1.4.2 purrr_0.3.4 hms_0.5.3
## [49] fastmap_1.0.1 yaml_2.2.1 colorspace_1.4-1 caTools_1.18.0
END of report